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ABSTRACT
Purine biosynthesis has been used as a paradigm for the study of metabolism of
unstable molecules. Both phosphoribosylamine (PRA) and N5 -carboxyaminoimidazole
ribonucleotide (N5-CAIR) have estimated half-lives in vivo of seconds. In order to avoid
metabolite decomposition, one strategy cells could employ is channeling-the direct
transfer of a rnetabolite between enzyme active sites without diffusion into the bulk media.
While kinetic evidence for channeling of PRA has been reported between
phosphoribosylpyrophosphate amidotransferase (PurF) and glycinamide ribonucleotide
synthetase (PurD), no evidence for a PurF:PurD complex has been found. In an effort to
detect this complex, stopped-flow fluorescence spectroscopy was used to detect changes
in PurF fluorescence that may result from interaction with PurD. Critical to the success of
these experiments was incorporation of tryptophan analogs (4-fluorotryptophan and 7-
azatryptophan) into the proteins in order to increase signal specificity for PurF. No
evidence for a PurF:PurD interaction was found under any of the conditions tested. The
implication of this finding is discussed with regard to the PurF:PurD channeling model.
Like all amidotransferase enzymes (ATs), channeling of NH3 between glutaminase
and AT active sites has been implicated in the formylglycinamide ribonucleotide
amidotransferase (FGAR-AT). In B. subtilis, the FGAR-AT is composed of three
proteins: PurS, PurQ, and small PurL. The first characterization of the B. subtilis FGAR-
AT complex was carried out, and it was determined that a complex between the three
proteins can only be isolated in the presence of Mg2+-ADP and glutamine. By analogy to
the Salmonella FGAR-AT, ADP is believed to be acting as a structural cofactor, while
formation of a PurQ-glutamine complex is essential for assembly of the FGAR-AT.
Subsequent biophysical studies have indicated that the physiologically relevant form of
the FGAR-AT complex contains 2 PurS, 1 PurQ, and 1 small PurL. Further studies on
PurQ have identified residues important for catalysis and complex formation, while
insight into the small PurL active site has been obtained by studies on the T. maritima
enzyme. The FGAR-AT complex provides a new system in purine biosynthesis to study
metabolite transfer among weakly interacting proteins.
Thesis Supervisor: JoAnne Stubbe
Title: Novartis Professor of Chemistry and Biology
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Chapter 1:
Introduction
18
It has been estimated that the 1 million polypeptide chains in E. coli cytoplasm along
with nucleic acids occupy 30% of the cell's total available volume, with macromolecule
concentrations of 300-400 mg/mL (1, 2). This leaves only 70% available for water, salts,
mnetabolites, and other small molecules. A cell is an amazingly close-packed system with a
solvent content similar to that observed in many protein crystals (Figure 1.1). This highly
crowded environment is very different from conditions under which enzyme activities are
normally determined. A typical enzyme assay consists of monitoring the activity of a single,
hc)mogenous enzyme at a concentration of 1-1,000 nM in a buffer containing a few salts and only
the small molecules of interest. It is surprising that only recently has the impact of the cellular
environment begun to be systematically studied with regard to enzyme function.
In particular, a crowded cellular environment is believed to present a barrier to molecular
diffusion which can consequently impact enzymatic activity (3). In an excellent analogy,
Verkman has compared the 3 barriers to cellular diffusion (fluid-phase viscosity, non-specific
binding, and crowding) to driving an automobile (Figure 1.2) (3). Cellular diffusion is much like
an early-morning commute. The time it takes to reach your destination depends on the speed
limit (fluid-phase viscosity), the number of stoplights (non-specific binding), and rush hour
traffic (molecular crowding).
Recent advances in fluorescence microscopy have allowed these barriers to be quantified
in vivo. Using a combination of spot photobleaching and time-resolved fluorescence anisotropy,
small molecule diffusion in the cytosol has been studied with 2',7'-bis-(2-carboxyethyl)-5-(and-
6)--carboxyfluorescein (BCEF). The diffusion of the fluorophore was found to occur at a rate of
2x10 -6 cm 2 /s in vivo, which is -4 times more slowly than in water (4). The
19
Figure 1.1- An artist's scientific representation of the crowded interior of an E. coli cell.
Illustration courtesy of David Goodsell, Scripps Research Insitute.
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Viscosity Binding Crowding
Figure 1.2- Obstacles encountered during diffusion in a crowded cell.
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relative contributions of visocity, non-specific binding, and crowding to this diffusion rate were
then evaluated. Surprisingly, despite the high concentration of macromolecules, the viscosity of
the cytoplasm was determined to be only slightly greater than that of water (4.5 cPoise), and
non-specific binding provided only a minor barrier to diffusion for BCECF (4). The greatest
barrier to the probe's cytoplasmic diffusion was determined to be collisions with
macromolecules due to crowding.
Diffusion of large molecules has also been studied using either fluorescently-labeled
clextrans, green fluorescent protein (GFP), GFP-derivatized metabolic enzymes, or fluorescently-
labeled DNA fragments. In all cases, the rates of diffusion were determined to be much lower in
cytoplasm than in water (Dcyto/Dwater < 0.25) (3). Dextrans larger than 2000 kDa and DNA
fragments larger than 250 bp had severely impaired rates of diffusion (3). Most relevant to
studies on enzyme activities and metabolism were the diffusion rates of GFP and labeled
glycolytic enzymes. When GFP was expressed in CHO cells, it possessed similar diffusion
properties compared to BCECF (8.7x10-7 cm 2/s) (5). However, very different results were
obtained for TCA cycle enzymes being expressed in either CHO or COS7 cells as GFP chimeras.
In this case, malate dehydrogenase, isocitrate dehydrogenase, citrate synthase, and succinyl-CoA
synthetase were all found to diffuse nearly 20-fold slower than GFP alone (4x10 -8 cm2/s) (6).
These results indicate that the cellular environment can restrict both small molecule and
macromolecule mobility.
The effects of crowding on enzyme activity are complicated (7, 8). Based on the results
mentioned above, crowding would be expected to lower enzyme activities due to diffusion
barriers encountered in forming an enzymeesubstrate complex. However, the excluded volume
in a crowded environment due to the space occupied by other macromolecules can increase
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effective concentration, leading to an activating effect. Therefore, the impact of crowding on
activity is highly enzyme specific and depends on the contributions of both of these factors. For
example, crowding has been shown to increase the activity of rabbit muscle pyruvate kinase (9),
inhibit adenosine deaminase (10), and have no net effect on Eco RV endonuclease kinetics due to
compensating changes in non-specific binding, Vmax, and Km for the DNA substrate (11).
The diffusion rates mentioned above for BCECF give rise to very fast linear velocities
compared to the size of an average bacterial cell (0.125 m/ts versus an average E. coli cell size
of 2.95 ym x 0.64 jim) (1, 4). Given an intracellular protein concentration of 1 /M, the
cliffusional transit time for a small molecule between proteins would only be -1 ms (12).
However, if one takes into account the rate of productive encounters in an enzyme active site
(which would be dependent on the correct orientation of the active site relative to the small
molecule among other factors), the transit time could increase to 0.1-1 s (12). Given this
observation and the impact of crowding on both small molecule and macromolecular diffusion, it
is a reasonable question to ask if cells have evolved mechanisms to overcome this barrier.
Recent advances in prokaryotic biology have indicated that Nature has taken a very sophisticated
approach to cytosolic organization in bacteria.
1.1 Organization in the Bacterial Cell
It is now clear that bacterial physiology contains many of the complex features
previously associated with eukaryotes. In the early 1990s it was discovered that the membrane
chemoreceptors and cytoplasmic chemotaxis proteins in E. coli could localize specifically at the
cell pole (13). Since then, the picture of a bacterium has changed from a "bag of enzymes" to
one of an exquisitely organized set of machines. This is exemplified in studies on asymmetric
cell division in Caulobacter crescentus and sporulation in Bacillus subtilis. In both cases,
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protein activities are regulated by transcriptional-timing to produce enzymes only during specific
stages of the cell cycle and by localization of enzymes to specific locations within the cell (14).
Furthermore, it has now been shown in Caulobacter that the chromosome position in the cell is
tightly controlled and specific genetic loci are found at defined chromosome locations with
respect to the cell axis (15). This positioning is maintained by careful remodeling and
segregation of the chromosome during cell division by transport proteins and linkage to a
cytoskeleton formed by the actin homologue MreB (16). Evidence for a cytoskeleton has also
been found in E. coli where the MreB protein filaments are essential for maintaining cell shape
(17, 18) and the dynamic MinCDE filamentous complex is responsible for localization of the
division septum at the cell midpoint (19).
The examples mentioned above for organization of the bacterial cell are limited to
processes involving either cell division or morphology. Cellular organization of primary
metabolic enzymes is less well-understood; however, formation of protein:protein complexes
could be used to circumvent many of the diffusion problems encountered in a crowded cellular
environment. This may be particularly important in the metabolism of unstable or reactive
molecules.
Cellular metabolism proceeds in aqueous solutions at pH -7 at 37°C despite the chemical
instability of many metabolites under these conditions in vitro. For example, de novo purine
biosynthesis in bacteria (Scheme 1.1) generates two different unstable intermediates.
Phosphoribosylamine (PRA) and N5 -carboxyaminoimidazole ribonucleotide (N5-CAIR) each
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have estimated half-lives in vivo on the order of seconds and rapidly decompose either by
hydrolysis (PRA) or decarboxylation (N5-CAIR) (20). In addition,
phosphoribosylpyrophosphate (PRPP), the precursor to PRA and a common metabolite in many
biosynthetic pathways, rapidly decomposes in the presence of Mg 2+ to a combination of ribose-
5'-phosphate, PPj, and 5'-phosphoribosyl-1',2' cyclic phosphate (21, 22). Many other metabolic
pathways contain unstable or reactive metabolites including carbamate and carbamoyl phosphate
in pyrimidine metabolism (23, 24), -aspartyl phosphate in the aspartate pathway (25), and
glutamate 1-semialdehyde in 5-aminolevulinic acid synthesis (26, 27).
One method that cells could use to avoid metabolite decomposition would be to directly
transfer these unstable metabolites between enzyme active sites. This process is called metabolic
channeling and is broadly defined as transfer of common metabolites between enzymes without
equilibration with the bulk solution (Figure 1.3) (28). There are several advantages to
channeling including decreasing the metabolite transit time between enzymes, avoiding
unfavorable equilibria, segregation of common metabolites from competing pathways, and
protection of chemically labile or toxic intermediates (28). Channeling sidesteps all of the
barriers to cellular diffusion present in the cytosol to provide an elegant solution for metabolism
in a crowded environment.
Key to the understanding of the channeling phenomenon is an analysis of the
protein:protein complex that is proposed to be involved in metabolite transfer. In the following
sections, small-molecule transfer via protein:protein complex formation will be described in two
well-studied model systems: carbamoyl phosphate synthetase (CPS) and the bacterial
chlemotaxis phosphorelay system. CPS is believed to channel NH3 between two enzymes in a
26
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Figure 1.3-Free diffusion versus channeling for transfer of common metabolite PI between
enzymes El and E2. If metabolite PI is unstable or reactive, channeling avoids metabolite
decomposition that may be encountered during diffusion into the cytosol.
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tight protein:protein complex, while bacterial chemotaxis relies on transient protein interactions
to catalyze phosphoryl transfer.
1.2 Carbamoyl Phosphate Synthetase: NH3-transfer in a Tight Enzyme Complex
Amidotransferases (ATs) are enzymes that catalyze hydrolysis of glutamine and
incorporation of the liberated NH3 into another metabolite. These enzymes are ubiquitous in
metabolism and can be classified according to their glutaminase active sites (Table 1.1). The
largest families are the NTN and triad classes of ATs (29). The NTN class contains a N-terminal
cysteine involved in glutamylthioester formation and liberation of NH3.
Table 1.1: Amidotransferases in Primary Metabolism
GlutaminaseEnzyme ClassClass
Anthranilate Synthase Triad
Asparagine Synthetase NTN
Carbamoyl Phosphate Synthetase Triad
(CPS)
Cobyrinic Acid a,c-Diamide Synthetase Triad
CTP Synthetase Triad
Formylglycinamide Ribonucleotide
Amidotransferase Triad
(FGAR-AT, PurL)
Glu-tRNAGIn Amidotransferase Amidase or
(GatABC or GatDE) Asparaginase
Glucosamine-6-Phosphate Synthase NTN
Glutamate Synthase NTN
GMP Synthetase Triad
Imidazole Glycerol Phosphate Synthase Triad
(HisHF)
NAD Synthetase (Eukaryotic) Nitrilase
p-Aminobenzoate Synthase (PabAB) Triad
Phosphoribosylpyrophosphate
Amidotransferase NTN
(PRPP-AT, PurF)
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The triad class also contains a catalytic cysteine residue; however, this residue may be located
anywhere within the peptide chain and is always followed by a conserved pair of histidine and
glutamate residues with a typical consensus sequence of Cx80 o00HPE (29). The crystal structures
of many AT enzymes have been solved, and every structure contains spatially separated
glutaminase and AT active sites (30). This observation has led to a general model in which AT
enzymes channel NH3 between two active sites (30). In the case of the NTN class,
intramolecular channeling has been proposed since the glutaminase and AT active sites are
always present on the same polypeptide chain. Channel formation and architecture has been well
studied in PurF (Scheme 1.1), the prototype for the NTN class, but no general paradigms have
emerged for AT enzymes as a whole (31-33).
Triad glutaminases may be located either on the same peptide chain as the AT or on a
separate protein. Intramolecular channeling has been proposed in this AT family in the former
case and intermolecular channeling in the latter. CPS is the best-studied triad AT and is an
example of an enzyme that exhibits intermolecular channeling between two tightly interacting
subunits. These subunits can only be separated by denaturation or by the presence of extremely
high salt concentrations, and full activity cannot be regained by reconstituting the separated
subunits (34-36). CPS catalyzes formation of carbamoyl phosphate from bicarbonate, glutamine,
and 2 equivalents of ATP. The enzyme is found as a heterodimer composed of 40 kDa and 120
kDa proteins. The former catalyzes glutamine hydrolysis (1), while the latter catalyzes
formation of carbamate (2) and carbamoyl phosphate (3). The overall reaction (4) is thus
composed of 3 reactions as shown below.
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Gin + H2 0 - Glu + NH3 (1)
NH3 + ATP + HC(O03- carbamate + ADP + Pi (2)
carbamate + ATP - carbamoyl phosphate + ADP (3)
Gin + 2ATP + HC03 + H2 0 carbamoyl phosphate + 2ADP + Pi + Glu (4)
Crystallographic analysis of the CPS complex revealed that the light and heavy subunits
have an extensive protein interface (Figure 1.4, -2150 A2 buried/subunit) (37). This interface is
formed by 35 inter-protein hydrogen bonds and 36 interactions mediated by water molecules
(38). The AT and glutaminase activities are coupled across this interface. Detailed kinetic
analysis of CPS by the Raushel laboratory has determined that in the presence of ATP and
HCO3-, glutamine hydrolysis is accelerated from 4 to 1100 min - in order to synchronize NH3 and
activated-bicarbonate formation for carbamate synthesis (39).
The crystal structure of CPS also revealed that three reactions carried out by the enzyme
occur in distinct, spatially-separated active sites (Figure 1.4). These active sites are connected by
a 96 A-long tunnel that winds through the enzyme (37). In the tunnel between the glutaminase
and carbamate synthetase sites, NH3 is proposed to channel over a distance of -45 A. This
tunnel is largely hydrophilic in character and has an average minimum radius of 3.2 A,
approximately the same size as NH3. A larger tunnel (average minimum radius of 3.5 A)
connects the synthetase and carbamate kinase active sites. This tunnel is hydrophobic and is
believed to convey carbamate between active sites within the heavy subunit. Channeling of
these metabolites avoids both protonation of NH3 and carbamate decomposition (half-life at
neutral pH of 70 ms) (23).
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Carbamate
Kinase
Glutaminase
Carbamate
Synthetase
Figure 1.4-Inter- and intramolecular channeling in carbamoylphosphate synthetase (CPS). The
overall reaction for CPS is shown above. The crystal structure of the enzyme revealed four
domains: a triad glutaminase occupies the light subunit (red) and the carbamate synthetase
(blue), carbamate kinase (teal), and regulatory (green) domains occupy the heavy subunit Inter-
and intramolecular tunnels for NH3 and carbamate (outlined by the green dots) connect the three
active sites of the enzyme.
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CPS is also the only AT enzyme for which NH3 -channeling has been demonstrated by
chemical methods. The evidence for channeling used 15 N-NMR to monitor product formation in
the presence of 25 mM [14 N]-glutamine and 100 mM 5NH4Cl (40). If the 14NH 3 released from
glutamylthioester formation does not channel, it should be able to equilibrate with the '5NH 4+
present in the buffer. Subsequent diffusion of ammonia (or ammonium) back into the carbamate
synthetase active site would result in 80% (100 mM 15NH4 - 125 mM total NH 4 ) of the product
being 15 N-labeled. In order to avoid carbamoyl phosphate decomposition during acquisition, the
reaction was coupled with ornithine carbamoyltransferase and integration of the citrulline
product NMR signal showed that < 5% contained '5N, providing evidence that 14 NH3 is being
channeled across the protein:protein interface between the glutaminase and AT active sites of
CPS.
1.3 Bacterial Chemotaxis: Phosphoryl Transfer in a Transient Enzyme Complex
Given the crowded cellular environment, one might expect that all protein complexes are
pre-organized into very tight interactions as in the case of CPS. However, there are many
examples of enzymes that interact weakly, or transiently, with one another. For example, weak
interactions are essential for electron transfer proteins involved in photosynthesis and oxidative
phosphorylation in order to maintain a continuous flow of electrons (41). Interactions between
cytochrome c and cytochrome c peroxidase as well as between photosystem I and cytochrome c6
or plastocyanin have been kinetically characterized by laser flash absorption spectroscopy. The
interactions exhibit very fast on and off rates (kon 107-109 M- s-' and koff > 103 s-') but the
interaction is sufficiently long-lived to permit electron transfer (41). Transient interactions are
not limited to electron transfer processes. Thioredoxin interacts weakly with ribonucleotide
reductase (RNR), despite a requirement for covalent disulfide reduction of RNR after every
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turnover (42). One of the best characterized examples of weak protein interactions involved in
small molecule transfer is the phospho-relay signaling pathway required for bacterial
chemotaxis.
Chemotaxis can be described as the biasing of random movement of the cell towards a
higher concentration of a nutrient source (or away from a toxic chemical) (43). The movement
bias is achieved by altering the frequency at which the flagellar motors spin counterclockwise
(which results in bundling of the flagella to produce forward motion) versus clockwise motion
(which disrupts the flagellar bundle and induces random tumbling) (43). Bacteria are too small
to sense a concentration gradient along their body length; so, the chemotactic response is
regulated by temporal stimulation of pole-localized transmembrane chemoreceptors. Higher
nutrient concentrations result in increased frequency of receptor:metabolite interaction at the cell
pole (43).
The best-characterized chemotactic signaling pathway is found in the Che system of E.
coli (Figure 1.5). While the details of the pathway are too complicated to address here, the basis
for chemotaxis in E. coli begins with interactions between the soluble CheA protein and a trans-
membrane methyl-accepting chemotaxis protein (MCP). The MCP acts as a bridge linking the
cytosol to nutrient conditions in the periplasm. A decrease in the number of interactions between
the MCP and a nutrient binding protein (such as maltose-binding protein) in the periplasm results
in a conformational change that is propogated into the cytosol and induces CheA
autophosphorylation at His48. This phosphate is transferred via protein:protein complex
formation to Asp57 of CheY (Figure 1.5). Phosphorylated CheY can then interact with the
flagellar motor and induce clockwise rotation and cell tumbling. CheY can subsequently be
dephosphorylated by interaction with CheZ.
33
•
8
•• •• •
••••• •
k1
P-CheA + Che Y -
~he~lkheAk,
CheA:CheY
k2 _ k3P-CheA:CheY::::;::::-==-=::CheA:CheY-P - - CheA + CheY-P
K2 K3
Figure 1.5-(Top) Protein components of the E. coli chemotaxis system. A transmembrane
protein receptor (grey, also known as a methyl-accepting chemotaxis protein or MCP) senses a
chemoattractant. Phosphoryl transfer from His48 of CheA to AspS7 of CheY by protein
complex formation triggers accumulation of phospho-Che Y, which can then interact with the
flagellar motor (green) to initiate clockwise rotation. Phospho-Che Y can then be
dephosphorylated by CheZ. Other proteins involved in chemotactic signaling (CheB, CheW, and
CheR) have been omitted for clarity. (Bottom) The kinetic scheme describing phosphoryl
transfer between CheA and CheY.
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The chemotactic response is remarkable for both its speed and sensitivity. For example, a
chemotactic response is observed in a methylaspartate gradient of 160- 163 PM despite only a
minimal change in calculated receptor occupancy under these conditions (44). These
chemotactic responses also occur very rapidly, within -100 ms of receptor stimulation (43). The
current model for sensitivity and speed in bacterial chemotaxis relies on signal amplification
from the receptor based on kinetic control of phosphoryl transfer between the cytosolic proteins.
An essential component of this model is the transient interaction between phospho-CheA (Pi-
CheA) and CheY that has been characterized in vitro (Figure 1.5).
Rapid-chemical quench methods have been used to analyze phosphoryl transfer kinetics
from 3 2Pi-CheA to CheY (45). Under these conditions, phosphoryl transfer was monitored by
SDS-PAGE and phosphorimaging to detecte the phosphorylated proteins after quenching of the
reaction with 0.1M EDTA/10% SDS. These experiments were complicated by
dephosphorylation of the proteins during analysis; however, data could be accurately modeled
after determining half-lives for the phosphoaspartate and phosphohistidine linkages of 115 + 20
min and 1000 + 100 min, respectively, under the analysis conditions (45). An alternative
strategy was used to indirectly detect phosphoryl transfer: changes in CheY tryptophan
fluorescence was monitored by stopped-flow spectroscopy and similar results were obtained (46,
47). The kinetics are remarkable for several reasons. First, saturation kinetics could be observed
for the proteins with a Km value of 6.5 + 2 M between Pi-CheA and CheY at 25°C (45). This
affinity indicates that the proteins interact relatively weakly in solution, even during phosphoryl
transfer. Second, under saturating conditions, the phosphoryl transfer was completed within the
dead time of the quench apparatus (2.5 mns) (45). Therefore, rate constants for the phosphoryl
transfer under saturating conditions had to be extrapolated from concentration- and temperature-
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dependence studies. The value for the apparent first-order rate of phosphoryl transfer is
remarkably fast, 650 + 200 s-' at 25°C (45). Given cellular CheA and CheY concentrations of
1-5 yM and 10-20 yM, respectively, these values have been used to extrapolate an in vivo
complex half-life of 2 ms (45).
Using advanced computer simulations, Stewart and coworkers have predicted that these
rapid kinetics are essential for the bacterial chemotactic response (47). A loss of one order of
magnitude in the rate of phosphoryl transfer (a decrease from -700s -' to -70 s-') was predicted to
result in an observable change in chemotaxis based on alteration of the frequency at which the
flagella are expected to rotate in a clockwise direction. These predictions have been confirmed
with the use of a CheA mutant enzyme that phosphorylates CheY at a 25-fold slower rate in vitro
(47). When the mutant CheA was expressed in ACheA E. coli, cell motility was decreased by
'5% in a chemotaxis assay compared to the wild-type strain (48). Visual observation of flagellar
rotation confirmed that about 66% of the mutant bacteria flagella were being rotated in
exclusively a counterclockwise direction (the direction not stimulated by phosphate transfer from
CheA to CheY) whereas no counterclockwise movement was observed in the wild-type strain
(48).
Given the transient nature of the Pi-CheA:CheY complex, obtaining evidence for the
interaction was challenging but successful using a number a methods. These experiments were
aided by the fact that CheY can interact with CheA independent of the presence of phosphate (Kd
^ 1-1.7 yM for CheA, while the Km for Pi-CheA is 6.5 pM) (45). Using a fluorescently-
derivitized CheY., steady-state and stopped-flow fluorescence spectroscopy have demonstrated
CheA and CheY binding interactions (49). Thermodynamic information about interactions
between CheA and CheY has been obtained using isothermal titration calorimetry (ITC), and a
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hexahistidine affinity tag on CheA was successful in enabling purification of a CheA:CheY
complex (50). Finally, several crystal structures are available for CheA:CheY protein complexes
(51-53). In these structures, only the CheY-binding domain of CheA (which has the same
affinity for CheY as the full length protein but does not contain the phospho-histidine site) was
crystallized with CheY. The hydrophobic interface buried only 600 A2 from each protein.
Comparison of the multiple crystal structures suggests that the interface is flexible, consistent
with transient complex formation. These results indicate that the bacterial chemotaxis system is
a paradigm for studies on transiently interacting proteins involved in small molecule transfer.
1.4 Protein:Protein Complexes and Purine Biosynthesis
The protein interactions illustrated by CPS and CheA:CheY have been used as models for
thinking about the role protein complexes play in de novo purine biosynthesis (Scheme 1.1). In
particular, the importance of protein complexes in channeling unstable metabolites has been of
long-standing interest in the Stubbe Laboratory, and purine biosynthesis has been used as a
paradigm for understanding metabolism of unstable intermediates such as phosphoribosylamine
(PRA, t, 2 in vivo,- 5 s) and N5 -carboxyaminoimidaxole ribonucleotide (N5-CAIR, t 2 in vivo
15 s ). The channeling of PRA between E. coli phosphoribosylpyrophosphate amidotransferase
(PurF) and glycinamide ribonucleotide synthetase (PurD), the first two enzymes in the pathway
(Scheme 1.1), has been investigated for a number of years. Like the CheA:CheY
phosphotransfer complex, this channeling interaction is expected to be transient in nature. In
Chapter 2 of this thesis, efforts are reported to detect complex formation between PurF and PurD
by stopped-flow fluorescence spectroscopy.
The presence of two ATs in the pathway (PurF and PurL/PurSQL) affords additional
opportunities to study protein complexes involved in channeling. Like all ATs, these enzymes
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are proposed to channel NH3 between glutaminase and AT active sites. The remainder of the
thesis will describe efforts to characterize the B. subtilis formylglycinamide ribonucleotide
amidotransferase (FGAR-AT). This enzyme is a member of the triad family AT enzymes and is
composed of a protein complex of PurS, PurQ, and smPurL. Initially, the complex was
presumed to be tight as in the cases of CPS and other AT enzymes. However, the data now
indicate that tight complex formation is mediated by the presence of metabolites and weak
protein interactions may be critical for transient NH3-channel formation between two active sites.
1.5 Channeling of PRA between PurF and PurD
PurF catalyzes the incorporation of NH3 released from glutamine hydrolysis into PRPP
(Scheme 1.1). While PRA was assumed to be the product of PurF for many decades, the extreme
lability of the molecule hampered its characterization. The first experimental evidence for PRA
synthesis by PurF came from 13C NMR studies (54). Using 40 ptmol of 1-1 3Cl- PRPP, an cc/3
mixture of PRA was formed in the presence of 200 U of PurF and glutamine after 4 min and
rapidly decomposed to ribose-5'-phosphate after 10 min. Subsequent saturation- and inversion-
transfer NMR experiments allowed determination of the rate constants for PRA anomerization
which result in rapid formation of a 60:40 mixture of f3:cL anomers. The rate of PRA
decomposition was studied by using an excess of PurD (glycinamide ribonucleotide synthetase,
Scheme 1.1) to convert available PRA to GAR (glycinamide ribonucleotide), a stable compound
that can be readily isolated (54). The kdecomp was found to be 7.0 x 10-4 s at pH 8.0 and 18°C.
Temperature- and pH-dependence studies on the decomposition rate allowed extrapolation to
physiological conditions. These results indicated that PRA half-life in vivo (pH 7.5, 37°C) is
5 s.
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Given this short half-life, it was postulated that PRA could undergo significant
decomposition in vivo if it were allowed to freely diffuse between PurF and PurD. A model was
proposed in which the PurFoPRA complex interacts transiently with PurD in order to channel
PRA and avoid metabolite decomposition. Work by Johannes Rudolph in the Stubbe Laboratory
provided steady state kinetic analysis of evidence for channeling of PRA (55). As an initial step
in Rudolph's experiments, a free diffusion model (Scheme 1.2) was generated to describe the
rate of GAR formation from PRPP by PurF and PurD in a standard coupled assay involving two
enzymes and assuming no channeling of PRA.
While the steady state parameters for PRA formation (VI, PurF activity) and
decomposition (kdecomp) were easily determined, the parameters for PurD were more difficult to
obtain. In order tlo assay PurD activity, PRA is typically synthesized as an cx/3 mixture in
equilibrium with ribose-5'-phosphate in 1 M NH4OH. This limits the amount of PRA that can be
added to an assay solution without altering pH. Analysis of initial velocity data revealed that
PurD exhibits substrate inhibition with PRA (K = 670 yM), which further complicates
determination of the Km for PRA and V2 (Vmax for PurD); however, these data could be modeled
by fits to standard equations for substrate inhibition. By using parameters obtained for the
enzymes and PRA decomposition, a kinetic model for the rate of GAR formation was
constructed based upon a standard coupled assay. This model revealed that if a small amount of
PurD is added to the assay (which results in a low V2), the rate of GAR formation will not be
coupled to the rate of PRA synthesis by PurF. This would result in an observable lag phase in
the rate of GAR synthesis (Figure 1.6).
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R5P
Scheme 1.2-A kinetic scheme for modeling GAR formation from PRPP in a standard coupled
assay with PurF and PurD. PRA synthesis is dependent on the PurF reaction velocity (V);
while GAR formation is dependent on both the PRA concentration (Km) and PurD reaction
velocity (V2). In addition, a significant portion of PRA will be decomposing to ribose 5'-
phosphate (R5P) during the experiment at a constant rate (kdecomp).
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When experiments were carried out using small amounts of PurD, the rate of GAR
formation observed by Rudolph was inconsistent with the free diffusion model (55). No lag
phase was observed, and the amount of GAR produced significantly exceeded predictions made
from the model (Figure 1.6). Error analysis of the parameters in the free diffusion model (V,, V2,
and Km(PRA)) indicated that their simultaneous variation by 20% could not account for the
observed kinetics. In addition, this behavior was found to be dependent on both the ratio of PurF
to PurD and the total protein concentration, properties expected for involvement of a
protein:protein interaction (56). Together the data were interpreted to indicate that PRA is being
channeled between PurF and PurD through their transient interactions.
Previous studies to look for interaction between PurF and PurD involved size-exclusion
chromatography (SEC) and co-immunoprecipitation (co-IP), both of which require tight
interactions. No evidence for an interaction could be found with either of these techniques.
H-owever, methods that should report on weaker interactions such as protein-affinity
chromatography, cross-linking in crude extracts and with purified proteins, and steady-state
fluorescence were also unsuccessful. The cross-linking and steady-state fluorescence data were
particularly striking since these experiments were carried out in the presence of PRA. Thus
despite the use of different methods to detect interactions on different time-scales (Table 1.2), no
evidence for a PurF:PurD interaction was found. This provided further evidence that the
enzymes are interacting transiently in solution and that the techniques listed in Table 1.2 did not
have sufficient temporal resolution to detect complex formation.
The requirement for a specific PurFoPRA protein complex as the docking partner for
PurD in the channeling model also requires that PurF undergoes conformational changes during
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Figure 1.6-Kinetic evidence for PRA channeling obtained by Rudolph and Stubbe. The
observed rate of GAR formation (solid line) is linear and exceeds that predicted from diffusion-
modeled kinetics for a standard coupled assay (dashed line).
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Table 1.2: Techniques Previously Used in Efforts to Detect a PurF:PurD Complex
Technique Ligands Utilized Time-Scale Temperature
Gel Filtration Chromatography None Hours 4°C
. .. 1.7 mM PRA, 20 mM Gn,.Co-Immunoprecipitation 1.7 mM PRA, 20 mM Gin, 15 min 0C3 mM ATP
Protein Affinity Chromatography None -20 h 4°C
Steady-State Fluorescence 2 mM PRPP, 0.1-2 mMPRA, Minutes 25°C
10 mM Gln, 1 mM ATP
Cross-linking of Purified 2 mM PRPP, 0.1-2 mM PRA, 0.52 h 250C
Proteins 10 mM Gln, 1 mM ATP
. .. 2~mM PRPP, 0.1-2 mM PRA,a Cross-linking in Cell Lysates 2 mM PRPP, 0.1-2 mM PRA, 0.5-2 ha 250C10 mM Gln, 1 mM ATP
aThis represents the amount of time that the proteins were exposed to the cross-linking reagents
and not the rates of the chemical steps for cross-linking. Since the cross-linking was
irreversible, it was expected that a cross-linked product would accumulate in solution over time.
catalysis. Structure determination of the E. coli PurF by X-ray crystallography has provided
evidence for conformational flexibility (Figure 1.7). Structures of the apo form and "closed"
form in the presence of 6-diazo-5-oxonorleucine (DON, a glutamine analog that alkylates the
catalytic cysteine present in glutaminase domains) and a carbocyclic analog of PRPP (cPRPP,
which also contained Mn2+ as a metal ligand) indicated that movements occur in the glutamine-
binding loop (blue), PRTase flexible loop (yellow), and the C-terminal helix (green) (Figure 1.7)
(31, 57). This structural reorganization is believed to be necessary to create an NH3-channel
between the glutaminase and the AT active sites. Additional evidence for conformational
flexibility of these loops has been obtained by studying fluorescence changes in PurF upon
substrate binding in both the pre-steady and steady state (32). These loop movements are
discussed in greater detail in Chapter 2. The structure of a PurFproduct complex remains
unknown.
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Open Closed
Figure 1.7-X-ray crystallographic studies have shown that upon binding of PRPP and
glutamine analogs, PurF goes from an open (lecb.pdb) to a closed conformation (lecc.pdb). The
PRTase flexible loop (yellow), glutamine-binding loop (teal), and C-terminal helix (red) all
undergo large conformational changes. The DON-adduct and cPRPP analog are shown in ball-
and-stick representation in the closed structure.
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I)etermination of the crystal structure of apo-E. coli PurD by the Ealick laboratory afforded the
opportunity to produce a model for interactions between PurF and PurD (58). The structure of
PurD revealed that it is a member of the ATP-Grasp superfamily of enzymes that all utilize acyl-
phosphate intermediates during ATP-dependent amide bond formation (59). Analysis of the
crystal structures of the E. coli PurF (closed form) and apo-PurD indicated that a docking model
could be constructed that aligns the enzyme active sites (Figure 1.8) (58). This model was based
on the observed shape and charge complementarity between the structures. Another central
feature of this model is that the proposed protein interface is comprised of the PurF mobile loops
(Figure 1.9). It was proposed that movement of these loops (specifically the PRTase flexible
loop) during complex formation with PurD leads to PRA channeling.
In Chapter 2, stopped-flow fluorescence spectroscopy has been utilized to provide direct
evidence for transient protein-protein interactions between PurF and PurD. Unlike the methods
listed in Table 1.2, stopped-flow fluorescence spectroscopy can be used to detect transient
interactions during which the complex half-life may be on the order of milliseconds.
Fluorescence reporters site-specifically incorporated into each of the PurF mobile regions have
been examined for changes occurring upon complex formation with PurD. With the use of a 3-
syringe stopped-flow apparatus, interactions between PurF and PurD during PRA synthesis in
the pre-steady state were probed. The success of these experiments hinged upon a dual-labeling
strategy in which tryptophans in PurF and PurD were replaced with unnatural amino acids.
Fluorescence from PurD was reduced by incorporation of 4-fluorotryptophan (4FW) and
additional specificity for PurF fluorescence was gained by incorporation of 7-azatryptophan
(7AW) to monitor fluorescence at X > 360 nm. No interactions between PurF and PurD were
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Figure 1.8- The PurF dimer (left) and PurD monomer (right) docking model proposed by the
Ealick and Stubbe laboratories. In this view, the docking model has been splayed open along the
vertical page axis. Yellow regions on PurF and PurD are proposed to be in contact. Symmetry
within the PurF dimer leads to 2 binding sites for PurD, but only one is shown in the figure for
clarity. Models for ATP (blue) and GAR (red) are shown in PurD to define the active site.
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Figure 1.9- In the PurF:PurD docking model, the active sites of PurF (grey) and PurD (red-
orange) are proposed to be in contact. The active site of PurF is noted by the substrate analog
from the crystal structure (Mn2+ -cPRPP). The active site is covered by the PurF mobile loops
(the glutamine loop (residues 73-85, teal), the flexible loop (residues 327-350, yellow), and the
C-terminal helix (residues 470-499, red)). The location of the PurD active site is shown by a
modeled GAR substrate and the partially disordered, ATP-binding P-loop (green).
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detected in the pre-steady state using this strategy. The implication of these findings with regard
to the validity of the docking model, transient protein:protein interactions, and PRA channeling
is discussed in detail.
1.6 The B. subtilis FGAR-AT Protein Complex
The fourth step in purine biosynthesis (Scheme 1.1) is carried out by a triad-class AT
enzyme that catalyzes the glutamine- and ATP-dependent conversion of an amide
(formylglycinamide ribonucleotide, FGAR) to an amidine (formyglycinamidine ribonucleotide,
FGAM), ADP, P, and glutamate. Searching for purL equivalents in diverse genomes has
revealed that this reaction is carried out in different organisms by one of two related enzymes
(Figure 1.10). Gram-negative bacteria and eukaryotes contain a large PurL (lgPurL, -140 kDa)
that is composed of 4 domains. The N-terminal domain occupies the first 150 amino acids and
is not homologous to any known protein motif. The middle -800 amino acids contain two
homologous regions similar to PurM, an enzyme that catalyzes the fifth step of purine
biosynthesis (Scheme 1.1). The C-terminal -220 amino acids contain a typical triad glutaminase
domain.
Analysis of the purine operon in B. subtilis by Zalkin and Nygaard indicated that instead
of one large enzyme, FGAM formation is carried out by a multi-protein complex composed of 3
proteins (Figure 1.10) (60). In B. subtilis, the smPurL enzyme (-750 amino acids) is
homologous to the central region of lgPurL, and PurQ (-220 amino acids) is a triad glutaminase.
No protein could be found with sequence homology to the N-terminal domain of lgPurL;
however, an orf was found in the purine operon near the smpurL and purQ genes. Genetic
disruption of this orf in B. subtilis created a purine auxotroph and subsequent analysis indicated
that the protein encoded by this gene (-80 amino acids) was necessary for FGAM
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Figure t.tO-Alignments between IgPurL and smPurL, PurQ, and PurS proteins. Sequence
analysis suggests that the IgPurLs contain 4 domains. In B. subtilis, smPurL is analogous to the
central PurM-like domains. PurQ is highly homologous to the C-terminal triad glutaminase
domain. PurS has no sequence homology to any domain of IgPurL and is half the size of the N-
terminal domain.
IPurS84 aa
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formation (61). The gene has since been renamed purS, and PurS, PurQ, and smPurL were
proposed to carry out FGAM formation in an FGAR-AT complex (61). The purS, purQ, and
smpurL genes have since been found in a number of Gram-positive, archae, and methanogenic
bacteria (61).
Prior to the work presented in this thesis, FGAM synthesis has been biochemically
characterized exclusively in lgPurLs from E. coli, Salmonella, and chicken liver by the Buchanan
and Stubbe laboratories. The previous work focused primarily on the mechanism of FGAM
formation. Buchanan and coworkers studied in great detail the glutaminase activity and reaction
stoichiometry of the enzyme. Much of this work stemmed from one of the first uses of a
mechanism-based inhibitor in enzymology, azaserine (-diazoacetyl-L-serine, Figure 1.1 1). This
glutamine analog stoichiometrically labeled the glutaminase domain of the enzyme on a cysteine
(Figure 1.11) (62). These studies led Buchahan to the hypothesis that a covalently bound
glutamylthioester was directly involved in release of NH3 and subsequently hydrolyzed to form
glutamate. In addition, Buchanan was also able to determine that glutaminase and ATPase
activities were coupled in the chicken liver enzyme such that one ADP and one glutamate were
produced during each round of FGAM synthesis (63).
While Buchanan's work indicated ADP and Pi are produced during every turnover, the
identities of any phosphorylated intermediates have remained elusive. In 1980, Westheimer
proposed that the enzyme may proceed either by a tetrahedral intermediate generated by NH3
attack on the amide followed by phosphorylation or by an iminophosphate mechanism, with the
latter being the favored and more thermodynamically stable intermediate (Figure 1.12) (64).
Intriguingly, the same types of mechanisms can be drawn for the PurM-catalyzed reaction
(Figure 1.13). The observation of sequence homology between
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Figure 1.11-(Top) Structures of the common glutaminase inhibitors azaserine and DON.
(Bottom) These inhibitors inactivate the glutaminase by alkylating the catalytic sulfhydryl group
to form a stable mimic of a glutamylthioester.
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Figure 1.12-Proposed reaction mechanisms for PurL by Westheimer (64). The reaction is
believed to proceed either through an iminophosphate intermediate (black arrows) or a
tetrahedral intermediate (red arrows). Buchanan has also postulated that the mechanism may
involve a phosphorylated-enzyme intermediate (not shown) during phosphate transfer from ATP
toFGAR.
52
PurL and PurM indicated that both enzymes may utilize similar structures to carry out a common
set of chemical transformations (20).
Significant efforts to find evidence for a phosphorylated intermediate during PurL or
PurM catalysis were carried out by Ernie Mueller in the Stubbe Laboratory (65). Rapid
chemical quench measurements, positional isotope exchange (PIX), and ADP/ATP exchange
experiments all failed to identify a phosphorylated intermediate in either enzyme. Insight into
these reactions was subsequently sought from X-ray crystallography studies, and the structure of
E. coli PurM was determined in 1999 by the Ealick and Stubbe Laboratories (66). PurM proved
to possess a novel structure and was the founding member of a new superfamily of ATP-binding
enzymes that also includes PurL. Unfortunately, due to uncertainties surrounding substrate
binding and the inability to co-crystallize either substrates or products with the enzyme,
structural clues to the reaction mechanism were difficult to obtain.
Given the limited success in understanding the mechanism or structure of the lgPurLs, a
new research direction for this step in purine biosynthesis was sought by focusing on the
smPurLs. Chapter 3 describes the first biochemical characterization of an FGAR-AT complex
composed of PurS, PurQ, and smPurL. Contrary to expectations, a complex of recombinant B.
subtilis PurS, PurQ, and smPurL could not be co-purified even when the proteins were co-
expressed in E. coli. The inability to isolate a protein complex indicated that unlike CPS and
most other AT enzymes, the FGAR-AT complex may be characterized by weak protein
interactions. By reconstituting activity from separately purified proteins, it was determined that
PurS was necessary for glutamine, but not NH3 -dependent FGAM synthesis. Protein titrations
revealed that the stoichiometry of the FGAR-AT complex consisted of 2 PurS: 1 smPurL: 1
PurQ. Surprisingly, a tight FGAR-AT complex could only be isolated by analytical size
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54
exclusion chromatography in the presence of glutamine and Mg2+-ADP. The role of ADP, a
product of the FGAM synthesis, was not clear until the crystal structure of the Salmonella lgPurL
enzyme was solved by the Ealick Laboratory (Figure 1.14) (67). This structure indicated that
ADP was not binding in the enzyme active site but appeared to function as a structural cofactor.
The remaining chapters of the thesis explore the structure-function relationship between
the Salmonella lgPurL and the B. subtilis FGAR-AT. The Salmonella lgPurL structure revealed
that it is a multi-domain enzyme composed of an N-terminal domain (residues 1-140), a linker
region (141-214)., a central domain containing the active and ADP-binding sites (215-979), and a
triad glutaminase domain (980-1295). One of the most intriguing aspects of the structure was the
N-terminal domain, which appears to link the glutaminase and FGAM-synthetase active sites.
This domain is connected to the body of the enzyme by a long linker region (18 amino acids),
suggesting that it is conformationally flexible. Finally, its location suggested that it may form, in
part, the NH3-tunnel that connects the two active sites.
The crystal structure of B. subtilis PurS presented in Chapter 4 revealed that the PurS
dimer is a structural homolog to the N-terminal domain despite the absence of sequence
homology (68). Thus PurS, like the N-terminal domain of lgPurL, may be involved in NH3-
channel formation. In addition, PurS appeared as a tetramer in two different crystal structures,
and homology modeling revealed that the B. subtilis FGAR-AT complex could be composed of
the initially proposed 2 PurS: smPurL: 1 PurQ complex or a 4:2:2 complex. Chapter 4
describes biophysical experiments designed to determine the quaternary structure of PurS and the
FGAR-AT complex in solution.
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Figure 1.14-Stereoview of the crystal structure of the Salmonella IgPurL.The four domains of
the enzyme are shown in green (the N-terminal domain), yellow (the linker domain), blue (the
central domain containing the active and ADP-binding sites), and red (the triad glutaminase
domain).
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Chapter 5 focuses on the glutamine-binding properties of PurQ and their impact in
FGAR-AT complex formation. PurQ is highly homologous to the glutaminase domain of the
Salmonella lgPurL (28% identity). Based on the structure of a glutamylthioester observed in the
Salmonella lgPurL glutaminase active site, site-directed mutagenesis was carried out on
conserved residues in PurQ involved in glutamine hydrolysis. FGAR-AT complex formation
was then studied by competing the mutant and wild-type PurQs with one another and monitoring
glutamine-dependent FGAM synthesis. Together with results obtained during efforts to affinity
purify the FGAR--AT complex from B. subtilis, these experiments provide additional evidence
for the importance of glutamine-binding in complex formation.
The final chapter of this thesis focuses on smPurL and the FGAM synthetase active site.
The 7'. maritima smPurL enzyme was cloned, purified, and assayed for NH4CI-dependent FGAM
synthesis. The crystal structure of the apo-enzyme was determined by the Joint Center for
Structural Genomics (JCSG) and allowed the determination of several structures in the presence
of FGAR, ADP, ATP, and both FGAR and a non-hydrolyzable ATP analog (AMP-PCP) by
Maria Morar and Ruchi Anand in the Ealick Laboratory by molecular replacement. These
results provided the first insights into the mechanisms of substrate-binding by members of the
PurM-superfamily of enzymes. Site-directed mutagenesis of T. maritima smPurL and activity
assays of the generated mutants confirmed the importance of conserved histidine residues within
the active site. These results provided new details concerning the mechanisms of catalysis by
PurLs and other members of the PurM-superfamily.
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Chapter 2:
Efforts to Detect a PurF: PurD Complex by Stopped-flow Fluorescence
Spectroscopy
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2.1 Introduction
PurF (phosphoribosylpyrophosphate amidotransferase, PRPP-AT) and PurD
(glycinamide ribonucleotide synthetase, GAR synthetase) catalyze the first two steps in de novo
purine biosynthesis (Scheme 2.1). The amidotransferase catalyzes the formation
phosphoribosylamine (PRA), PPi, and glutamate from phosphoribosylpyrophosphate (PRPP) and
glutamine. PurD then converts PRA in the presence of ATP and glycine into GAR, ADP, and Pi.
Early experiments on PurF failed to detect PRA and its structure was inferred by trapping with
PurD. These studies suggested that PRA was chemically unstable, not surprising given its
structure. Subsequent experiments estimated the t/ 2 of PRA under physiological conditions (pH
7.5, 37°C) to be - 5 s (1). The instability of PRA suggested that PurF and PurD have evolved to
directly transfer this metabolite between their active sites. Steady state kinetic studies on each
protein provided the required kinetic parameters to test the model that PRA was directly
transferred from PurF to PurD. The results of these experiments supported the proposal that the
first two enzymes in the purine biosynthetic pathway were able to channel this chemically
unstable intermediate (2).
To provide further support for this model, efforts were initially undertaken to look for
PurF interactions with PurD. Gel filtration chromatography, co-immunoprecipitation (Co-IP)
studies using antibodies to both PurF and PurD, protein-affinity chromatography, steady-state
fluorescence, and chemical cross-linking were all utilized in attempts to characterize a
PurF:PurD complex (2). All of these methods failed to detect any interaction between the
enzymes. Gel filtration and protein affinity chromatography experiments are carried out on a
time-scale (hours) that would not report on transient interactions. However, the failure to detect
a protein complex in the presence of PRA (generated using an equilibrium mixture of ribose-5'-
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phosphate and NH3 ) using steady-state fluorescence and chemical cross-linking methods is
problematic. In particular, the irreversibility of chemical cross-linking should have allowed
build-up of a cross-linked protein complex over the course of the experiment (0.5-2 h) even if
only a small percentage of the proteins were interacting at any given time. These results led to a
model in which PurD reacts transiently with the PurF.PRA product complex (2).
In the years subsequent to these kinetic studies, crystal structures of PurF and PurD
provided the basis for thinking about how the two proteins might transiently interact (3-5).
Crystallographic analyses of apo PurF and 6-diazo-5-oxonorleucine (DON)-inactivated PurF
with a bound Mn2+-carbocylic PRPP (cPRPP) indicated that the enzyme undergoes dramatic
structural reorganization upon substrate analog binding (Figure 2.1A) (3). Large movements
were observed in the glutamine-binding loop (residues 73-84), the phosphoribosyl transferase
(PRTase) flexible loop (326-350), and the C-terminal helix (471-492). In an attempt to
characterize these movements, Zalkin and coworkers used steady state and stopped-flow
spectroscopic methods to monitor changes in tryptophan fluorescence, taking advantage of the
fact that E. coli PurF contains only a single tryptophan (W290) (6). Mutation of this tryptophan
to phenylalanine was shown to have no effect on activity. Site-directed mutagenesis was then
employed to place tryptophans in each of the three mobile regions to monitor loop or C-terminal
helix movement (6). While many mutants were constructed, A82W in the glutamine-binding
loop, S345W in the PRTase flexible loop, and F477W in the C-terminal helix (Figure 2.1A) were
used as reporters for kinetically-competent conformational changes that accompanied substrate
binding to the enzyme (6).
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Figure 2.1-{A) Open and closed conformational states ofPurF from the POB files lecb.pdb
and lecc.pdb, respectively. Mobile loops that change conformation upon binding of cPRPP and
DON alkylation are shown in green. Tryptophan mutants studied in this chapter are shown in
blue and have been mutated in silica using SWISS POB- Viewer from the respective POB files.
In the closed form of PurF, cPRPP and the DON adduct are shown in ball-and-stick
representation; however, the DON adduct is obscured by the C-terminal helix. (B) Surface
representation of the docking model ofPurO onto the PurF dimer as previously described (5).
The two halves of the PurF dimer are colored red and pink. Proposed interactions between PurF
(Iecc.pdb) and PurO (Igso.pdb) are shown in yellow. Locations of the tryptophan mutants used
in these studies are shown in blue and labeled on one of the PurF monomers. (A) and (B) were
generated using MacPyMOL (DeLano, W.L., http://www.pymol.org).
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The conformational differences in PurF structures between the apo- and substrate-bound
forms played a key role in creating the docking model between PurF and PurD proposed by the
Ealick and Stubbe Laboratories (5). This model was created based on shape and charge
complementarity between the PurF dimer and the PurD monomer (Figure 2.1 B). While there is
some debate concerning PurF quaternary structure in solution and both dimers and tetramers
have been observed by X-ray crystallography(3, 4), one hypothesis is that the PurF dimer
structure closely mimics the PurFPRA complex, since dimeric structures are observed with
II)ON and cPRPP ligands in the closed PurF active site. Two key features of this docking model
were that the active sites of the enzymes were aligned (28 A apart) and that the mobile regions
of PurF correspond to the interface between PurF and PurD (Figure 2.1). Movement of the
PRTase flexible loop after PRA formation was proposed to allow direct transfer of PRA between
enzyme active sites (5). The experiments described in this chapter were designed to test the
proposed docking model and to obtain evidence for transient PurF-PurD interactions. The three
mobile regions (A82W, S345W, and F477W) previously studied in detail by Zalkin have been
investigated in an effort to detect interactions between PurF and PurD by monitoring changes in
PurF fluorescence in the pre-steady state.
Two technical problems must be overcome to test for PurFPRA transient interactions
with PurD. A continuous method to detect interactions is essential as is a method to determine
PurFPRA concentration at different stranges of the pre-steady state. Global incorporation of 7-
azatryptophan (7AW, Figure 2.2) into PurF and non-fluorescent 4-fluorotryptophan (4FW,
Figure 2.2) into PurD was successful and has provided the required sensitive probes of PurF
conformational flexibility in the pre-steady state.
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Figure 2.2 Absorbance and fluorescence properties of tryptophan and the 7AW and 4FW
tryptophan analogs used in these studies. Data from Ref. (7)
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Determination of the concentration of PurFoPRA, however, has been technically very
challenging. First, the instability of PRA precludes direct testing of this interaction. Second,
typical pre-steady state experiments using rapid chemical quench have thus far not been
successful due to instability of PRPP and PRA and unavailability of a method to rapidly trap
PRA. This chapter describes pre-steady state experiments, using 3 syringes, in an attempt
to detect interactions between PurF and PurD during PRA synthesis. In addition, a variety of
stopped-flow fluorescence experiments have also been carried out to look for PurF:PurD
interactions under conditions in which PurF resides in different conformational states. No
evidence for interaction between PurF and PurD was found under any of the conditions
examined. The implications of these findings and their impact on the docking model and PRA
channeling are discussed in detail.
2.2 Experimental
Materials
NADH, ATP, bovine serum albumin (BSA), ribose-5'-phosphate (R5P),
phosphoribosylpyrophosphate (PRPP), phosphoenolpyruvate (PEP), and pyruvate kinase/lactate
dehydrogenase (pre-mixed glycerol solution 660 U/mL PK, 1350 U/mL LDH, Sigma P-0294)
were obtained from Sigma. PRPP solutions were made in 50 mM Tris pH 7.5, frozen in liquid
N2, and stored at -80°C. PRPP concentration was determined enzymatically using the PurF:PurD
coupled assay (2). PRA was synthesized chemically, and its concentration determined
enzymatically (1). Glycine was obtained from Mallinckrodt and glutamine from Fluka.
Scintillation fluid (Emulsifier-Safe) was obtained from Perkin-Elmer. Dowex 50W-X8 resin,
200-400 mesh, was obtained from Bio-Rad. ESI-MS was performed at the MIT Biopolymers
Facility. PurF, W290F, A82W/W290F, ClS/A82W/W290F, W290F/S345W,
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C S/W290F/S345W, W290F/F477W, and C1 S/W290F/F477W mutant PurFs in pET-plasmids
were all the generous gift of Howard Zalkin, Purdue University (6).
Sub-cloning of PurD into pET-24a
The wild-type (wt) purD gene from pJK33 (5) was amplified by PCR with Pfu DNA
polymerase (Stratagene) using the PurD-NdeI (5'-
GCCATATGAAAGJTATTAGTGATTGGTAACG-3') and PurD-BamHI primers (5'-
CGGATCCTTAGTTCTGCTCGCGTTCGATAGCG-3'). The product was then digested with
NdeI and BamHI and ligated into pET-24a (Novagen) cleaved with the same restriction
enzymes. This construct allows IPTG-inducible expression of PurD, and the gene sequence was
verified by DNA sequencing (MIT Biopolymers Facility).
Expression ofpET-PurD
PurD was expressed as previously described except in E. coli BL21(DE3) (6).
Growth and Expression of [4FWI-labeled PurD and [7A W-labeled PurF
Both [4FW]-PurD and [7AW]-PurF were expressed in BL21(DE3) E. coli grown in
minimal media using methods developed for studies on ribonucleotide reductase (E. Artin, H.
Nguyen, and J. Stubbe, unpublished results). The minimal media at pH 7.4 contained 0.5 g/L
ala, 0.1 g/L cys, 0.6 g/L gly, 0.25 g/L ile, 0.4 g/L lys, 0.15 g/L phe, 2.1 g/L ser, 0.25 g/L val, 0.5
g/L arg, 0.7 g/L glu, 0.15 g/L his, 0.25 g/L leu, 0.25 g/L met, 0.15 g/L pro, 0.25 g/L thr, 0.15 g/L
tyr, 40 g/L glycerol, 2.0 g/L (NH 4 )2 SO 4 , 1.6 g/L KH 2PO 4 , 0.5 g/L Na citrate, 10 g/L Na2HPO4,
0.5 g/L adenine, 0.3 g/L cytosine, 0.70 g/L guanine, 0.5 g/L uracil, 0.3 g/L thymine, and 4 mM
MgSO4. All components except for the amino acids were autoclaved in 865 mL of water/L of
media. Amino acids (133 mL) were then added from a 7.5x sterile-filtered solution at pH 9.0.
Metals were added to the media from a 1000x stock solution containing 33 g/L FeCl3 -6H20, 180
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mg/L ZnSO4 o7H20, 160 mg/L CuSO4o6H2 0, 180 mg/L CoCl 2o6H20, and 38 g/L
Na2EDTA*2H 20. Biotin and thiamine were added from sterile filtered solutions to a final
concentration of 25 mg/L and 5 mg/L, respectively. Precipitation from the media was frequently
observed during the growth.
A single colony from a fresh transformation of BL21 (DE3) E. coli with either pET-PurD
or one of the pET-PurFs was used to inoculate 5 mL of LB with 70 [tg/mL kanamycin and
allowed to grow for 10 h at 37°C in a Glas-Col culture rotator at 50 rpm. An aliquot of the
culture (100 tL) was then used to inoculate 100 mL of LB with 70 [tg/mL kanamycin and
allowed to grow overnight with shaking at 200 rpm in a 500 mL flask at 37°C. Cells (40 mL)
from the overnight culture were then collected by centrifugation and washed twice with 25 mL
of minimal media. The cell pellet was resuspended in 10 mL of minimal media and used to
inoculate a L culture of minimal media with 70 ~tg/mL kanamycin. This culture was then
grown at 37°C with shaking at 200 rpm in a 4 L flask.
At OD 6 0 0 = 0.7, 200 mg of either DL-4FW or DL-7AW (both from Sigma) were added to
the flask as a solid. After 20 min, IPTG (Promega) was added from a 1 M solution in water to a
final concentration 1 mM. The cells were then allowed to grow for an additional 4 h before the
cell pellet was collected by centrifugation, frozen in liquid N2, and stored at -80°C.
Purification of wt PurD, [4FW]-PurD, and [7A W-PurFs
The labeled and unlabeled PurDs and PurFs were purified as previously described for the
wt enzymes with a minor modification (6, 8). Cells were lysed using a sonicator to avoid
particulates which interfered with French press cell disruption. Typically, cells from a 1 L
growth were sonicated in a flask cooled in an ice water bath for 16 min at 40% power with
stirring and shaking every 4 min (3/32" microprobe, VirSonicO 100, VirTis). Enzyme
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concentration was determined using the Lowry assay and a BSA standard. The identity of each
PurF mutant was confirmed by ESI-MS. These studies also indicated that all N-terminal
rnethionines had been removed.
ESI-MS Characterization of the [7A W]-PurF Mutants and [4FW]-PurD
The identity of each PurF mutant was confirmed by ESI-MS with a Sciex Model API 365
triple stage mass spectrometer at the MIT Biopolymers Facility. These studies also indicated
that all N-terminal methionines had been removed. However, the extent of 7AW incorporation
into PurF could not be monitored by ESI-MS because the mass difference between the labeled
and unlabeled enzymes was only 1 Da. On the other hand, extent of 4FW incorporation into
PurD was readily assessed by ESI-MS using wt PurD, [4FW]- PurD, or a mixture of wt/[4FW]-
PurD.
Enzymatic Assays for [7A W]-PurFs and [4FW]-PurD
[7AW]-PurF mutants were assayed at 18°C using a spectrophotometric assay with
PurD/PK/LDH as the coupling enzymes as previously described (2). C S and DON-inactivated
PurFs, while incapable of glutamine-dependent PRA synthesis, were assayed with the
PurD/PK/LDH coupling enzymes for NH4Cl-dependent activity. [4FW]-PurD was also assayed
at 18°C as previously described using the spectrophotometric assay with chemically synthesized
PRA (2).
Km and Vmx Determinations for the [7A W]-PurF Mutants and [4FW]-PurD
Kinetic constants for the [7AW]-PurFs (Km(Gln), Km(PRPP), and Vmax) and [4FW]-PurD
(Km(PRA), Km(gly), K(ATP), and Vmax) were determined as previously described for the wt enzymes
(2). Data for [7AW]-PurFs and for glycine-dependent or ATP-dependent activities in [4FW]-
PurD were fit using non-linear least squares fitting with KaleidaGraph software (Synergy) to
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Equation 2.1. As has been previously reported for wt PurD, substrate inhibition was observed
with [4FW]-PurD. These data were fit to Equation 2.2, also with KaleidaGraph software.
v = Vmax[S l/(Km + IS]) (2.1)
v = Vmax IS] (2.2){SI2.~ ~ ~ ~~(22(Kin + S! -)
Removal of Diketopiperazine Contamination from Radioactive Glycine Stocks
Diketopiperazine was removed from [14C(U)]-glycine stock solutions (New England
Nuclear, now Perkin Elmer) directly before use by passing the solution (10 ptCi) through a 1.5
mL column of Dowex 50W-X8 resin (400 mesh) equilibrated in 50 mM ammonium formate pH
3.33. The column was washed with 10 mL of 250 mM formic acid to remove the
diketopiperazine. Glycine was then eluted with 250 mM ammonium formate (pH 7.0).
Fractions containing radioactivity were combined and dried under vacuum. [14C(U)]-glycine
was added to 120 mM glycine to a final concentration of 12 mM. The specific activity was
determined by scintillation counting and enzymatic quantitation of glycine using the PurD
spectrophotometric assay.
Channeling Assays
Channeling assays were carried out using the [7AW]-PurF mutants and [4FW]-PurD as
previously described for the wt enzymes (2). Each assay was carried out at pH 8.0 and 18°C with
[14C(U)]-glycine (specific activity 1,587 cpm/nmol) to monitor GAR formation. Enzyme
activities and the Km(PRA) were determined immediately prior to each experiment. [7AW]-PurF
mutants and [4FW]-PurD were added to achieve product synthesis rates of 10.5 M PRA/min
and 17 M GAR/min, respectively, based upon analysis of the activity of each enzyme.
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Kinetics assuming no interaction between PurF and PurD were modeled based on the
parameters measured above and using Equations 2.3 and 2.4 and Microsoft Excel spreadsheet
software. The Krn(plA) determined for [4FW]-PurD was 102 IiM for a 40:60 equilibrium mixture
of ct/3-PRA (61 ptM for 3-PRA alone) (2). The rate of PRA decomposition (kdecomp) was 0.005
rnin -1 under these conditions (2).
6IPRA] V2[PRAI
- VVI - kecomp [PRAI (2.3)
& Km(,PRA) + [ PRA eo
61GAR _ V2 [PRA] (2.4)
bt Km (PRA) + [PRA
Inhibition of [4FW]-PurD by PP
The inhibitory effects of PP on GAR synthesis were determined by assaying [4FW]-
PurD in the presence of varying concentrations of PPi and subsaturating concentrations of the
variable substrate (8). A typical assay contained in a final volume of 600 PtL: 100 mM Tris HCl
pH 8.0, 6 mM Mg(OAc) 2, 50 mM KCl, 1.5 mM PEP, 0.2 mM NADH, 4 U PK, and 7 U LDH.
The disappearance of NADH (E340 = 6,220 M' l cm') was used to monitor activity, and the
reaction was initiated by the addition of PRA. For PPi vs. ATP studies, PPi was varied from 0 to
2.5 mM, ATP was varied from 13-250 jIM and PRA was 300 ~tM and glycine was 3 mM. In the
PPj vs. PRA studies, PPI varied from 0 to 2.5 mM, PRA from 25-100 gM and ATP was 250 ItM
and glycine was 3 mM. For the PPi vs. glycine studies, PP was varied from 0 to 2.5 mM,
glycine from 50-750 pM with ATP at 250 pM and PRA at 300 pIM. Global data analysis was
carried out using FisualEnzymics (Softzymics, Inc.) and IgorPro (Wavemetrics, Inc.) software.
Each data set was fit to Equations 2.4, 2.5, and 2.6, equations for competitive, uncompetitive,
and noncompetitive inhibition, respectively. Statistical analysis was carried out using the F test
to determine the appropriateness of the chosen inhibition model.
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v Vmax ISI (2.4)
KM(1+ K )+ [S]
v = Vmax [S] (2.5)
KM + [](1+ )
v = Vmad ISI (2.6)
I]) IKM(I+ss )+[S](1+ )K/
'(is K~ii
Removal of PP, Contamination from PRPP for Stopped-Flow Experiments
PPi contamination in the PRPP stocks was found to contribute to PurD background
fluorescence and was removed by pre-incubation with yeast inorganic pyrophosphatase (PPase)
at 25°C for 15 min before the addition of PurF. PPase (100 U, Sigma I-1891) was dissolved in
1 00 mM Tris pH 7.5, 10 mM MgCl 2 to a final concentration of 1 U/gL. It was then added at a
concentration of I U/pmol PRPP to all PRPP-containing buffer solutions used in fluorescence
studies.
Inactivation of PurF by DONfor Stopped-Flow Experiments
The reaction mixture contained in a final volume of 1 mL: 200 tM PurF, 2 mM PRPP,
10 mM DON, 10 mM MgCl 2, and 50 mM Tris HC1 pH 7.5. The mixture was incubated at 25°C,
and the progress of the inactivation was followed by removal of 5 gL aliquots which were
measured for activity using the spectrophotometric assay with PurD. Once the inactivation was
complete, the enzyme was dialyzed against 2 x 500 mL 10 mM Tris pH 8.0, 10 mM MgCl 2 in a
10 kDa MWCO Slide-A-Lyzer cassette (Pierce) at 4°C overnight. PurF was then assayed for
both glutamine-dependent and NH4 Cl-dependent activity.
Steady State Fluorescence of the [7A W]-PurF Mutants and [4FW]-PurD
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Steady state fluorescence spectra were obtained using a sensitivity-enhanced PTI
QuantaMaster-4 fluorimeter (Photon Technology International) with temperature regulation at
25°C using a Lauda water bath. Spectra were acquired using a constant volume (900 pL) in a 5
mm x 5 mm microcuvette (Starna). All spectra were background corrected using a buffer
solution containing all components except for enzyme. Spectra were obtained in 0.5 nm
increments at a rate of 0.4 s/nm. All slits were set to 4 nm, and typically 2 scans were averaged
during each experiment. The excitation wavelength was set to either 295, 300, or 310 nm
ldepending on the enzyme being studied, and emission was monitored between 320-420 nm.
Spectra were collected in 10 mM Tris, 10 mM MgCl 2, pH 8.0 at 25°C. Enzyme was added to a
final concentration of 2 tM. In the case of C S PurFs, glutamine and PRPP were also present at
20 mM and 1.5 mM, respectively.
General Stopped-Flow Fluorescence Methods
All stopped-flow experiments were carried out in SF buffer: 10 mM Tris pH 8.0 at 18°C
with 10 mM MgC12. Buffer components associated with each experiment are summarized in
Table 2.1. Data was collected on an Applied Photophysics SX. 18MV stopped-flow with a
measured dead time of -1.3 ms at 18°C. Samples were excited from a Xenon arc lamp source
passed through a monochrometer with slits set to 3 mm. Fluorescence was detected from a PMT
mounted directly onto the observation cell with the appropriate cutoff filter as described below.
Reaction temperature was controlled at 18°C with the use of a Lauda water bath. Data was
collected with oversampling and in-line filtering set to 200 is. The PMT voltage was set to 80%
77
Table 2.1: Stopped-Flow Experiments
Number Experiment Syringe Syringe 2 Syringe 3
1 PurFPRPP vs. Gln 10 jtM PurF, 40 mM Gln ....
3.0 mM PRPP
2 PurFoPRPP vs. Glna vs. 15 M PurF, 4.5 mM PRPP, 40 mM Gln 20 mM Gln
Buffer 4.5 U/mL PPase
3 PurF.PRPP vs. Gln 15 M PurF, 4.5 mM PRPP, 40 mM Gln 15 gM PurD,
vs. PurD 4.5 U/mL PPase 20 mM Gln
4 PurF vs. PurD 10 gM PurF 10 gM PurD ....
5 PurFoPRPP vs. PurD 10 AM PurF, 3.0 mM PRPP, 3 10 AM PurD 
U/mL PPase
6 PurFoPRPPGln 10 M C1S PurF, 3.0 mM 10 M PurD, 
vs. PurD PRPP, 3 U/mL PPase, 20 mM 20 mM Gln
Gin
7 PurFoPRPP*GTE h 10 AM DON-PurF, 10 jiM PurD ....
vs. PurD 3.0 mM PRPP,
3 U/mL PPase
PurF-GTE vs. PurD 10 AM DON-PurF 10 M PurD ....
"A 10 ms mixing time was used in all 3-syringe experiments. GTE = glutamyl thioester
intermediate. The covalent glutaminase inhibitor DON was used to mimic the GTE.
of maximum for each experiment in order to maximize sensitivity. The PMT voltage was reset
between experiments; thus, the absolute fluorescence intensities between different experiments
are not directly comparable and have all been arbitrarily set to 0 V unless stated otherwise. For
each experiment, data (1000 points) were collected between 0- s for the W290F/S345W and
W290F/F477W [7AW]-PurFs and 0-2 s for the A82W/W290F [7AW]-PurF. Data were also
collected in a split time base in which 500 data points were collected for the pre-steady state
periods described above and 500 data points were collected over the next 50-100 s to monitor
changes in the steady state. Data was collected such that the drive pressure was not removed
until after the pre-steady state data collection period had been completed. For each experiment,
2-5 kinetic traces were averaged. Data was analyzed using the SX. 18MV workstation software,
and the quality of the fit judged by the variance as well as the residuals plot.
Slopped-Flow Experiments of [7A W-PurF.PRPP Mutants vs. Glutamine for Determination of
Mixing Time for 3-Syringe Experiments with [4FW]-PurD
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Interactions between a pre-formed [7AW]-PurFPRPP complex and glutamine were
studied to examine changes in fluorescence upon glutamine binding and turnover and to
determine mixing times to be used in subsequent 3-syringe experiments with PurD. In a typical
experiment, 10 ItM [7AW]-PurF mutant was pre-mixed with 3.0 mM PRPP and placed into
syringe 1. This solution was then rapidly mixed with an equal volume (60 jtL) of 40 mM
glutamine in SF buffer from syringe 2 (Experiment 1, Table 2.1). Samples were excited at 300
nm and emission was monitored through a WG 335 nm cutoff filter (Applied Photophysics).
Kinetic traces from the A82W/W290F mutant exhibited fluorescence changes containing
3 distinct phases, and the data were fit to Equation 2.7. Biphasic kinetics were observed with the
W290F/S345W and W290F/F477W mutants, and the data were fit to Equation 2.8.
AFobt) = Ale-lt + A2ek2t + A3 e - k3t + C (2.7)
AFob(t) = Ale- k t + A 2e- k2t + C (2.8)
3-Syringe Stopped Flow Experiments to Detect Interactions between [7A W]-PurF.PRA mutants
and [4FW]-PurD
A 3-syringe set-up was used to detect interactions between [7AW]-PurF mutants and
[4FW]-PurD during PRA synthesis by monitoring 7AW fluorescence (Experiments 2 and 3,
Table 2.1). Syringe 1 contained 15 M [7AW]-PurF mutant and 4.5 mM PRPP. This solution
was then rapidly mixed against an equal volume (100 VtL) of 40 mM glutamine from syringe 2.
After 10 ms, this reaction mixture was then rapidly mixed with either 15 [tM [4FW]-PurD, 20
mM glutamine solution or 20 mM glutamine solution from syringe 3 (100 VtL). The final
concentrations were 5 M [7AW]-PurF mutant, 5 jIM [4FW]-PurD (if included), 1.5 mM PRPP,
and 20 mM glutamine in a volume of 300 [L. Samples were excited at 310 nm and emission
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monitored through a 345 nm cutoff filter (Applied Photophysics). The data were fit to Equations
2.7 and 2.8.
2-Syringe Stopped Flow Experiments to Detect Interactions between [7A W]-PurF mutants and
/4FWj-PurD during Mimics of Complexes Generated during PurF Catalysis
A summary of the experimental conditions is shown in Table 2.1 (Experiments 4-8). In a
typical experiment, active, DON-inactivated, or C1S mutant [7AW]-PurFs (10 tM) in the
presence or absence of PRPP (1.5 mM) and glutamine (20 mM) in syringe 1 were rapidly mixed
with an equal volume (-60 tL) of a 10 pM [4FW]-PurD solution from syringe 2. Emission was
monitored through a 345 nm cutoff filter (Applied Photophysics) using an excitation wavelength
of 310 nm.
Analytical Ultracentrifugation Studies on PurF to Determine the Relevance of the
(irystallographically-Observed Dimer to the Docking Model
Sedimentation velocity analytical ultracentrifugation (SV-AUC) and sedimentation
equilibrium analytical ultracentrifugation (SE-AUC) experiments were performed using an
Optima XL- analytical ultracentrifuge (Beckman Coulter, Fullerton, CA) at the Biophysical
Instrumentation Facility for the Study of Complex Macromolecular Systems (Department of
Chemistry, MIT). Sedimentation was monitored by scanning at 280 nm along the length of the
cell. Before each experiment, wt PurF was dialyzed against 10 mM Tris, 10 mM MgCl 2 pH 8.0
for 24 h in a 10 klI)a MWCO Slide-A-Lyzer cassette (Pierce) and subsequently diluted with the
dialysis buffer to the desired concentration. SEDNTERP software from Dr. John Philo was used
to calculate buffer density (0.99918 g/mL), viscosity (0.01002 Poise), and protein partial-specific
volume from the amino acid content (0.7341 mL/g) (9).
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SE-AUC experiments were performed at speeds of 6,400; 8,000; and 12,000 rpm with
PurF concentrations of 7, 14, 21, 29, and 36 pM over the course of 70 h. These experiments
were carried out using six-sector Epon centerpieces (110 tL sample volume) with quartz
windows in an An60Ti 4-hole rotor at 18°C. Equilibria were analyzed, and data were edited
using the program Winreedit (courtesy of Dr. David Yphantis, National Analytical
lJltracentrifugation Facility). Global data analysis to determine the number of species in solution
and their reduced apparent molecular weight () was carried out using WinNonLin ver. 1.06
software (courtesy of Dr. David Yphantis, National Analytical Ultracentrifugation Facility) in
which oc is equivalent to the change in protein concentration (c) versus radius (r) at equilibrium
(Equation 2.8). The molecular weight (MW) was determined from a using SEDNTERP and the
protein partial-specific volume (v), buffer density (p), and angular velocity () according to
Equation 2.8.
dln(c(r)) MW(1-vp)w (2.8)
d(r2 /2) RT
SV-AUC experiments were carried out at 35,000 rpm over 24 h with wt PurF at 18 M in
400 L using double-sector Epon centerpieces with quartz windows in an An60Ti 4-hole rotor at
18°C. In addition, SV-AUC was also carried out on samples of DON-inactivated wt PurF at 18
pM. The inactivation was carried out using procedures described above for the stopped-flow
experiments. Data (-100 traces for each experiment) were fit using Sedfit88 software from 1 to
20 S using a continuous distribution of sedimentation coefficients generated by Lamm equation
solutions (10).
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2.3 Results
While many techniques exist to study strong protein-protein interactions, relatively few
options exist to study transient interactions. Stopped-flow fluorescence spectroscopy with site-
specifically incorporated, environmentally-sensitive fluorophores offers the potential to study
these weak interactions in the pre-steady state by monitoring fluorescence changes or
fluorescence resonance energy transfer (FRET). The postulate that a PurFoPRA complex is the
clocking partner for PurD in the channeling model and the chemical lability of PRA made
stopped-flow fluorescence the method of choice. Initial experiments focused on site-specific
attachment of fluorescent probes to PurF and PurD (at Cys41 and Cys413, respectively) based on
the docking model, so that transient interactions could be monitored by FRET. However, this
approach was abandoned after difficulties were encountered with labeling procedures and
quantitative probe-attachment (data not shown).
Recent experiments by Zalkin and coworkers designed to monitor conformational
changes of PurF in the presence of substrates provided an alternative strategy. Zalkin
determined that the single tryptophan residue in PurF (W290) could be changed to a
phenylalanine with no effect on activity (6). His laboratory subsequently generated a variety of
single tryptophan mutants in the glutamine-binding loop (A82W/W290F), PRTase flexible loop
(W290F/S345W), and the C-terminal helix (W290F/F477W) (Figure 2.1) that were used in
stopped-flow fluorescence experiments to monitor conformational changes in PurF in the
presence of glutamine and PRPP (6). Since these regions constitute the protein:protein interface
in the PurF:PurD d(locking model (Figure 2. 1B), changes in the environments of these tryptophan
residues by monitoring fluorescence could provide a means to directly test this model.
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Detection of PurF Fluorescence Changes in the Presence of PurD Requires Incorporation of
[7A J'] into PurF and [4FW] into PurD
The PurF mutants contain a single, site-specifically positioned tryptophan, while PurD
contains 5 tryptophans. Initial studies with PurD and PurF rapidly revealed that PurD was much
more fluorescent than the PurF mutants (Figure 2.3A), which resulted in a high fluorescence
background. The second problem encountered was that PurD fluorescence was very sensitive to
environmental changes (pH, ionic strength, or PPi concentration). Small changes in PurF
fluorescence were completely masked by large changes in PurD fluorescence making this
approach intractable.
The solution to this problem came from the use of a dual labeling strategy involving the
biosynthetic incorporation of 7AW and 4FW into PurF and PurD, respectively. These analogs
(Figure 2.2) were chosen for their ability to quench PurD fluorescence (4FW has a quantum yield
of 0.001) and to red-shift PurF fluorescence away from normal tryptophan emission (7AW has a
fluorescence Xmax of 403 nm). Recent reports have shown successful biosynthetic incorporation
of these tryptophan analogs into a variety of proteins with a high degree of efficiency (>90%
incorporation) (11-20). The 5 tryptophans in PurD were globally replaced with non-fluorescent
4FW (see below for details). This incorporation dramatically reduced PurD's fluorescence as
shown in Figure 2.3B. The PurF mutant enzymes were then generated with the single
tryptophan replaced with 7AW, which can be excited specifically in the presence of tryptophan
at 310 nm, and its fluorescence monitored at >360 nm (21). Despite the low quantum yield
associated with 7AW (q = 0.016), fluorescence changes were readily detectable because stopped-
flow experiments described subsequently were designed to mimic the high concentrations of
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Figure 2.3-(A) Emission spectra ofW290F F477W PurF (dashed) and PurD (solid) containing
tryptophan. Each sample contains 2 11M protein and was excited at 295 nm. Emission was
monitored between 315-420 nm. (B) Emission spectra ofPurD (solid) and 4FW-substituted
PurD (dashed). Each sample contains 2 11M protein and was excited at 295 nm, and emission
was monitored between 310-400 nm. (C) Emission spectra of 7AW substituted W290F F477W
PurF (dashed) and 4FW substituted PurD (solid). Each sample contains 2 11M protein and was
excited at 310 nm. Emission was monitored between 325-420 nm. The fluorescence intensities
present on the y-axis in (A-C) are directly comparable.
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PurF and PurD found in vivo (2.3-40 M PurF, 2.6-20 M PurD) (22). By combining [7AW]-
PurF and [4FW]-PurD, even the most weakly fluorescent PurF enzyme (W290F F477W) proved
tlo be much more fluorescent than [4FW]-PurD (Figure 2.3C).
Biosynthesis of [7A W]-PurF and [4FW]-PurD
The Stubbe Laboratory has recently incorporated labeled tyrosines into E. coli
ribonucleotide reductase in high yield and efficiency (E. Artin, H. Nguyen, and J. Stubbe, in
preparation). The same strategy was employed to incorporate 4FW into PurD and 7AW into
PurF, while maintaining very high levels of protein expression (Figure 2.4A): 80-100 mg
PurD/L cell culture and 50-80 mg PurF mutant/L cell culture. Proteins were easily purified to
near homogeneity (Figure 2.5). Activities of the purified proteins relative to their wt
counterparts and ESI-MS analysis are reported in Tables 2.2-2.5. [7AW]- and [4FW]-analogs
appeared to have little effect on enzymatic activity when compared to their tryptophan
counterparts. The extent of 4FW incorporation into PurD was determined using ESI-MS (Figure
2.4B). The data show that the predominant protein in solution is [4FW]-PurD containing five
4FWs (MW = 46,030 Da), while only a small contamination of PurD is observed (MW = 45,941
Da).
The 7AW incorporation into PurF cannot be monitored by ESI-MS due to the small
increase in molecular weight (1 Da). Analysis of 7AW incorporation by deconvolution of the
absorption spectra in an enzyme as large as PurF (which contains 17 tyrosines and 22
phenylalanines) is difficult, and this method is prone to large errors even in small proteins (7, 23,
24). As has previously been demonstrated with 7AW incorporation into mannitol permease (23),
high incorporation levels of 7AW into PurF were expected based on a red-shift in the excitation
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Figure 2.4-{A) 12% SDS-PAGE ofBL21(DE3) cells transformed with either pET-PurD or
pET-PurF (W290F/F477W) after 4 h of IPTG induction during expression of 4FW-Iabeled PurD
and 7AW-Iabeled PurF. (B) De-convoluted ESI-MS of [4FW]-PurD. Peak 1, MW = 45,941.0
Da corresponds to contaminating WT PurD, Peak 2, MW = 46030.0 Da corresponds to the fully
labeled [4FW]-PurD. Peak 3, MW = 46110.0 Da corresponds to the fully labeled [4FW]-PurD
with 2 additional K+ ions from the enzyme storage buffer.
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Figure 2.5-12% SDS-PAGE of [4FW]-PurD and [7AW]-PurF mutants show the purity of the
enzymes used in these studies. Lanes 1 and 3: Bio-Rad Precision MW markers, Lane 2: [4FW]-
PurD, Lane 4: W290F PurF, Lane 5: A82W/W290F [7AW]-PurF, Lane 6: W290F/S345W
[7AW]-PurF, Lane 7: W290F/F477W [7AW]-PurF. -3-5 ~g of protein was loaded into each
lane.
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Table 2.2: Activities of Trp and 7AW-labeled PurF Mutants
Specific Activity
Specific Activity 7AW-Enzyme Km(PRPP) Km (Gln)
PurF Mutant Trp-Enzyme (U/mg)a (U/mg)a [tMb ItMb
W290F PurF 5.9C 5.9C 31 647
A82W/W290F PurF 0.42 0.56 49 616
W290F/S345W PurF 2.3 3.3 52 5901
W290F/F477W PurF 4.2 5.8 41 702
aActivity determined by monitoring glutamine-dependent PRA synthesis with PurD at
18°C and pH 8.0 bKm values are for the 7AW-labeled enzymes only c This enzyme
contains no tryptophans and is presented for comparison to the double mutant enzymes.
Table 2.3: Activities of Glutaminase-Inactivated 7AW PurF Mutants
Gln-PRA Specific Activity NH3-PRA Specific Activity
Inactivated 7AW PurF Mutanta (U/mg)b (U/mg)C
C S/A82W/W290F NDa 0.92
A82W/W290F-DON 0.21e 1.3
C1S/W290F/S345W ND 7.0
W290F/S345W-DON ND 2.2
CI S/W290F/F477W ND 24.0
W290F/F477W-DON ND 9.1
aThe glutaminase site was inactivated by either a C 1 S mutation or by alkylation with DON.
bActivity determined by monitoring glutamine-dependent PRA synthesis with PurD at 18°C and
pH 8.0 c Activity determined by monitoring NH 4Cl-dependent PRA synthesis with PurD at 18°C
and pH 8.0 No activity could be detected above the background. eThis enzyme could not be
fully-inactivated with DON.
Table 2.4: Kinetic Parameters for WT and 4FW-labeled PurDs
PurD Specific Activity (U/mg)a Km(PRA) M Km(ATP) JaM Km(Gly) tM
WT 42.5 98 170C 270C
4FW 35.5 102 47 229
aSpecific activity determined at pH 8.0 and 18°C as previously described (8).
bValues from (2) CValues from (8).
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Table 2.5: ESI-MS Results for the Purified Enzymes
Enzyme Predicted MW (Da) Observed MW (Da)
4FW PurD 46,030.3 46,030.0
W290F PurF 56,317.8 56,314.0
7AW A82W/W290F PurF 56,433.9 56,433.0
7AW C S/A82W/W290F PurF 56,417.9 56,424.0
7AW W290F/S345W PurF 56,417.9 56,415.0
7AW Ci S/W290F/S345W PurF 56,401.9 56,409.0
7AW W290F/F477W PurF 56,357.8 56,357.0
7AW Cl S/W290F/F477W PurF 56,341.8 56,348.0
spectrum and the observation of a shoulder between 290-320 nm (Figure 2.6A). This shoulder
was observed independently of monitoring emission at either 350 or 380 nm, indicating that the
observed fluorescence is due entirely to 7AW (Figure 2.6B).
[7A W]-PurF Mulants and [4FW]-PurD Exhibit Channeling Behavior
In order to use [7AW]-PurF mutants to study channeling interactions with PurD, the
W290F 7AW substitutions as well as the mutations themselves must not interfere with the
channeling process. Thus, as a prelude to the stopped-flow fluorescence experiments, each
protein was characterized individually and each [7AW]-PurF mutant:[4FW]-PurD pair was
shown to exhibit channeling behavior despite the substitutions. [4FW]-PurD was shown to have
Km(PRA) = 102 + 22 pM and Vmax = 35.5 + 5.3 U/mg (2 determinations, Figure 2.7), similar to the
wt PurD values under identical conditions (Km(pRA)= 98 + 12 M, Vmax = 42.5 + 2.5 U/mg) (2).
The specific activities and the Km values for PRPP and glutamine for all of the 7AW PurF
mutants were determined and are shown in Table 2.2. The A82W mutation, similar to previous
results by Zalkin, has 10-fold lower activity compared to the other mutants,
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Figure 2.6-Evidence for 7AW incorporation into W290F/F477W PurF. (A) Excitation spectra
collected between 260-320 nm while monitoring emission at 380 nm for tryptophan (solid line)
and 7AW-labeled (dotted line) PurFs. The red-shift in the excitation spectra and the shoulder
between 290-320 nm indicates high levels of 7AW incorporation. (B) The shoulder peak can
easily be seen by subtraction of the tryptophan excitation spectrum from the 7AW excitation
spectrum. This shoulder is present if the emission is monitored at 350 (solid line) or 380 nm
(dotted line), which indicates that the observed fluorescence is due primarily 7AW.
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while the S345W mutant has an increased Km for glutamine. The remaining parameters are
similar to those observed for W290F PurF.
Channeling assays were performed as previously described using VI = 10.5 gM PRA/min
and V2 = 17 tM GAR/min (2). As shown in Figure 2.8, by the criteria of no predicted lag phase,
all the 7AW PurF mutants appear to channel PRA in the presence of [4FW]- PurD. At extended
times, the rates of the S345W and F477W mutants reach the predicted steady-state rates for GAR
formation. Thus, these mutations and the tryptophan substitutions do not appear to disrupt the
proposed transient PurF:PurD interactions. The A82W/W290F mutant consistently showed a
higher rate of GAR formation in channeling assays with [4FW]-PurD than the other mutants.
Due to its low activity, -lOx more A82W/W290F PurF was added to the assay solution to
maintain a rate of PRA synthesis of 10.5 [tM/min compared to wt PurF and other mutants.
Previously, channeling between wt PurF and PurD has been shown to possess a dependence on
the protein concentration, with increased PRA channeling at higher enzyme concentrations (22).
This provides support for the importance of protein:protein interactions in PRA transfer. The
enhanced amount of GAR formed with the A82W/W290F mutant could be related to the higher
concentration of PurF present in the assays, a possible indicator of PurF:PurD complex
formation.
[7A W]-PurF Mutants Fluorescence Changes Can Be Monitored at > 360 nm
Given that all of the 7AW PurF mutants appear to channel PRA with [4FW]-PurD, the
7AW fluorescence must next be characterized in the steady state in order to determine excitation
wavelengths and emission filters for use in stopped-flow experiments. In these experiments, C S
[7AW]-PurFs were used in which the catalytic cysteine in the glutaminase active site was
mutated to a serine in order to prevent glutamine hydrolysis. As previously shown by Zalkin
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Figure 2.7-Kinetic Parameters for [4FW]-PurD. Data was fit to a model for substrate
inhibition (Equation 2.2). For [4FW]-PurD, Km= 102:t 22 flM (a/~), Vmax = 35.5 flM:t 5.3
U/mg, and Kj = 210 flM:t 55 flM.
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Figure 2.8-Channeling assays of the [7AW]-PurF mutants with [4FW]-PurD using VI = 10.5
!LM PRA/min and V2 = 17 M GAR/min. () = A82W/W290F PurF. () = W290F/S345W
PurF, () = W290F/F477W PurF. Solid lines represent the best linear fit for each data set. The
dashed line represents modeled, diffusion kinetics based on kinetic properties determined for the
enzymes (Tables 2.2 and 2.4). W290F/S345W and W290F/F477W PurF display channeling
behavior identical to what has previously been observed between wt PurF and wt PurD.
A82W/W290F shows an enhanced rate of GAR synthesis.
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with the tryptophan-containing PurF mutants, the C S PurFs can bind PRPP and glutamine
without substrate turnover (6). C S/A82W/W290F and C1 S/W290F/S345W PurFs exhibit
fluorescence changes in response to PRPP- and PRPP- and glutamine-binding similar to those
previously described by Zalkin, albeit with a 20-30 nm red shift in the observed fluorescence due
to 7AW incorporation (Figure 2.9). Interestingly, Cl S/W290F/F477W [7AW]-PurF showed a
decrease in fluorescence in the presence of PRPP and PRPP/glutamine. In the corresponding
tryptophan-containing mutant, fluorescence increases were observed (6). These steady state
experiments indicate that [7AW]-PurF fluorescence can be monitored for all the mutants at >
360 nm with excitation at 310 nm, well removed from normal excitation and emission
wavelengths for tryptophan.
[7A W]-PurF Mutants Rapidly Bind Glutamine at 18°C
In order to design stopped-flow experiments to test for interactions between [7AW]-
PurFs and [4FW]-PurD during PRA synthesis, fluorescence changes associated with glutamine
binding to a [7AW]-PurF-PRPP complex followed by enzyme turnover in the absence of PurD
were first characterized in the pre-steady state. These experiments were modeled after those
carried out by Zalkin using inactive C S PurFs to monitor PRPP and glutamine binding in the
pre-steady state by monitoring tryptophan fluorescence (6).
Steady state fluorescence emission and quenching studies by Zalkin with glutamine,
PRPP, and PRPP followed by addition of glutamine to C 1S-PurF mutants support an ordered
addition of substrates to PurF: PRPP followed by glutamine (6). These results are consistent
with steady state experiments carried out using the [7AW]-PurF mutants in which no change in
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Figure 2.9-Changes in CIS [7AW]-PurF mutant fluorescence upon binding PRPP and
Glutamine. Each sample contains 10mM Tris pH 8.0, 10 mM MgCh, and 211M of the
respective CIS W290F PurF mutant Red = apo enzyme. Blue = enzyme + 1.5 mM PRPP.
Green = enzyme + 1.5 mM PRPP + 20 mM L-gln. The fluorescence intensities on the y-axis in
A, B, and C are directly comparable.
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fluorescence was observed upon addition of glutamine in the absence of PRPP (data not shown).
Kinetic studies further supported an ordered addition as PRPP lowers the Km for glutamine 100-
fold and increased kcat 3-fold (6). By monitoring movement of the PRTase flexible loop with the
S345W reporter, Zalkin used stopped-flow tryptophan fluorescence to show that PRPP binds in a
rapid, reversible ashion (Ki = 88 M) followed by a slow isomerization (43 s- l) (6). This latter
step is proposed to place PurFoPRPP in a conformation to enhance glutamine binding.
Zalkin used a similar approach to study glutamine binding to the PurFoPRPP complex.
I-le demonstrated that glutamine induces conformational changes in all of the PurF mobile
regions: the glutamine-binding loop, the PRTase flexible loop, and the C-terminal helix (6).
Zalkin further used stopped-flow tryptophan fluorescence and PRTase flexible loop (S345W)
and C-terminal helix (F477W) reporter PurFs to measure glutamine binding. Results from the C-
terminal helix reporter with changing glutamine concentrations are consistent with a 2-step
mechanism of glutamine-binding involving rapid, reversible formation of the PurF.PRPP-Gln
ternary complex followed by a slower enzyme isomerization which gives rise to the observed
fluorescence changes. While the rate of ternary complex formation could not be determined from
this data, the isomerization step was fit to a rate constant of 220 s under saturating glutamine
conditions (6). These studies, in addition to similar studies with S345W PurF suggest that
glutamine-binding is accompanied by rapid conformational changes that convert PurF to an
"active" form capable of glutamine-hydrolysis and PRA synthesis (6).
Since the goal of experiments in this chapter is to test for interactions between [7AW]-
PurFs and [4FW]-PurD during PRA synthesis, initial experiments were patterned after those
described above by Zalkin using active, [7AW]-PurFs. In this case, the observed fluorescence
changes are reporting on conformational changes related to both binding and catalysis. In a
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typical experiment, a [7AW]-PurFoPRPP complex was pre-mixed and placed into syringe 1. The
contents of this syringe were then rapidly mixed with a saturating concentration of glutamine
from syringe 2 and changes in fluorescence were monitored for each [7AW]-PurF mutant.
In agreement with Zalkin's findings with tryptophan mutants, multi-phase changes in
fluorescence were observed with each PurF mutant upon mixing with glutamine (Figure 2.1 OA-
C). For the glutamine-binding loop reporter (A82W/W290F, Figure 2.10 A), data were fit to
three distinct exponentials (Equation 2.7, Table 2.6). The rate of the first phase was 235.5 s and
was found to be dependent on the concentration of glutamine (Figure 2.11). It is assumed that
this change is due to initial closure of the glutamine-binding loop accompanying ternary complex
formation. The two slower phases occurred with rate constants of 23.9 and 2.9 s', both of
which are faster than the steady state turnover of 0.53 s- for this mutant. Neither of these rate
constants can be attributed to a specific conformational or catalytic event.
Changes in fluorescence for reporters on the PRTase flexible loop (S345W) and the C-
terminal helix (F477W) gave results that were fit to two exponentials (Figure 2.10, Table 2.6).
With both the W290F/S345W and W290F/F477W [7AW]-PurFs, a rapid phase (175.9 and 122.0
s' l, respectively) was followed by a slower phase (14.5 and 5.5 s'). It is possible that the fast
phase observed with each mutant represents a similar fluorescence change to that characterized
by Zalkin studying glutamine binding to the corresponding inactive C S PurFoPRPP complexes.
The slow change observed with the W290F/S345W [7AW]-PurF during turnover of 14.5 s is
still faster than the steady state turnover of 3.1 s l. In contrast, the slow phase with the C-
terminal helix reporter (W290F/F477W) was very similar to the observed steady state turnover
(both 5.5 s-l). The changes in C-terminal helix fluorescence may thus be reporting on a rate-
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Figure 2.10-Fluorescence changes upon mixing [7AW]-PurFePRPP with GIn (Experiment 1,
Table 2.1). Shown in blue are the fits to the data as described in Table 2.6. In (A) and (B) data
was collected with 500 data points between 0 ~ 0.2 s and 500 data points between 0.2 ~ 2 s for
(A) and 0.2 ~ 1 s for (B). In (C) data was collected with 500 data points between 0 ~ 0.1 s and
500 data points between 0.1 ~ 1 s. The dead time is shown on the expanded regions shown in
each trace. The rapid increase in fluorescence observed in (C) was found to occur largely within
the instrument dead time, and was therefore not included in the data analysis.
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Figure 2.11-The effect of glutamine concentration on the rate of the first phase of the
fluorescence changes observed upon mixing A82W/W290F [7AW]-PurFoPRPP in syringe 1 with
varying concentrations of glutamine in syringe 2 (Figure 2.1 OA).
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limiting step. The results from studies on changes with [7AW]-PurF mutant fluorescence
during PRA synthesis are complex and indicate that multiple conformational changes are
occurring in the enzyme after ternary complex formation; however, without knowledge of the
pre-steady state rate of PRA formation and release, one cannot assign these changes to either a
specific chemical or conformational step.
Table 2.6: Calculated Fits for 7AW PurFoPRPP vs. Gln Stopped Flow Experiments
Enzyme A1 kl (s') A2 k2 (1) A3 k3 (s 1) Variance
A82W W290Fa -0.176 + 0.005 235.5 + 14.1 -0.195 + 0.003 23.9 +0.7 -0.325 + 0.002 2.9+0.1 4.02 x 10-
NV290F S345W b -0.395 + 0.003 174.3 + 3.0 -0.518 + 0.002 14.5 + 0.1 3.41 x 10-5
W290F F477Wh 0.070 + 0.002 122.0 + 4.4 0.036 + 0.001 5.5 +0.3 9.14 x 10-6
aFit to Equation 2.7 from t = 0.002-2 s. hFit to Equation 2.8 from t = 0.002-1 s. CFit to Equation 2.8 from t = 0.002-1 s.
Removal of PP Contamination from PRPP Stocks Prior to Stopped-Flow Fluorescence
Experiments due to Interference with PurD
The above experiments set the stage for designing experiments to look for interactions
between the [7AW]-PurF mutants and [4FW]-PurD. During preliminary experiments to look at
this interaction, variable changes in fluorescence were observed upon addition of PurD.
Systematic analysis revealed that rapid mixing of PRPP and PurD resulted in small changes in
PurD background fluorescence (Figure 2.12A). Further investigation revealed that PPi, a product
of PRPP breakdown, was responsible for these observations. These changes could potentially
mask fluorescence changes associated with PurF:PurD interactions in the pre-steady state.
Therefore, a method to remove PP1 from the PRPP stock solutions using yeast inorganic
pyrophosphatase (PPase) was developed. Addition of PPase (2 ptg/mL) completely removed
the background fluorescence, did not interfere with [7AW]-PurF mutant fluorescence, and did
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Figure 2.12-PurD background fluorescence due to PPj contamination of PRPP solutions and
removal ofPPj with PPase. (A) [4FW]-PurD (Syringe 1) was rapidly mixed with PRPP (3.0
mM, Syringe 2). (B) The same experiment as in (A) except that the PRPP had been pre-
incubated with yeast PPase to destroy contaminating PPj.
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Figure 2.13-Inhibition of [4FW]-PurD by PPjwith respect to [ATP]. PPj concentrations are 0
(blue), 0.5 (red), 1 (green), 1.5 (pink), and 2.5 mM (brown). The best fit was obtained from a
competitive model, Kjs = 1.04 ! 0.06 mM, Km = 30 :!: 1 J-lM,leeat= 21.5 :!: 0.2 U/mg.
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Figure 2.14-Inhibition of [4FW]-PurD by PPj with respect to [PRA]. PPj concentrations are 0
(blue), 0.5 (red), 1 (green), 1.5 (pink), and 2.5 mM (brown). The best fit was obtained from a
uncompetitive model, Kjj= 6.7 i:0.7 mM, Km= 11.8 i: 1.5 JiM, kcat = 21.3 i:0.6 U/mg.
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Figure 2.1S-Inhibition of [4FW]-PurD by PPi with respect to [Gly]. PPi concentrations are 0
(blue), 0.5 (red), 1 (green), 1.5 (pink), and 2.5 mM (brown). The statistically relevant (by the F
test) fit was obtained from a competitive model (A), Kis= 0.72 :t 0.12 mM, Km = 0.18 :t 0.03
mM, kat = 27.7:t 1.8. The data could also be fit to a noncompetitive model (B), Kis= 0.81 :t
0.23 mM, Kii= 20:t 39 mM, Km= 0.18 :t 0.04 mM, kcat = 28.3 :t 2.3 U/mg.
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not consume PRPP (Figure 2.12B). PRPP solutions used in stopped-flow experiments described
subsequently always contained PPase.
Efforts to determine the basis of the PPi interaction with PurD were not successful. Not
surprisingly based on prior inhibition studies with PurD, PPi was found to be a competitive
inhibitor of ATP, either a noncompetitive or competitive inhibitor with glycine, and an
uncompetitive inhibitor of PRA with [4FW]-PurD (Figures 2.13-15). However, the inhibition
constants were all in the mM range (Figures 2.13-15). The amount of PP contamination in
PRPP stock solutions (3%) would only give rise to a 50-100 !tM contamination in a typical
stopped-flow experiment. Thus, it is unlikely that the fluorescence background associated with
PPi results from its binding to the PurD active site. Its removal, however. was essential for
stopped-flow experiments described subsequently.
NAo Detectable Interaction between [7A W]-PurF Mutants and [4FW]-PurD During PRA
Synthesis as Monitored by Stopped-Flow Fluorescence
As previously described, 2-syringe stopped-flow fluorescence experiments of [7AW]-
PurF-PRPP versus glutamine report on conformational changes or chemistry within the enzyme
and are not informative about the pre-steady state rate of PRA formation or dissociation. Due to
the chemical instability of both PRPP and PRA, these values cannot be easily obtained by rapid
chemical quench methods. Chemical instability also complicates determination of the Kd for the
PurF.PRA complex. The inability to form a known concentration of PurF-PRA at defined times
after glutamine mixing with PurF-PRPP unfortunately limits how experiments can be carried out
to test for interactions between [4FW]-PurD and a [7AW]-PurF.PRA complex.
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Based on 2-syringe experiments of A82W/W290F [7AW]-PurF.PRPP against glutamine,
it is assumed that ternary complex formation is fast and leads to a conformational change
involving closure of the glutamine-binding loop with a rate constant of 235.5 s- . A further
assumption is that PRA formation occurs sometime after this observable change in fluorescence.
Based on these assumptions, a [7AW]-PurF.PRPPoGln ternary complex with a closed glutamine-
binding loop can be exposed to [4FW]-PurD, and fluorescence changes can be monitored.
While this experiment probes fluorescence changes accompanying PRA synthesis and [7AW]-
P'urF conformational changes, it is unclear when and how much [7AW]-PurF.PRA complex is
present in the pre-steady state.
The ternary complex was formed using 3-syringe stopped flow methods. [7AW]-PurF
and PRPP were first mixed and placed into syringe 1 to form the [7AW]-PurFoPRPP complex
necessary for glutamine binding. This solution was then mixed with glutamine from syringe 2 to
form the [7AW]-PurFPRPPoGln ternary complex. Based on the assumption that the fast change
(235.5 s') in fluorescence observed with the A82W/W290F [7AW]-PurF mutant is due to
glutamine-binding loop closure, a mixing time of 10 ms should allow closure of this loop. This
complex was then mixed with [4FW]-PurD from syringe 3 and changes in fluorescence during
PRA synthesis were monitored. By comparing results from experiments in which syringe 3
contains either [4FW]-PurD or buffer, changes in fluorescence due to the presence of [4FW]-
PurD can be identified and interpreted as evidence for a protein interaction during PRA
synthesis.
As shown in Figure 2.16 and Table 2.7, the presence of [4FW]-PurD in syringe 3 made
no difference to the observed changes in fluorescence compared to experiments in which syringe
3 contained only buffer. The measured rate constants for the A82W/W290F and W290F/S345W
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Figure 2.16-3 syringe experiments to detect interactions between [7A W]-PurF Mutants and
[4FW]-PurD during PRA synthesis. Syringe contents are described in Table 2.1, Experiments 2
and 3. Solutions from syringe 1 (PurFePRPP) and 2 (Glutamine) were aged for 10 ms before
being mixed with syringe 3 and data collection. Syringe 3 contained either buffer or [4FW]-
PurD. Only in the experiment shown in (B) are the changes in fluorescence directly comparable
between samples containing buffer and [4FW]-PurD. In all other cases, the addition of
fluorescence from [4FW]-PurD necessitated re-zeroing of the PMT detector between samples.
Data has been offset for clarity.
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Figure 2.17-Expansion of data from A82W1W290F and W290F/S345W [7AW]-PurFs from
Figure 2.16 showing the fits to the data (blue lines). The titted rate constants (Table 2.7) are
similar between the 2-syringe and 3-syringe experiments, independent of the presence of [4FW]-
PurD.
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[7AW]-PurF changes in fluorescence were similar between the 2-syringe and 3-syringe
experiments (Figure 2.17 and Tables 2.6 and 2.7). These results indicate that the 3-syringe
experiments with a 10 ms mixing time are successfully reproducing data obtained from 2 syringe
experiments of [7AW]-PurF.PRPP versus glutamine. For the W290F/F477W [7AW]-PurF,
increased noise from the 3-syringe experiment led to difficulty in fitting the fast kinetic phase;
however, it is clear that the presence of [4FW]-PurD does not significantly alter the observed
fluorescence changes compared to experiments carried out with buffer (Figure 2.16). Results
firom the 3-syringe experiments indicate that [4FW]-PurD is not interacting with any of the
[7AW]-PurFs in a detectable manner during PRA synthesis.
Table 2.7: Calculated Fits 3 Syringe Stopped Flow Experiments of 7AW PurFoPRPP vs. Gln vs.
4FW PurD or Buffera
Enzyme A1 kl (s' l) A2 k2 (s') Variance
A82W W290F/Bufferb -0.055 + 0.006 26.6 + 5.9 -0.397 + 0.004 2.7 + 0.1 3.57 x 10-5
A82W W290F/PurD' -0.034 + 0.018 19.1 + 11.0 -0.329 + 0.006 2.8 + 0.5 2.66 x 10-5
W290F S345W/Bufferh -0.105 + 0.011 179.7 + 32 -0.394 + 0.005 13.6 + 0.2 4.68 x 10 5
W290F S345W/PurD b -0.094 + 0.011 139.7 + 29 -0.426 + 0.006 12.6 + 0.2 6.22 x 10-5
W290F F477W/Bufferc 0.072 + 0.008 11.0 + 1.1 0.015 + 0.007 4.1 + 1.3 1.10 10-4
W290F F477W/PurDc 0.053 + 0.001 15.2 + 0.3 -0.001+ 0.001 2.5 + 2.8 7.97 x 10-5
a In all cases data was best fit to Equation 2.8 Fit from t = 0.002-0.5 s. CFit from t = 0.002-1 s.
Mimics of Reactive Intermediates of [7A W-PurF Mutants Reveal No Interactions with [4FW]-
PurD by Stopped-Flow Fluorescence
Since the .3-syringe experiments failed to detect any interactions during PRA synthesis,
the possibility was examined that specific [7AW]-PurF-substrate or glutamylthioester complexes
could be recognized by [4FW]-PurD. The stopped-flow experiments were designed based on a
simplified reaction for PurF shown in Scheme 2.2. As noted above, while Zalkin and
coworkers have studied PRPP and glutamine binding to PurF in detail, little is known about the
PurF reaction after ternary complex formation. PurF mechanistic studies have been complicated
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PurF + PRPP PurFPRPP ,PurF'PRPP + Gin
PurFPRPPGLN kchem PurF'PRPP'IGLN - .-
PijrF'PRA'GTF /
PurFGTE
9 PurF
GTE = covalent PurF-glutamylthioester
Scheme 2.2-Hypothetical PurF reaction pathway.
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by several factors including the irreversibility of the reaction and the instability of both PRPP
and PRA. Nevertheless, the hypothetical pathway shown in Scheme 2.2 served as a guide to
experimental design. After fast ternary complex formation, a chemical step occurs that leads to
bformation of PRA and PPi in one active site (abbreviated as just PRA) and a glutamyl-thioester
intermediate (GTE) in the glutaminase domain. Nothing is known about the order of release of
products and two possibilities are shown.
Stopped flow methods were used to examine PurD interactions with chemically inert
analogs of various PurF complexes shown in Scheme 2.2. The experiments carried out are listed
in Table 2.1, numbers 4-8. Initially, [4FW]-PurD interactions with [7AW]-PurF alone were
tested (Figure 2.18A). The evidence for an interaction would be a kinetically competent and
reproducible change in fluorescence that could be observed above the experimental noise. As
expected from previous attempts to measure steady state fluorescence changes, no interaction
was observed. In a second set of experiments interactions between PurD and PurF saturated with
PRPP were examined. As shown in Figure 2.1 8B, no interaction was observed in this case
either. Interactions between the PurFoPRPP*Gln ternary complex and PurD were tested using
inactive C 1 S PurF mutants which have been previously shown to bind substrates but not turnover
(). Again, no change in fluorescence was observed with any mutant (Figure 2.18C).
With the use of the mechanism-based inhibitor DON, several states of PurF containing a
stable analog of the GTE can be probed. First, each PurF mutant was inactivated with DON until
no detectable glutamine-dependent activity remained. Unreacted DON and PRPP were then
removed by dialysis, after which the enzymes were assayed for NH4 Cl-dependent PRA synthesis
(Table 2.3). While this inactivation with 10 mM DON and the W290F/S345W and
W290F/F477W mutant PurFs was readily accomplished, the A82W/W290F PurF could not be
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with [4FW]-PurD at various stages of
the PurF reaction pathway. Data has been offset for clarity. (A) PurF vs. PurD (Table 2.1,
Experiment 4) (B) PurFPRPP vs. PurD (Table 2.1, Experiment 5) (C) PurFPRPPGln vs. PurD
(Table 2.1, Experiment 6) (D) PurFoPRPPGTE vs. PurD (Table 2.1, Experiment 7) (E)
PurF°GTE vs. PurD (Table 2.1, Experiment 8). No changes in fluorescence were observed for
any [7AW]-PurF enzyme under any condition.
112
A
0
CU)
8
0
U. - .-- ._.._ l ..
t 1 1
completely inactivated. DON appeared to rapidly inactivate -50-60% of PurF within 15 min,
after which no further inactivation was observed. Increasing the inactivation time, raising the
temperature to 37°C, adding additional PRPP, or increasing DON concentrations up to 50 mM
did not cause any further inactivation. Similar results were observed with the inhibitors
azaserine and acivicin, with slightly lower levels of inactivation (data not shown). Thus,
experiments with the A82W/W290F contain a mixture of active and DON-inactivated enzyme.
Whether or not this observation is related to the enzyme's low specific activity or increased
channeling behavior is unknown.
The DON-inactivated [7AW]-PurF mutants were saturated with PRPP, which mimics a
hypothetical state in PurF in which NH3 has been released from glutamine in the glutaminase
domain but has not yet been incorporated into PRPP. Importantly, this state also comes closest
to mimicking the crystal structure of DON-inactivated PurF bound to cPRPP upon which the
docking model was based (3). As shown in Figure 2.18D, no interaction between [7AW]-PurF
mutants and [4FW]-PurD was observed.
The final experiment was designed to mimic the PurFoGTE. This was performed using
DON-inactivated PurF in the absence of PRPP. Again, no change in fluorescence was observed
(Figure 2.18E). Together with the 3-syringe experiments, interactions between [7AW] PurFs
and [4FW] PurD could not be detected using any of the stopped-flow methods described in this
chapter.
Analytical Ultracentrifugation Studies on PurF Provide Evidence for the Use of PurF Trimers or
Tetramers in Future Docking Models with PurD
The proposed docking model of PurF and PurD was based on a dimer of PurF interacting
with a monomer of PurD in a shape and charge complimentary fashion (5). This model depends
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on the ability to predict interactions between protein surfaces, an essential step of which is the
use of a closed, PurF dimer crystal structure. The crystal structure of PurF (Figure 2.1 B) was
obtained by co-crystallizing DON-inactivated PurF with a carbocyclic PRPP analog (cPRPP) (3).
Since this structure contains neither the natural substrate nor an actual glutamylthioester, the
structure likely represents a subtle variation of the catalytically active form. In addition, over the
years there has been extensive debate about the quaternary structure of PurF. Dimers (MW
112,714 Da), trimers (MW 169,071 Da), and tetramers (MW 225,248 Da) have all been reported
using gel filtration chromatography, analytical ultracentrifugation, and chemical cross-linking
methods of analysis (2-4, 25). The quaternary structure could have important implications in any
docking model and, thus, preliminary SE- and SV-AUC studies were carried out to resolve this
issue.
SE-AUC was carried out in Tris buffer at 3 speeds using PurF concentrations ranging
from 7-36 ItM (Figure 2.19). The choice of buffer and temperature (18°C) was designed to
mimic conditions present in channeling assays and stopped-flow experiments. Global data
analysis revealed that only a single species was present in solution. This species was determined
to have a MW of 194,752 + 8,000 Da, which was obtained directly from the reduced MW
(0.97259 at 6,400 rpm). This is in good agreement with data obtained by Zalkin for the enzyme
in phosphate buffer with 1 mM glutamine at 2.5°C (194,000 Da) (25). Unfortunately, the data
do not clearly define a specific PurF species. The MW data obtained by SE-AUC is closest to a
PurF trimer, although there is still a 25,000 MW difference. Based on the available crystal
structures of PurF, it is unclear what structure a trimeric species would possess.
Intriguingly, slightly different results were obtained by SV-AUC using either the wt or a
DON-inactivated enzyme (Figure 2.20). The active PurF enzyme sedimented with an observed
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Figure 2.19--Analysis ofPurF quaternary structure by SE-AUC. Each data set shows the
change in concentration (y-axis) ofPurF versus the square of the radial distance (x-axis) at
equilibrium. (A) Data from 36 JIM PurF at 6,400 (black), 8,000 (red), and 12,000 (green) rpm.
(B) Data from 7 JIM PurF at 6,400 (dark blue), 8,000 (red), and 12,000 (light blue) rpm. The
best-fit lines obtained by global data analysis using WinNonLin software are shown with each
data set.
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Figure 2.20-Results from SV-AUC experiments to determine PurF quaternary structure. The
solid lines indicate data for active PurF (observed MW = 203, 120 Da), while the dashed line
shows results for DON-inactivated PurF (observed MW = 166, 450 Da).
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MW of 203,120 Da, which is closest to the PurF tetramer MW. However, the DON-inactivated
enzyme sedimented as a 166,450 Da species, very close to the PurF trimer MW (Figure 2.20).
The possibilities that a structurally-uncharacterized PurF trimer may be the active species in
solution and that PurF quaternary structure may change during catalysis complicate any future
proposed docking models between PurF and PurD.
2.4 Discussion
Kinetic analysis of GAR formation from PRPP using both PurF and PurD in solution has
provided compelling evidence for channeling of PRA between enzyme active sites (2). Kinetic
modeling based on the steady state parameters of PurF and PurD can be used to predict the rate
of GAR formation with defined amounts of each enzyme with saturating substrates. In typical
sets of experiments where a lag phase in GAR formation was predicted to preceed the steady-
state rate, no lag phase was detected, that is the GAR produced exceeded predictions made by
modeling the free diffusion kinetics (2). The kinetic analysis is robust and even modeling with
experimental errors of 20% for PurF and PurD activities, the Km for PRA, and the rate of PRA
decomposition cannot account for the observed rate of GAR formation (2).
Considerable effort was made to show evidence for a PurF:PurD complex to provide
further support for a channeling model in vitro and in vivo-all without success (2). A model
was thus formulated that PurD interacts transiently with a PurFoPRA product complex. The
presence of PRA is postulated to alter the PurF surface to maximize interactions with PurD and
form a transient channeling complex.
Evidence that small molecules can alter weak protein interactions is provided in Chapter
3. The PurS, PurQ, and small PurL proteins from B. subtilis catalyze formation of
formylglycinamidine ribonucleotide (FGAM) during the fourth step of purine biosynthesis, but
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can only form an isolatable complex in the presence of Mg2+-ADP (which acts as a structural
cofactor) and glutamine (a substrate). A second example is PabA and PabB proteins involved in
p-aminobenzoate synthesis. A complex of PabA and PabB has only been isolated in the
presence of the glutamine substrate (26).
Transient interactions in the channeling model require an alternative method to those
previously employed to detect PurF:PurD interactions. Stopped-flow fluorescence using
specifically incorporated fluorescent probes has been used to characterize weak, protein-protein
interactions. Phosphoryl-transfer between the chemotaxis proteins CheA and CheY, which
occurs with a kcat of -750 s-l and a Km of -6.5 M, has been detected, for example, using this
method (27, 28). Consequently, the focus of this chapter is on using this method to look for
PurF/PurD interactions under physiological concentrations of 5 M. These efforts required
using 7AW and 4FW tryptophan substitutions so that changes in PurF fluorescence could be
specifically monitored.
As shown in Figures 2.16, 2.17 and Table 2.7, no interactions between [7AW]-PurF
mutants and [4FW]-PurD were detected during PRA synthesis. Definitive interpretation of these
results is not possible due to uncertainties surrounding the concentration and timing of
PurFoPRA formation during the pre-steady state. While no interactions were observed, it is
possible that a sufficiently high enough concentration of [7AW]-PurF.PRA was not generated to
allow detection of the desired interaction. Several 2-syringe stopped-flow fluorescence
experiments were then employed to investigate the possibility that specific, static [7AW]-PurF
complexes might interact with [4FW]-PurD. Complexes were designed to mimic PurF reaction
intermediates; however, no change in fluorescence was observed with [4FW]-PurD in any case
with any of the [7AW]-PurF mutants (Figure 2.18). Based on these results, it can be concluded
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that fluorescent probes on the PRTase flexible loop, the glutamine-binding loop, and C-terminal
helix all failed to detect any interaction with PurD during the experiments carried out in this
chapter.
There are several possible interpretations of these results. The first is that perhaps the
enzymes interact too rapidly to monitor by stopped-flow fluorescence. Given the dead time of
the stopped-flow apparatus (-1.3 ms), rates constants of -500 s can be accurately measured
(50% completion during the dead time). There is precedence for rapidly interacting proteins in
E. coli. For the CheA and CheY phospho-transfer interaction, the estimated protein complex
half-life in vivo is believed to be -2 ms (29). This interaction is too rapid to accurately monitor
by stopped-flow spectroscopy under saturating protein concentrations, and a rate of -800 s for
the protein association under saturating conditions has been extrapolated from concentration-
dependence studies on fluorescence changes that occur during complex formation in the pre-
steady state (27-29). Similar experiments could be performed on the PurF:PurD system;
however, a stronger fluorophore than 7AW should be used to detect possible interactions that
may occur in only a small percentage of the PurF in solution.
A second interpretation of these results would be that the docking model is incorrect and
that the probes were not placed at the correct positions to monitor protein interactions. As
described in the results section, a key component of the docking model is the use of a PurF dimer
containing the substrate analogs DON and cPRPP. It is unknown how well this structure mimics
the PurFoPRA complex, and it is possible that the enzyme undergoes further conformational
changes upon product formation. The use of cPRPP in the crystal structure is particularly
problematic since there is kinetic evidence that while this analog is a competitive inhibitor of
PRPP, it does not convert the enzyme into an active conformation capable of glutamine
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hydrolysis (30). Furthermore, the catalytically relevant quaternary structure of PurF remains
undetermined. Dimers and tetramers have been observed by crystallography (3, 4), while
dimers, trimers, mand tetramers have all been reported in solution (2, 25).
Unfortunately, the AUC experiments presented in this chapter were unable to provide
new insight into PurF quaternary structure (Figures 2.19 and 2.20). The AUC experiments
indicated that a PurF trimer may be present in solution, although it is unclear what structure this
species would have. Future experiments may benefit from the generation of new docking
models taking into account alternate PurF structures; however, any reasonable channeling
complex should align the enzyme active sites to allow direct transfer of PRA. The most striking
result from the stopped-flow experiments is that none of the mobile regions of PurF appeared to
interact with Purl) in any detectable manner. These results are especially surprising with the
W290F/S345W 7AW PurF mutant, since movement of this loop is required for PRA transfer in
the docking model. It is currently unclear and seems unlikely that a PurF:PurD channeling
complex could be formed that would align the enzyme active sites for PRA transfer and not
involve any of the mobile regions that cover the PRPP binding site of PurF.
The final possibility is that the enzymes do not channel PRA, and channeling kinetics are,
instead, an artifact of an incomplete kinetic analysis of the enzymes in solution. Due to the
reproducibility of the channeling kinetics, this is not the favored interpretation. The largest
source of error in the modeling PRA diffusion kinetics between PurF and PurD comes from
measurement of the PRA Km. A large degree of substrate inhibition is observed with PRA, and
this could affect the accuracy of this value (Figure 2.7). However, even large errors in the Km
should still result in the observation of a lag phase in the rate of GAR formation during
channeling experiments (2). In addition, experiments by Zalkin and Smith using heterologous
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thermophilic/mesophilic PurF:PurD pairs have provided additional evidence for transfer of PRA
between PurF and PurD, although these experiments were not designed to detect a lag phase
(31). Unfortunately, due to PRPP and PRA instability, a detailed kinetic analysis of PurF and
PurD remains challenging. In particular, the amount of kinetic information concerning PRA
bformation and binding (such as kon, koff, and Kd'S) that can be learned from the enzymes and
applied to future models of metabolite transfer is limited, and any attempts to measure these
values will be extremely difficult. It may be possible in the future to measure the pre-steady
state rates of PRA formation and release by PurF using rapid chemical quench methods and a
sufficient amount of PurD to trap PRA as a more stable molecule, GAR, for analysis. These
experiments would require a detailed kinetic analysis of PurD prior to the experiment to ensure
that every step in the conversion of PRA to GAR in the pre-steady state is faster than the PurF
kinetics under investigation.
In conclusion, these results provide no evidence for any interaction between PurF and
PurD in the pre-steady state, even during PRA synthesis. This indicates that either the
interaction is too fast to detect using stopped-flow methods, or that the fluorescent probes were
not positioned to detect an interaction. The latter interpretation indicates that the docking model
between PurF and PurD may be incorrect. Future stopped-flow experiments may benefit from
the use of stable, carbocyclic analogs of PRA (cPRA). cPRA has been synthesized by the
Caperelli laboratory and is an efficient substrate for E. coli PurD (kcat/Km 2.1 x 103O M-' s-1 for
(:) cPRA compared to 2.4 x 105 M' l s-1 for a/[-PRA) (32, 33). Use of cPRA to mimic a
PurFoPRA complex may provide additional information concerning PurF structure and PRA
binding. However, given previous findings that cPRPP does not bind to PurF in a conformation
that activates the enzyme for catalysis (30), it is unclear how sensitive the enzyme will be to
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substitution of the PRA ribose ring with cyclopentane. A complete kinetic characterization of
cPRA binding to PurF followed by pre-steady state kinetic experiments using [7AW]-PurFs and
[4FW]-PurD in the presence of cPRA may provide additional data in support of the findings
presented in this chapter.
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Chapter 3:
Characterization of the B. subtilis FGAR-AT Complex
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3.1 Introduction
The purine biosynthetic pathway requires eleven enzymatic transformations in
prokaryotes, each of which has been studied in detail (Scheme 1.1). With the exception of the
fourth enzyme in this pathway, formylglycinamide ribonucleotide amidotransferase (FGAR-AT
or PurL), all of the enzymes have previously been structurally characterized as well (1). FGAR-
AT catalyzes the transformation shown in Scheme 3.1 in which glutamine (gin) supplies the
ammonia to an ATP-activated, formylglycinamide ribonucleotide (FGAR) to generate ADP,
inorganic phosphate (Pi), glutamate (glu), and formylglycinamidine ribonucleotide (FGAM).
This reaction can be divided into two half-reactions. In one half-reaction, glutamine is
hydrolyzed to glutamate through a covalent thioester intermediate (Equtaion 3.1). In the second
half-reaction, ATP is proposed to activate the amide oxygen of FGAR for nucleophilic attack by
the ammonia generated in the first half-reaction (Equation 3.2) (1).
Gin + H 20 -> Glu + NH3 (3.1)
FGAR + ATP +NH 3 -> FGAM + ADP + Pi (3.2)
Recently, interest in FGAR-ATs has re-surfaced for several reasons. First, the most
extensively studied PurLs, those isolated from E. coli and chicken liver, are monomers of MW
-140 kDa (lgPurLs). The large size, more than adequate to convert an amide to an amidine
(Scheme 3.1), has lead to the hypothesis that this protein might serve as a scaffold to organize
the eleven proteins involved in purine biosynthesis into a biosynthetic metabolon (1, 2). No
evidence for "tight" interactions have been reported for the proteins in this pathway (2, 3).
However, the instability of many of the nucleotide intermediates has lead to a model in which
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Scheme 3.1-Proposed mechanisms of the FGAR-AT (PurL) and AIR Synthetase (PurM)
catalyzed reactions.
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transient protein-protein interactions between successive enzymes in this pathway may be
important to avoid nucleotide decomposition (1).
Second, recent studies on the structure and function of the fifth enzyme in the purine
pathway, aminoimidazole ribonucleotide (AIR) synthetase (PurM, Scheme 3.1), in conjunction
with genomic sequence information, suggested that PurL might be a member of a new
superfamily of ATP requiring enzymes with a unique structural fold (4, 5). This superfamily of
enzymes, identified only by a DX4GAXP motif, was proposed to use ATP to phosphorylate an
amide oxygen of its substrate to generate an iminophosphate intermediate that is activated for
nucleophilic attack (Scheme 3.1). Further information on the structure and function of the
FGAR-AT would shine light on this proposal.
As noted above, most of the mechanistic studies on the FGAR-AT have focused on the
lgPurLs. In the 1980s, Zalkin and co-workers, studying the contiguous purine biosynthetic
operon in Bacillus subtilis, sequenced a gene cluster that was composed of purC-orf-purQ-purL-
purF (6). The purL gene coded for a protein of only 80 kDa and hence was designated small
PurL (smPurL). Furthermore, purQ was found to be homologous to triad glutaminase domains
including the glutaminase domain of gPurLs. Recently genetic and biochemical studies by
Saxild and Nygaard demonstrated that the orf within this gene cluster is essential for production
of FGAM (7). This of has now been designated purS. Thus it appears that three proteins
(smPurL (80kDa), PurQ (25 kDa), and PurS (10 kDa)) form the B. subtilis FGAR-AT. Sequence
gazing has further identified PurS homologs in a wide range of Gram-positive bacteria,
cyanobacteria, and mnethanogens. In each case, purS is accompanied by a purL and a purQ.
Difficulties encountered during attempts to obtain a structure and elucidate the mechanism of the
lgPurLs suggested that the FGAR-AT involving three proteins might be an alternative source of
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insight into the amidation process. As an initial step towards this goal, this chapter describes the
first expression and characterization of the FGAR-AT complex from B. subtilis. This FGAR-AT
complex, as with all ATs examined to date, is proposed to supply ammonia from glutamine to
FGAR by a channeling mechanism (8). This enzyme may therefore provide a paradigm for
thinking about the dynamics of protein-protein interactions in channeling of an unstable
intermediate in an enzymatic complex as well as between successive enzymes in primary
metabolic pathways. The key to the interpretation of many of the findings discussed in this
chapter came from the simultaneous structure determination of the Salmonella gPurL by the
Ealick Laboratory. The structure of this enzyme will be briefly described and correlated to
discoveries made with the B. subtilis FGAR-AT complex.
3.2 Experimental
MAaterials
All reagents were purchased from Sigma or Mallinckrodt and used without further
purification unless otherwise indicated. 6-Diazo-5-oxo-L-norleucine (DON) was purchased from
BACHEM. Isopropyl -D-thiogalactoside (IPTG) was purchased from Roche. -FGAR was
prepared from chemically synthesized ct/f-GAR using the non-folate dependent glycinamide
ribotide transformylase, PurT (9). The PurT plasmid was a gift from H. Holden, U. of
Wisconsin-Madison (10). L-Glutamine was purchased from Fluka and found to contain the
lowest percentage of contaminating L-glutamate among commercial sources. DNA primers were
obtained from either the MIT Biopolymers Facility or from Invitrogen and were desalted before
use. All cloned genes were sequenced at the MIT Biopolymers Facility. ESI-MS and N-
terminal protein sequencing were also performed at the MIT Biopolymers Facility. PurM
containing a N-terminal histidine tag (MGSSHHHHHHSSGLVPRGSH) was purified as
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previously described (his-PurM, specific activity of 1-2 U/mg) (4). The E. coli and Salmonella
lyphimurium gPurL enzymes (2 and 3 U/mg, respectively) were purified as described (11, 12).
Pyruvate kinase (PK) and lactate dehydrogenase (LDH) were used from a premixed glycerol
solution (660 U/mL PK, 1350 U/mL LDH Sigma P-0294). Bovine L-glutamate dehydrogenase
(GDH) was obtained from Sigma (49 U/mg, Sigma G-2626). All spectrophotometric assays
were performed on either a Cary 3 or a Cary 118-OLIS spectrophotometer. In both cases, the
temperature was regulated using a Lauda water bath. Protein concentrations were determined
using the method of Lowry with a BSA standard unless otherwise indicated (13). Calculated
extinction coefficients were obtained using the ProtParam program from the EXPASY website
(www.expasy.ch). To examine the extent of protein purification, standard SDS-PAGE gels were
employed (10% for smPurL and 12.5% for PurQ). Tricine gels (16.5%) were used with PurS
(14). A Bio-Rad BioLogic LP system was used for protein purifications at 4°C using the
procedures mentioned below.
Cloning of the B. subtilis FGAR-AT Components
PurS was cloned from isolated B. subtilis genomic DNA (B. subtilis strain #A607,
courtesy of A. Grossman, MIT). The gene was cloned using the AmpliTaq DNA Polymerase
(Perkin Elmer) and the primers listed in Table 3.1 (primers 1 and 2). The gene was then ligated
into the pET-1 la vector (Novagen) at the NdeI and BamHI sites. This construct yielded pET-
PurS.
PurQ was also cloned from the isolated B. subtilis genomic DNA. The gene was first
subcloned into pSTBlue-1 (Novagen) (primers 3 and 4, Table 3.1). Amplification with the
VENT DNA polymerase (NEB) resulted in an A128T mutant of PurQ. Amplification with the
AmpliTaq DNA Polymerase (Perkin Elmer) or the KOD HiFi DNA Polymerase (Novagen)
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resulted in the cloning of the wild type (wt) gene. Both genes were then subcloned into pET-24a
(Novagen) at the NdeI and EcoRI sites creating pET-PurQ-A128T (A128T mutant) and pET-
PurQ-wt.
smPurL was cloned from the pDE51 B. subtilis sequencing vector (gift of H. Zalkin,
Purdue University) (6). The gene was cloned using the Pfu Turbo DNA polymerase (Stratagene)
and standard PCR techniques (primers 5 and 6, Table 3.1). The gene was ligated into the pET
24a vector at the NdeI and BamHI sites to create pET-smPurL. The gene isolated by this
procedure several times always contained a L513F mutation based on the published sequence
(6).
In order to co-express all the FGAR-AT components, PurQ A 128T and smPurL were
placed into pACYC-DUET-1 (Novagen). This vector contains two multiple cloning sites (MCS1
and MCS2) and is compatible with all pET vectors. The gene for smPurL was PCR-amplified
from pET-smPurL (primers 6 and 7, Table 3.1) and placed into the NcoI and BamHI sites of
MCS , creating pDUET-L. This method resulted in the insertion of an amino acid at the N-
terminus: Met-Ser-Leu was replaced by Met-Gly-Ser-Leu. The gene for PurQ was amplified
from pET-PurQ-A128T plasmid (primers 8 and 9, Table 3.1) and placed into MCS2 of pDUET-
L at the NdeI and KpnI sites to create pDUET-L-A128T-Q.
Co-expression of the wt PurQ gene with PurS and smPurL was achieved by using
Quikchange mutagenesis (Stratagene) with the pDUET-LQ plasmid. The mutagenic primers are
listed in Table 3.1 (primers 10 and 11). Plasmids containing the mutation were identified by
DNA sequencing. This created plasmid pDUET-L-wt-Q.
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T'Fable 3.1: Primers Used in Cloning of the FGAR-AT
lID Name Sequence Restriction Plasmid
Enzyme
1 PurS-F GCCATATGTATAAAGTAAAAG NdeI pET-PurS
TTTATGTC
2 PurS-R CGGGATCCTCACTGTGCGACTA BamHI pET-PurS
CCTCCTCAAC
3 QDN TCTTTACTCGAGTCAAGCAGTA XhoI pET-PurQ-WT
GTGACATGAG and A128T
4 QUP AGTCGCCATATGAAATTTGCGG NdeI pET-PurQ-WT
TGATTGT and A128T
5 Bs-L-F GCCATATGTCACTACTGCTTGA NdeI pET-smPurL
ACCAAGTAAAGAAC
6 Bs-L-R CGCATTGGATCCTTAAGCCTTTG BamHI pET-smPurL
ATTTCAGCAAGCATGG and pDUET-L
7 SL- GCCCATGGCACTACTGCTTGAAC NcoI pDUET-L
NcoI CAAGTAAAGAAC
8 Q-NdeI GCCATATGAAATTTGCGGTGATT NdeI pDUET-LQ
GTGTTACCC
9 Q-KpnI GGGGTACCTCAAGCAGTAGTGA KpnI pDUET-LQ
CATG
10 Q-wt-F GACGAAACCTTATTCACAGCATG N/A pDUET-LwtQ
GTACGAAAAGGGAG
11 Q-wt-R CTCCCTTTTCGTAGGATGCTGTGA N/A pDUET-LwtQ
ATAAGGTTTCGTC
Co-expression PurS, PurQ, and smPurL
For co-expression of all 3 subunits of the FGAR-AT, BL21-Gold DE3 cells (Stratagene)
were transformed with pDUET-L-A128T-Q (or pDUET-L-wt-Q), pET-PurS, and pET-smPurL
using the heat-shock method and 20 ng of each plasmid (15). The cells were selected for
growth on LB/agar plates containing 100 g/mL chloramphenicol, 50 tg/mL ampicillin, and 35
tg/mL kanamycin.
A single colony was used to inoculate 50 mL of LB containing the above antibiotics. The
cells were grown overnight at 37°C with shaking at 200 rpm. Cells from this culture were then
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collected by centrifugation, washed with fresh LB, and then used to inoculate 2 L of LB
containing the above mixture of antibiotics in a 6 L flask. This flask was then shaken at 200 rpm
at 37°C. Cells were grown to an OD600 of 0.7, at which point they were induced with 1 mM
IPTG and grown for an additional 5 h. The cells were then harvested and frozen in liquid
nitrogen.
Efforts to Purify the FGAR-ATfrom Co-expressed Proteins
Glutamine-dependent FGAR-AT activity was monitored at all stages of the purification
with the modified Bratton-Marshall assay described subsequently. Cells (4 g) were resuspended
in 25 mL of SL buffer (50 mM Tris, 25 mM NaCI, 1 mM EDTA, 1 mM DTT, 5% glycerol, pH
7.8) along with 1 mL of Sigma Protease Inhibitor Cocktail (Sigma P-8465). Cells were then
lysed by two passes through a French press at 14,000 psi. Cell debris was removed by
centrifugation for 25 min at 17,000 rpm. Streptomycin sulfate (0.2 volumes, 6% w/v in SL
buffer) was then added over 15 min, followed by stirring for an additional 15 min. Solids were
removed by centrifugation.
The supernatant was next applied to DEAE Sepharose FF (2.5 x 10 cm, Sigma) column
equilibrated in SL buffer. The column was washed until the A2 80 < 0.1. The protein was eluted
with a linear gradient (350 x 350 mL) of 25 to 500 mM NaCI in SL buffer. A flow rate of 2
mL/min was used and 8 mL fractions were collected. The proteins eluted in 3 separate peaks:
PurS (100 mM NaCI), PurQ (150 mM NaCI), and smPurL (180 mM NaCI). Glutamine-
dependent FGAR-AT activity was observed in fractions at -170 mM NaCI. These fractions
were pooled and concentrated to 40 mg/mL using a YM-3 Centriprep (Millipore). This protein
(0.5 mL) was then applied to a Sephacryl S-200 (1.5 x 100 cm, Sigma) column equilibrated in
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SL buffer. The column was eluted at 0.3 mL/min and 5 mL fractions were collected and assayed
for activity.
Purification of PurS
pET-PurS was transformed into BL21(DE3) E. coli cells (Novagen) and grown in LB at
37°C in the presence of 100 tg/mL ampicillin. The cells were typically grown in 2 L with
shaking at 200 rpm in a 6 L flask. At an OD 60 0 of 0.7-0.9, the cells were induced with 1 mM
IPTG and grown for an additional 4 h. The cells were then harvested and frozen in liquid
nitrogen.
The cell pellet (6.5 g) was resuspended in 30 mL of S buffer (50 mM Tris, 25 mM NaCI,
1 mM EDTA, 5 mM DTT, pH 7.8) and 1.5 mL of Sigma Protease Inhibitor Cocktail. Cells were
then lysed by two passes through a French press at 14,000 psi. Cellular debris was removed by
centrifugation at 17,000 rpm for 40 min. Streptomycin sulfate (0.3 volumes, 6% w/v made in S
buffer) was then added to the supernatant over 20 min while stirring on ice. The solution was
stirred for an additional 20 min and then cleared by centrifugation. DNase I (500 U, Roche) was
added to the supernatant, and this solution was allowed to stir at room temperature for 20 min.
The supernatant was next loaded onto a DEAE Sepharose FF (1.5 x 25 cm, Sigma)
column equilibrated in S buffer. The column was washed with buffer until A280 < 0.1. A linear
gradient (600 x 600 mL) was applied from 25 to 500 mM NaCI in S buffer. The flow rate was 2
mnL/min and 10 mL fractions were collected. PurS eluted at 50 mM NaCI. Protein from this
peak was then concentrated with an Amicon device over a YM-30 membrane (Millipore). The
concentrated protein was applied to a Sephacryl S-300 (1.5 x 100 cm, Sigma) column
equilibrated in S buffer, but the concentration of DTT was lowered to 1 mM. The protein was
eluted at a rate of 0.3 mL/min and 5 mL fractions were collected. PurS eluted as a single peak.
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The protein was again concentrated with an Amicon device over a YM-30 membrane, followed
by a Centriprep YM-30 (Millipore) to 20-40 mg/mL. Glycerol was added to 20% of the final
volume, and the protein was rapidly frozen in liquid nitrogen. PurS (13.4 mg/g cells) was
obtained in >95%3 purity. The purified protein had a mass of 9,755 Da by ESI-MS (calculated,
9,755 Da). The final protein was quantified using a calculated 280 = 7,680 M-lcm- .
Purification of PurQ
pET-PurQ-wt or pET-PurQ-A128T were transformed into BL21(DE3) E. coli cells and
grown in LB at 30°C in the presence of 70 ~tg/mL kanamycin. Cells in 2 L of media were grown
in 6 L flasks with shaking at 200 rpm. At an OD6 00 of 0.7-0.9, the cells were induced with 1 mM
IPTG and grown for an additional 5 h. The cells were then harvested and frozen in liquid
nitrogen.
Both the A128T and wt PurQ proteins were purified using the following procedure based
on the purification of E. coli HisH (16). PurQ activity was monitored at all stages of the
purification in the absence of PurS and smPurL using the GDH-coupled glutaminase assay
described below.
Cells (13 g) were resuspended in 35 mL of Q buffer (50 mM Tris, 1 mM EDTA, pH 7.4)
and then lysed by two passes through a French press at 14,000 psi. Solids were removed by
centrifugation at 17,000 rpm for 40 min in a Beckman JA-25.50 rotor.
Streptomycin sulfate (10% w/v in Q buffer) was then added to a final concentration of
1% and the solution was stirred on ice for an additional 15 min before centrifugation. The
supernatant was applied to a DEAE Sepharose FF column (2.5 x 10 cm) equilibrated in Q buffer.
The column was washed until the A280 <0.1. A128T PurQ was eluted with a linear gradient (200
x 200 mL) of 0 to 300 mM KCI in Q buffer. A flow rate of 3 mL/min was employed and 6 mL
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fractions were collected. A128T PurQ eluted in the main protein fraction at 100 mM KCI. In
contrast, wt-PurQ eluted at 250 mM KCI with a linear gradient (200 x 200 mL) of 0 to 500 mM
KCl in Q buffer (data not shown).
The PurQ fractions were then pooled and diluted 1:1 with 40 mM KPj, pH 7.0. This
solution was applied to a Biogel HTP column (2.5 x 5 cm, Bio-Rad) equilibrated in 20 mM KPj,
pH 7.0. The flowthrough and a 40 mL wash were combined and then concentrated with an
Amicon device over a YM-30 membrane to 50 mg/mL. This solution (1 mL) was then applied to
a Sephacryl S-100 (1.5 x 75 cm, Sigma) column equilibrated in 20 mM KPj, 100 mM KCI, pH
7.0. The column was eluted at 0.2 mL/min and 5 mL fractions were collected. The protein was
then concentrated to 15-30 mg/mL with a Centriprep YM-10 (Millipore). Glycerol was added to
a concentration of 20%, and the protein was rapidly frozen in liquid nitrogen and stored at -
80°C. A typical yield of homogeneous A128T PurQ was 9.1 mg/g cells. Purification of wt PurQ
resulted in a significantly lower yield (1.5 mg/g cells) of 50-60% homogeneous PurQ. The
purified A128T protein had a mass of 24,816 Da by ESI-MS (calculated, 24,814 Da) and was
quantified with a calculated 280 = 20,580 M- cm- .
Purification of snPurL
pET-smPurL was transformed into BL21(DE3) E. coli cells and grown in LB at 27.5°C
in the presence of 70 tg/mL kanamycin. The cells were typically grown in 2 L volumes with
shaking at 200 rpm in a 6 L flask. At OD 6 00 of 0.7-0.9, the cells were induced with 1 mM IPTG
and grown for an additional 5 h. The cells were then harvested and frozen in liquid nitrogen.
Cells (8g) were resuspended in 30 mL of SL buffer along with 2 mL of Sigma Protease
Inhibitor Cocktail. Cells were then lysed by two passes through a French press at 14,000 psi.
Cell debris was removed by centrifugation for 25 min at 17,000 rpm. Streptomycin sulfate (0.2
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volumes, 6% w/v in SL buffer) was then added over 15 min while stirring on ice, followed by
stirring for an additional 15 min. Solids were removed by centrifugation.
The supernatant was next applied to a DEAE Sepharose FF (2.5 x 14 cm, Sigma) column
equilibrated in SL buffer. The column was washed until the A 280 < 0.1. The protein was eluted
with a linear gradient (300 x 300 mL) of 0 to 500 mM KCI in buffer SL. A flow rate of 4
mnL/min was used and 8 mL fractions were collected. smPurL eluted in the major protein
containing peak at 125 mM KCI. The protein was then concentrated to 20 mL with an Amicon
device and a YM3() membrane before dialysis overnight in a 12 kD molecular weight cut-off
membrane (Sigma D-0405) against 2 x 500 mL of SL buffer. This protein (diluted to 50 mL)
was then applied to a Reactive Red 120 Agarose (2.5 x 13.5 cm, Sigma) column equilibrated in
SL buffer. The column was washed with 2.5 column volumes of buffer at mL/min. smPurL
was then eluted by continuing to wash the column with SL buffer at a flow rate of 3 mL/min
until the A28 0 < 0.1. The entire elutate was concentrated with an Amicon device over a YM-30
membrane (Millipore) and a Centriprep YM-50 (Millipore) to a concentration of 20-30 mg/mL.
Glycerol was then added to 20% and the protein rapidly frozen and stored at -80°C. A typical
yield of smPurL was 4.2 mg/g cells. The purified protein had a mass of 80,213 Da by ESI-MS,
similar to the 80,194 Da mass predicted by removal of the N-terminal methionine revealed by
Edman degradation. The purified protein was quantified with a calculated 280 = 51,520 M-
-1
cm
Enzyme Reconstitution
To reconstitute FGAR-AT activity, 2 equivalents of PurS, 1 equivalent of smPurL, and 1
equivalent of PurQ were combined, in that order, in 100 mM Tris pH 7.5, 5 mM MgCI2 such that
the complex concentration was 10-20 btM. The mixture was allowed to equilibrate on ice for 5
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min before use and was stable on ice for several hours at these concentrations. Diluted enzyme
was prepared from this stock immediately before use.
Enzyme Assays
Enzymatic activity was determined using three different assays: one to monitor FGAM,
one for ADP, and one for glutamate. FGAM synthesis was monitored by a coupled assay with
his-PurM using the modified Bratton-Marshall assay (11). The buffer for the B. subtilis enzymes
contained in a final volume of 400 tL: 50 mM HEPES pH 7.2, 20 mM MgCI2, 80 mM KCl, 50
rnM L-glutamine, 10 mM ATP, 1 mM 3-FGAR, and 0.2 U of his-PurM. When the NH3-
dependent activity was determined for smPurL, the glutamine was replaced with 400 mM
NH4 CI. The amount of FGAR was also increased to 2 mM 13-FGAR. The reaction was initiated
by addition of enzyme and incubated at 37°C before being quenched by the addition of 100 ~tL of
1.33 M potassium phosphate/20% trichloroacetic acid (TCA) pH 1.4. The AIR product was then
derivatized and quantified as previously described (17).
ADP formation was monitored using a coupled assay with PK and LDH. The reaction
mixture was identical to that described for the modified Bratton-Marshall assay above except
that it contained 0.2 mM NADH, 3 mM PEP, and PK (3.0 U) and LDH (6.75 U) in place of his-
PurM. In the NH3 -dependent reactions, the glutamine in the buffer was replaced with 400 mM
NH4CI. The reaction was initiated with the addition of enzyme and was monitored by AA 3 40 ( =
6,200 M-'cm -') at 37°C.
Formation of glutamate was monitored using a continuous glutaminase assay (18). The
assay buffer was identical to the Bratton-Marshall assay buffer except that 2 mM 3-
acetylpyridine adenine dinucleotide (APAD, Sigma) was added to the reaction mixture and 20 U
of GDH was used as the coupling enzyme instead of his-PurM. Since very high glutamine
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concentrations were used in these assays, the reaction buffer was incubated for 10 min at 37°C
with GDH to oxidize all the contaminating glutamate. The reaction was then initiated with
enzyme and incubated at 37°C. The reaction was monitored by AA 36 3 (= 9,100 M-cm-).
D)etermination of Kinetic Parameters
kcat and Km values were generally determined by varying the concentration of the
substrate from 0.2 to 10 times the Kin, while using saturating concentrations of the other
substrates. Kinetic parameters were obtained by fitting initial velocity data to Equation 3.3 using
non-linear regression analysis with KaleidaGraph (Synergy) computer software.
v = V [S]/(K + [S]) (3.3)
max m
In cases where substrate inhibition was observed, data were fit to Equation 3.4.
V = Vmx i S]V [SaxI~ 2 (3.4)
(Km+[S]2 (Km + IS +[SI)
K
Parameters for PurQ were determined using the glutaminase assay in the absence of PurS,
srnPurL, FGAR, and ATP. The Km value for glutamine was determined by varying its
concentration from 0 to 24 mM.
The kinetic parameters for the NH3 -dependent reaction of smPurL were determined using
either the modified Bratton-Marshall assay (NH3, FGAR) or the PK/LDH coupled assay. The
Kmapp value for f3-FGAR was obtained by varying its concentration from 0 to 8 mM in the
presence of 400 mM NH4CI and 10 mM ATP. The Km,app for NH3 was obtained by varying the
concentration of NH4CI from 0 to 700 mM, with 2 mM 3-FGAR and 10 mM ATP. Up to 1 U of
140
his-PurM was added to this reaction to offset the effects of NH4 CI on his-PurM activity. The
concentration of NH3 was calculated using the Henderson-Hasselbalch equation. The K,app
value for ATP was obtained by varying its concentration from 0 to 2 mM using 2 mM 3-FGAR
and 400 mM NH4CI.
Kinetic parameters for the PurS:smPurL:PurQ complex were determined using either the
modified Bratton-Marshall assay or the glutaminase assay. All specific activity and kinetic
parameter measurements were made at enzyme concentrations of 0.2-0.4 tM, using the A128T
PurQ mutant. The Km value for 3-FGAR was obtained by varying its concentration from 0 to 8
mnM using 10 mM ATP and 25 mM glutamine. The Km,app value for ATP was determined by
varying its concentration from 0 to 3.25 mM in the presence of 1 mM -FGAR and 25 mM
glutamine. The Kmzapp glutamine was determined by varying its concentration from 0 to 24 mM
in the presence of 1 mM 3-FGAR and 10 mM ATP.
Metal Ion Dependence
Metal ion dependence (Mg2+ and K+) was measured by using the glutaminase assay since
both the his-PurM and PK coupling enzymes are dependent on these ions. The glutaminase
buffer consisted of 100 mM Tris pH 7.2, 2 mM APAD, 10 mM ATP, 1 mM -FGAR, 25 mM L-
glutamine, and 20 U of GDH in a volume of 300 ~tL. In experiments to examine magnesium
dependence, KCI was 80 mM, and the enzyme reconstitution was carried out in Tris buffer
without magnesium. The concentration of MgCI2 was varied from 0 to 40 mM. In experiments
to), test potassium dependence, MgCl2 was at 20 mM, and the concentration of KCI was varied
from 0 to 80 mM.
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Titrations to Examine the Stoichiometry of the FGAR-AT
Titrations of the FGAR-AT proteins with one another were monitored using the modified
Bratton-Marshall assay and could only be successfully performed at enzyme concentrations
above 0.1 ItM, which required 1 U of his-PurM as a coupling agent.
A. Titrations with PurQ
smPurL (1 nmol) was reconstituted with PurS (2 nmol) and PurQ (0.2 to 4 nmol) in 100
[tL of 50 mM HEPES pH 7.2, 20 mM MgCI2, 80 mM KCI, 10 mM ATP, and 25 mM L-
glutamine. This mixture was allowed to incubate on ice for 5 min. The enzyme was then diluted
50-fold into the Bratton-Marshall assay buffer at 37°C to initiate the reaction.
B. Titrations with PurS
smPurL ( nmol) was reconstituted with PurS (0.25 to 4 nmol) and PurQ (1 nmol) in 100
[j.L of 50 mM HFIEPES pH 7.2, 20 mM MgCI2, 80 mM KCI, 10 mM ATP, and 25 mM L-
glutamine. The incubation and enzymatic reaction were then carried out as described with the
titration of PurQ.
pH Rate Profile
The pH rate profile was determined with the Goods series of buffers using the modified
Bratton-Marshall assay. The buffers used were MES (pH 5.5-6.25), MOPS (pH 6.5-7.0),
HEPES (pH 7.25-8.0), TAPS (pH 8.5), and CHES (pH 9.0-9.5). A typical assay in 400 tL
contained 100 mM buffer, 1 mM 03-FGAR, 10 mM ATP, and 50 mM L-glutamine. The enzyme
concentration for these reactions was 0.2 rtM. In determining the pH rate profile for the NH3 -
dependent reaction, 2 mM -FGAR, 10 mM ATP, and 400 mM NH4CI were used. The amount
of PurM used in the assays varied between 0.2 and 2 U to ensure full coupling of the reaction at
all pH values.
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Product Stoichiometry of FGAR-AT
Product stoichiometry of the FGAR-AT reaction was determined by measuring endpoint
concentrations of ADP, glutamate, and FGAM. Enzymes were reconstituted as described
above. The enzyme mixture was then diluted 1:40 into 400 tL of 50 mM HEPES pH 7.2, 20
rnM MgCl2, 80 mM KCI, 25 mM L-glutamine, 2 mM -FGAR, 1.5 mM ATP, 2.5 U/mL his-
PurM at 37°C. The reaction was allowed to proceed for several minutes before quenching by
immersion in boiling water for 2 min. Precipitated protein was removed by centrifugation. Six
time points were taken for the stoichiometry determination and a control reaction containing no
FGAR-AT was performed at each time point. The final stoichiometry was determined by
averaging the stoichiometries obtained at each time point. In addition, these methods were used
to determine the stoichiometry of both the E. coli and S. typhimurium lgPurLs.
FGAM formation was determined by using the modified Bratton-Marshall assay
described earlier to calculate the amount of AIR present in the sample (50 tL).
ADP formation was determined using the PK/LDH assay. The quenched reaction or
control (60 tL) was added to 610 tL of 50 mM HEPES pH 7.2, 20 mM MgCI2, 80 mM KCI, 3
mM PEP, 0.2 mM NADH, 3.0 U PK, and 6.75 U LDH, and the AA34 0 was measured. The
amount of ADP produced by the FGAR-AT was determined by subtracting the control followed
by division by 2 to account for ATP consumed by his-PurM.
Glutamate was measured using two methods with GDH. In the first method, 100 tL of
the quenched reaction or control was added to 610 tL of 50 mM HEPES pH 7.2, 20 mM MgC 2,
80 mM KCI, 2 mM APAD, and 20 U GDH. The reaction was incubated for 30 min at 37°C and
the AA3 6 3 (experimental-control) was measured. In the second method, known concentrations of
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glutamate were included in the control reactions to generate a standard curve using the method of
Lund (19).
DON Inactivation of PurQ
A typical reaction (150 FL) contained 20 tM PurQ, 20 tM smPurL, 40 tM PurS, 0.45
mM FGAR, 0.5 mM ATP, 10 mM DON, 50 mM KPi pH 7.25, 75 mM NaCl, and 5 mM MgC12
at 25°C. Inactivation of PurQ alone was carried out in the absence of the other proteins, FGAR,
and ATP. The inactivation was monitored as a function of time by removal of 2 tL aliquots,
which were diluted into 400 tL of the modified Bratton-Marshall assay buffer. With
inactivation of PurQ alone, the assay buffer contained PurS and smPurL as well. The DON-
inactivated FGAR-AT mixture was used directly in subsequent SEC experiments without the
removal of unreacted DON or substrates.
Analytical SEC to Look for Complex Formation
Analytical SEC was performed at 4°C using a BioCAD Sprint perfusion chromatography
system (Applied Biosystems) or at 25°C using a Rainin HPLC with an analytical Bio-Silect
SEC250 column 300 x 7.8 mm, Bio-Rad). The column was equilibrated and eluted in filtered
and degassed SEC buffer (50 mM KPi, 75 mM NaCI, pH 7.25). Protein was applied to the
column using a 100-tL injection loop and eluted with a flow rate of 1 mL/min. Bio-Rad Gel
Filtration standards (a mixture of thyroglobulin (670 kD), gamma globulin (158 kD), ovalbumin
(44 kD), myoglobin (17 kD), and vitamin B 12 (1.4 kD)) were injected prior to each set of
experiments. Typically, 0.6 mg of protein in 125 tL of buffer was injected. All solutions were
filtered with CENTREX spin filters (Schleicher & Schuell). Experiments were also performed
using SEC buffer containing (25 mM L-glutamine and 5 mM MgCI2), (5 mM MgCI2 and 0.5 mM
ATP), (5 mM MgCI2 , 0.5 mM ADP, and 25 mM L-glutamine), and (5 mM MgCI2, 0.5 mM ATP,
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and 0.5 mM -FGAR). In addition, experiments were performed using enzyme that had either
been allowed to synthesize FGAM for 5 min at 37°C before application to the column or had
been pre-incubated with a combination of 0.5 mM ADP, 5 mM MgCI2, and/or L-glutamine.
Approximate values for molecular weight were determined using the gel filtration standards and
by linear-regression analysis using the KaleidaGraph software. Activities of proteins eluting
from the analytical SEC column were determined using the modified Bratton-Marshall assay to
monitor glutamine-dependent FGAM formation. Peak volumes were determined by integration.
Quantitation of ADP Binding to the Salmonella lgPurL
Salmonella gPurL (10-20 nmol, specific activity 3 U/mg in 25 mM HEPES pH 7.0, 1
mM glutamine) was diluted into 1 mL of water, and protein was precipitated by immersion into a
boiling water bath at 100°C for 10 min. The precipitated protein was then removed by
centrifugation, and an absorbance spectrum was taken of the supernatent (220-400 nm) after
blanking against a control solution containing no protein. The spectrum revealed only nucleotide
in solution by the Xmax at 260 nm. The A260 value was then used to determine the ADPoprotein
sl:oichiometry.
Efforts to Detect ADP Dissociation from the Salmonella lgPurL
Dialysis Experiments: gPurL was placed into a 30 kDa MWCO Slide-A-Lyzer cassette
(Pierce) and dialyzed against 5 x 1 L of 20 mM KPj pH 7.0 and 10 mM EDTA for 72 h. Aliquots
(-250 yL) were periodically removed during the dialysis and the ADP remaining bound to
lgPurL was quantified by protein denaturation and measurement of the A260 obtained from an
absorbance spectrum of the supernatent.
Exchange Reactions with [2,8-3H]-ADP: In a final volume of 500 ,IL, gPurL (10 nmol)
was mixed with 20 mM KPi pH 7.0, 5 mM MgCI2, and 1 mM [2,8- 3HI-ADP (1,158 cpm/nmol,
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Perkin Elmer) at 37°C. Aliquots (100 L) were removed after 1, 3, 6, and 16 h. The protein was
then separated from the small molecules by passage of the solution through a Sephadex G-50
column (1 x 20 cm, Sigma) equilibrated in 20 mM KPj pH 7.0 and 5 mM MgCI2. The amount of
13H I-ADP in the protein-containing fractions was analyzed by scintillation counting.
Quantitation of [8-'4 C]-ADP Binding to smPurL and the FGAR-AT Complex
Radioactive ADP was used to monitor ADP binding to both smPurL and the FGAR-AT
complex. In a final volume of 250 yL containing 50 mM HEPES pH 7.2, 20 mM KCI, 20 mM
MgCI2, 3 mM 18--4C]-ADP (789 cpm/nmol, Moravek Biochemicals), smPurL (40 nmol) was
added, and the reaction mixture was incubated at 37°C for 5 min.
The sample was then applied directly to a Sephadex G-50 column (1 x 20 cm, Sigma)
equilibrated in the incubation buffer at room temperature. Fractions of 0.5 mL were collected
and 0.2 mL was mixed with 7 mL of Emulsifier-Safe scintillation fluid (Perkin-Elmer) and
analyzed by scintillation counting. The remainder of the fraction was characterized by UV
absorbance at 260 and 280 nm using a Bio-Rad Ultramark plate reader in a 96-well UV-
transparent plate (Corning). Protein content was quantified using both a Lowry assay and by the
A 28 0.
18- 4CI-ADP binding to smPurL was also monitored in the presence of PurQ, PurS, or
both proteins by adding molar equivalent of PurQ and/or 2 molar equivalents of PurS to the
srnPurL solution. The proteins were allowed to incubate on ice for 5 min before the addition of
ADP. Due to the influence of glutamine on complex assembly, additional experiments were
carried out in the presence of 20 mM L-glutamine.
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3.3 Results
Genetic and biochemical studies using crude extracts of B. subtilis deletion strains
suggested that PurS, smPurL, and PurQ were all required for FGAM synthesis (7). Based upon
these results, an in vitro biochemical characterization of the proteins was initiated. Two
approaches were taken to obtain active protein: the first examined co-expression methods and
the second involved expression of the individual proteins and reconstitution of the complex. The
success of each approach was based upon observation of glutamine-dependent FGAM
production (Scheme 3.1) using the modified Bratton-Marshall assay.
Cloning, Co-Expression, and Co-Purification of the FGAR-AT Complex
A variety of different strategies were pursued for co-expression. A128T PurQ and
smPurL were cloned into pACYC-DUET-1, yielding pDUET-L-A128T-Q. Subsequent to
observations made with purified PurQ containing the A128T mutation versus the wt sequence
(see below), the A128T PurQ gene in pDUET-L-A128T-Q was mutagenized to the wt sequence.
This plasmid was named pDUET-L-wt-Q.
When these constructs were transformed into BL21(DE3) E. coli, expression of A128T
PurQ was 20% of soluble protein, while that of smPurL was < 1% of soluble protein (data not
shown). pDUET-L-A128T-Q was then co-transformed with pET-PurS. The expression level of
PurS was high; however, no expression of A128T PurQ or smPurL was observed (data not
shown). Next, pDUET-L-A128T-Q, pET-PurS, and pET-smPurL were all co-transformed, into
BL21(DE3) E. coli. Under these conditions, PurS, A128T PurQ, and smPurL were all expressed
as soluble proteins (Figure 3.1). No smPurL or A128T PurQ were detected in the insoluble
protein fraction. The crude cell lysate produced FGAM at 0.4 U/mg (Table 3.2). Given that
-20% of the total protein is associated with the FGAR-AT (estimated from SDS-PAGE, Figure
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Figure 3.1-15% SDS-PAGE of the co-expressed FGAR-AT. Lane 1, molecular weight
markers; lane 2, soluble crude cell lysate; lane 3, the activity-containing fraction from the DEAE
column.
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Table 3.2: Co-Purification of the FGAR-AT Complex (A128T PurQ)
step protein (mg) total units (U) SA (U/mg) % yield
cell ysatea 399 167.6 0.42 100
streptomycin 328 127.9 0.39 76
DEAE Sepharose 84 22.7 0.27 14
Sephacryl S-200 9.6 0.12 0.013 0.1
'From 4 g of cells
Table 3.3: Co-Purification of the FGAR-AT Complex (wt PurQ)
step protein (mg) total units (U) SA (U/mg) % yield
cell lysatea 372 126.5 0.34 100
streptomycin 330 122.1 0.37 76
DEAE Sepharose 105 22.1 0.21 14
Sephacryl S200 Peak 1 = 42 Peak 1=0.46 Peak 1 = 0.011 14
e cyekPeak 2 = 46 Peak 2 = 1.3 Peak 2 = 0.028
aFrom 33 g of cells
3.1), activity for the pure protein was estimated at 2-3 U/mg. Similar results were observed for
co-expression of wt PurQ from the pDUET-L-wt-Q plasmid (Table 3.3).
Purification of the FGAR-AT complex was attempted using DEAE Sepharose anion-
exchange chromatography. During chromatography, the three proteins separated (Figure 3.2)
based on SDS-PAGE analysis. One peak of FGAR-AT activity was observed using the Bratton-
Marshall assay. The specific activity of this complex (Figure 3.1, lane 3) had fallen to 0.27 U/mg
due to dissociation of the complex during chromatography (Table 3.2). The fractions containing
activity were pooled and applied to a Sephacryl S-200 SEC column. During elution, smPurL
completely separated from PurS and A128T PurQ, which co-migrated under these conditions
(Figure 3.3). In addition, only very low levels of activity were recovered (0.013 U/mg, Table
3.2). Thus, the proteins of the FGAR-AT are weakly associated. Purification results obtained
with wt PurQ or A128T PurQ were very similar under co-expression conditions (Tables 3.2 and
3.3). These results indicate that any study of the subunit stoichiometry, assembly, and kinetic
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Figure 3.2-DEAE elution chromatogram of the co-expressed FGAR-AT complex using A128T
PurQ. The solid line represents the A 280 values and the dashed line represents the [NaCI].
Activity () was measured as A500oo using the glutamine-dependent Bratton-Marshall assay. The
elution of PurS (S), PurQ (Q), smPurL (smL), and cellular DNA are noted.
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Figure 3.3-Sephacryl S-200 SEC elution chromatogram of the activity-containing fractions
from the DEAE column. Activity () was measured as A500oo using the glutamine-dependent
Bratton-Marshall assay. Elution of PurS (S), A128T PurQ (Q), smPurL (smL) are noted.
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parameters of the FGAR-AT complex must be carried out by reconstituting the separately
purified enzymes or by identification of other components that allow for co-purification of the
intact complex.
Cloning, Expression, and Purification of the Individual FGAR-AT Components
PurS: The purS gene was cloned from B. subtilis genomic DNA and ligated into pET-
1 la. The protein was over-produced in E. coli and was purified to homogeneity (Figure 3.4, lane
4) by DEAE anion-exchange chromatography followed by size exclusion chromatography (SEC)
(Figures 3.5 and 3.6). Typical yields were 13 mg/g cells. The molecular weight of the protein
was confirmed by ESI-MS.
PurQ: The purQ gene was also cloned from B. subtilis genomic DNA and placed into
pSTBLUE- 1. The gene was then subcloned into pET-24a for protein expression. E. coli
containing this plasmid were grown at 30°C to obtain soluble protein. PurQ was purified on a
DEAE Sepharose anion-exchange column (Figure 3.7). The fractions eluting at 100 mM KCI
were pooled, diluted with phosphate buffer, and loaded onto a Biogel HTP column. The flow-
through of the column contained PurQ. The eluate was concentrated and loaded onto a SEC
column (Figure 3.8). The resulting PurQ was homogenous by SDS-PAGE (Figure 3.4, lane 2)
with typical recoveries of 9 mg/g cells. The activity of PurQ was monitored using the continuous
glutaminase assay (Table 3.4). The variability in total activity is due to removal of an
endogenous glutaminase activity from E. coli during the purification (Figure 3.8). The molecular
weight of PurQ determined by ESI-MS was 24,816 Da (calculated 24,784), suggesting that the
clone contained a mutation.
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Figure 3.4-12% SDS-PAGE (lanes 1-3) and 16.5% tricine (lanes 4-5) gels of the purified
FGAR-AT components. Lanes 1 and 5, molecular weight markers; lane 2, A128T PurQ; lane 3,
smPurL; lane 4, PurS. 2 ~g of each protein was loaded.
153
0.6
0.5
0.4
0.3
0.2
0.1
n
z
0 100 200 300 400 500 600 700 800
Volume (mL)
Figure 3.5-DEAE Elution profile of PurS. Elution of PurS (S) is noted.
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Figure 3.6-Sephacryl S-300 elution profile of PurS. The elution of PurS (S) is noted.
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Subsequent to purification, the gene was sequenced which revealed an A128T mutation
consistent with the ESI-MS data. This residue is not conserved among PurQ enzymes. To
establish the actual identity of this residue, purQ was recloned from genomic DNA in five
separate reactions, using the high fidelity KODHiFi DNA polymerase. Sequencing of all of the
PCR products revealed an alanine at position 128. The wt-gene was also placed into pET-24a.
The purification of the wt PurQ protein was carried out as described for the A128T mutant.
However, the protein behaved differently from the mutant on DEAE Sepharose, eluting at 250
mM KCI. The purity of wt PurQ (50-60% homogeneous by SDS-PAGE, data not shown) and
recovery were both low. A variety of additional chromatographic methods were examined in an
effort to obtain homogeneous protein, all without success. The specific activity of the purified
wt PurQ using the glutaminase assay was 20 nmol min - mg -', higher than that of the mutant (5
nmol min - mg-]). However, the specific activity of the wt PurQ in the FGAM synthesis assay
described later was ten fold lower (0.12 U/mg vs. 1.2 U/mg) than the mutant PurQ. It is possible
that the high glutaminase activity of the wt PurQ could be due to an endogenous E. coli
golutaminase, as was seen in the SEC purification of the A128T mutant. In the reconstitution
experiments described subsequently, the A128T PurQ has been employed.
Table 3.4: Purification of A 128T-PurQ
step protein (mg) total SA % yield
units (U) (U/mg)
cell lysatea 1159 3.93 0.003 100
streptomycin 1214 1.52 0.001 39
DEAE 303 2.14 0.007 54
Sepharose
HTP Biogel 204 3.39 0.02 86
Sephacryl S-100 118 0.590 0.005 15
"From 13 g of cells
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Figure 3.7-DEAE elution profile of A128T PurQ. Activity () was
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Figure 3.8-Sephacryl S-200 SEC elution profile of A128T PurQ. FGAR-AT activity (,
dotted line) is represented as As0o from the gin-dependent Bratton-Marshall assay. Glutaminase
activity (, dashed line) is represented as the change in A363 per min from the GDH-coupled
assay. Notice that an endogenous E. coli glutaminase co-purified with PurQ. The glutaminase
was removed during SEC and eluted at 300 min. PurQ eluted at 350 min.
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It is interesting to note that both wt and A128T PurQ behaved similarly during the co-
expression experiments (Tables 3.2 and 3.3). This indicates that the low activity and inability to
purify wt PurQ may originate from expression of the enzyme in the absence of smPurL and
PurS.
smPurL: The purL gene was amplified by PCR from the pDE51 sequencing vector and
then ligated into pET-24a (6). Sequencing of the cloned gene revealed a L513F mutation, which
resulted from a single nucleotide mutation (CTC to TTC) in the codon. In contrast with the
observations with the purQ gene, a similar set of experiments revealed that the wt smPurL
contains a phenylalanine at position 513, not a leucine as previously reported (6). All work has
thus been carried out with smPurL containing F513.
In contrast to the co-expression experiments described above, expression of smPurL
alone resulted in aggregation and inclusion bodies. To maximize expression of soluble smPurL,
E. coli containing the smpurL expression plasmid were grown at 27.5°C. The enzyme was
purified using DEAE Sepharose anion exchange chromatography (Figure 3.9) followed by
chromatography on Reactive Red Agarose 120. The red agarose column removed inactive
aggregates of smPurL that eluted in the flowthrough of the column. These aggregates, unable to
re-equilibrate with active smPurL, accounted for 40% of the soluble smPurL. The active smPurL
also flowed through the dye affinity column, but only subsequent to the elution of the aggregate.
A small amount of smPurL remained bound to the column and eluted at 250 mM NaCI. While
recoveries from this column were low (18% of units, Table 3.5), recovery was sacrificed for
purity to enhance crystallographic efforts. The smPurL was typically recovered at 4 mg/g of
cells and judged to be 90% homogeneous based on SDS-PAGE (Figure 3.4, lane 3). N-terminal
protein sequencing of smPurL indicated loss of methionine, consistent with the ESI-MS
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molecular weight. Activity of smPurL (33 nmol min-
Marshall assay with NH4Cl as the ammonia source.
were not needed for FGAM synthesis.
Table 3.5: Purification of smPurL
step protein (mg) total un
(U)
cell lysatea 800 6.07
streptomycin 778 4.25
DEAE 236 5.43
Sepharose
Reactive Red 34 1.11
mg') was monitored using the Bratton-
Under these conditions, PurS and PurQ
[its SA
(U/mg)
0.008
0.006
0.02
0.03
% yield
100
70
89
18
Agarose 120
aFrom 8 g of cells
Reconstitution ojf Enzymatic Activity
Based on the stability and solubility problems encountered with both PurQ and smPurL,
it is perhaps not surprising that reconstitution of FGAR-AT proved to be challenging. Attention
to the concentration and ratios of the proteins in the reconstitution mixture as well as the order of
addition of the proteins was essential. Reconstitutions were carried out on ice to avoid
aggregation of both A128T PurQ and smPurL that was observed at higher temperatures (> 25°C).
The concentration of enzymes in the assay mixture was also critical to the success of the
reconstitution.
Determination of Subunit Stoichiometry: Initial efforts focused on determination of the
stoichiometry of PurS, smPurL, and A128T PurQ required to achieve maximal FGAR-AT
activity. After extensive experimentation, successful titrations were shown to require premixing
of all three component proteins at 10 tM at 4°C in the presence of glutamine and 10 mM
MNgATP. It was later determined that the ADP necessary for reconstitution of activity (see
below) could be completely supplied by ADP contamination present in the 10 mM ATP (data not
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shown). This mixture was then diluted 100-fold into the assay buffer at 37°C and monitored for
FGAM production. The results of a typical titration of A128T PurQ with PurS and smPurL (2:1)
are shown in Figure 3.10 (0). The titration reveals that maximal activity is achieved at a ratio of
A128T PurQ to smPurL of 1:1. PurS was titrated with A128T PurQ and smPurL (1:1) using a
similar procedure. Under these conditions, 2 equivalents of PurS are needed for maximal
activity (Figure 3.10, *). These results suggest the stoichiometry of PurS: smPurL: PurQ is
2:1:1.
Steady-State Kinetics
As noted in the introduction, FGAM synthesis can be divided into 2 half-reactions (Eq.
3.1 and 3.2): the hydrolysis of glutamine to glutamate and NH3 and ATP-dependent amidine
formation. Kinetic characterizations of the individual components (PurQ and smPurL) as well as
the complex (PurS, smPurL, and PurQ) have been investigated. The results are summarized in
Table 3.6 and are shown in comparison to previously studied lgPurLs.
Glutaminase Activity of PurQ: PurQ is a member of the triad class of glutaminases that
includes PabA (the glutaminase of the PabA/PabB aminodeoxychorismate synthase), HisH (the
glutaminase of the HisH/HisF imidazole glycerol phosphate synthase), and the lgPurLs (11, 16,
18, 20). In all cases, these enzymes possess very low (or in some cases undetectable)
glutaminase activity in the absence of the amidotransferase and/or other substrates. The kinetic
parameters of the A128T-PurQ are summarized in Table 3.6. As in the case of PabA and the
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Figure 3.10-Determination of the ratio of PurS: smPurL: PurQ required for maximal activity.
(0) 2 PurS: 1 smPurL (10 tM) and variable amounts of PurQ (0 to 40 tM) were pre-incubated
at 4C for 5 min. The reaction mixture was then diluted 100-fold and assayed for FGAM
production. () 1 PurQ: 1 smPurL (10 tM) and variable amounts of PurS (0 to 40 FM) were
pre-incubated at 4°C for 5 min. The reaction mixture was then diluted 100-fold and assayed for
FGAM production.
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chicken liver gPurL, a lag phase was present in the kinetics prior to the reduction of APAD (18,
21). The activity of A128T PurQ alone (0.002 s-1) is 0.08% that in the complex. The presence of
smPurL, PurS, and MgATP did not increase the activity. However, incubation with smPurL and
Purs (2 PurS: 1 smPurL: 1 PurQ) and -FGAR increased the turnover 30-fold (0.066s-1). No
additional increase in glutaminase activity was observed upon addition of the non-hydrolyzable
ATP analog ,y-rnethyleneadenosine 5'-triphosphate (AMP-PCP).
Table 3.6: Selected Kinetic Parameters of FGAR-AT Enzymes
Property smPurLa PurQ FGAR-AT E. colib Chicken
Complex' Liverc
Km FGAR 2.5 mM 507 tM 30 tM 100 tM
K, ATP 398 M 181 [AM 51 M 1.5 mM
Km Gin 2.5 mM 1.3 mM 64 MM 40 M
Km NH3 -3.5 mM 54 mM 10 mM
Magnesiumd 20 mM 20 mM 20 mM
Potassiumd 20 mM 10 mM 60 mM
kClt FGAM 0.044 2.49 5.00 0.47
synthesis (s-')'
kclt Glutaminase 0.002 0.066 0.001 0.002
(S-'),
'For smPurL and the FGAR-AT complex these values are Km,app due to substrate
inhibition. Values from (11). Values from (22) and (21). dDefined as the concentration
of Mg2+ or K+ required for maximal activity. eMeasured by the rate of FGAM synthesis
using either NH3 or gin as the nitrogen source. 'Measured by the rate of gin hydrolysis
using the continuous glutaminase assay in the absence of FGAM synthesis. For the
FGAR-AT complex, this was measured in the presence of FGAR but not ATP.
Amidotransferase Activity of smPurL: smPurL alone can catalyze formation of FGAM in
the presence of NH4Ci with a turnover number of 0.044 s- l, 1.8% the rate of FGAM synthesis
using glutamine. This number is similar to those previously reported for the E. coli (2%) and
chicken liver lgPurLs (5%) (11, 23).
The steady state kinetic parameters of smPurL with ammonia have been investigated at
pH 7.25 (see pH rate profile, Figure 3.12) and are shown in Table 3.6. FGAM formation was
measured using the Bratton-Marshall assay, and ADP production was measured using the
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PK/LDH assay. Substrate inhibition was observed at concentrations of NH4CI > 400 mM and -
FGAR > 2 mM. While the inhibition seen with 3-FGAR could be fit to Equation 3.4, inhibition
kinetics observed with NH 4CI could not be fit to standard inhibition equations. The Kms reported
in Table 3.6 are therefore apparent Kms (Km,app).
Activity of the FGAR-AT Complex: The three assays described above have been used to
measure FGAM, ADP, and glutamate formation by the FGAR-AT complex. These assays were
performed using the ratio of 2 PurS: 1 smPurL: 1 A128T PurQ and at protein concentrations >
0.1 FM. At lower enzyme concentrations, the specific activity of the complex dropped sharply
(Figure 3.11). This result may be related to the high FGAR-AT enzyme concentration in vivo
(see Chapter 4) and the Kd for the protein interactions. Similar to observations made in the
smPurL assays, -FGAR exhibited substrate inhibition at > 2 mM. Consequently, Equation 3.4
was used to fit the data, giving a Km of 507 EM. Kinetic analyses to determine Km,apps for
glutamine and ATP were carried out at 1 mM -FGAR (Table 3.6). The FGAR-AT complex
gave a turnover number of 2.5 s-l, which is comparable to that of gPurLs (Table 3.6). While the
assays to measure FGAM and glutamine formation gave complementary results, the coupled
PK/LDH assay monitoring ADP formation was problematic. Long lag phases were observed.
Similar assays on the E. coli and S. typhimurium gPurLs exhibited no lag phases. The source of
the lag phase was determined to be associated with the ATP regenerating system because
addition of PK and PEP (or, alternatively, creatine kinase and phosphocreatine) resulted in the
observation of lag phases in the glutaminase and Bratton-Marshall assays. These results
suggested that a small amount of ADP is required for FGAR-AT complex assembly and
turnover. The source of the ADP in these assays appears to be from background ATPase
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Figure 3.11-Concentration dependence of the specific activity of the FGAR-AT complex. The
FGAR-AT complex was reconstituted as described and diluted into assay buffer at varying
concentrations.
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activity of the his-PurM coupling enzyme and from ADP contamination of the ATP stocks (data
not shown).
Metal Ion Dependence: As with both the E. coli and chicken liver lgPurLs, the FGAR-
AT reaction for the smPurL was found to be metal ion dependent (11, 22). Magnesium is
required for the reaction, while saturating potassium levels stimulated FGAM synthesis 5-fold.
The optimal magnesium and potassium concentrations were 20 mM. These values are similar to
those previously reported for the lgPurLs (Table 3.6).
pH Dependence of the FGAR-AT Reaction: During these efforts to examine the NH3-
dependent smPurL activity, the assays were initially carried out at elevated pH ( 8.0). Previous
studies of the ammonia dependence of many glutamine-requiring enzymes have shown that
elevated pH is essential to increase the concentration of available NH3 (11, 16). At pH 8.0,
however, no activity was detected for smPurL. This prompted studies of the pH-dependence of
the FGAR-AT reaction. As shown in Figure 3.12, the complex has a sharp pH profile with an
optimum of -7.0. The pH rate profile for the NH3-dependent reaction is very similar to the
glutamine reaction, with a shift of the pH optimum to pH -7.25. These results indicate that the
pH-dependence of this enzyme resides on smPurL.
Stoichiometry of the Reaction: Given the complexity associated with optimization of the
active FGAR-AT, the product stoichiometry of the reaction was carefully examined. It was
determined to be 1 FGAM: 1.1 + 0.2 ADP: 1.7 + 0.2 glutamate, in contrast to the expected
results of 1:1:1. The glutamate was quantitated by two independent methods (experimental
section). As a control for this assay, the ratio of FGAM to glutamate formation was determined
for the E. coli and S. typhimurium gPurLs. It was found to be 1: 1.5 + 0.1 and 1: 1.6 + 0.1,
respectively. These results contrast with the earlier report of 1 ADP: 1 glutamate for the chicken
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Figure 3.12-pH dependence of the FGAR-AT reaction using either glutamine (E) or NH3 ()
as the nitrogen source.
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liver gPurL (21, 22). These results with 3 bacterial FGAR-ATs indicate that under these assay
conditions glutamine hydrolysis is uncoupled from FGAM production.
)ON Inactivation of PurQ
Support for catalytic coupling of the glutaminase activity to substrate interactions within
the smPurL enzyme was sought using the mechanism-based inhibitor 6-diazo-5-oxo-L-
norleucine (DON). This compound inactivates many glutaminases by alkylating the cysteine
required for covalent catalysis (20). A128T PurQ was also inactivated by DON but required the
presence of smPurL, PurS, MgATP, and -FGAR. The half-life for inactivation was < 1 s when
saturating in all substrates. A128T PurQ mixed with DON alone lost only 70% of its activity
after more than 20 h at 25°C. Therefore, formation of the FGAR-AT complex and binding of
NMgATP and FGAR accelerates the rate of DON labeling by a factor of 104. This rate
acceleration is comparable to the 1250-fold increase in glutaminase activity seen upon complex
formation and FGAM synthesis (Table 3.6). This feature is common to all ATs, but it is still not
well-understood.
Evidence for FGAR-AT Complex Formation
Analytical SEC on a Bio-Rad Bio-Silect SEC250 column was used to study the
quaternary structure of PurS, PurQ, smPurL individually and in the FGAR-AT complex. While
this column has limited resolution, the small excluded volume was essential for equilibrating the
column with substrates (FGAR, glutamine, ATP) to determine if their presence alters complex
formation.
As shown in Figure 3.13, PurS, A128T PurQ, and smPurL all migrated as discrete species
when separately injected. PurS (Figure 3.13, A) and A128T PurQ (Figure 3.13, B) eluted with
identical retention volumes of 6.8 mL. smPurL eluted at 5.4 mL (Figure 3.13, C). Thus,
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Figure 3.13-Analytical SEC results of the FGAR-AT component proteins injected individually.
PurS (A), PurQ (B), and smPurL (C) elute at 6.8, 6.8, and 5.4 mL, respectively. The shoulders
on the left hand side of the PurQ and smPurL peaks represent aggregated protein.
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complex formation could be monitored by disappearance of the PurS and A128T PurQ peaks and
by either an increase in the smPurL peak or the appearance of a new peak in the chromatogram.
In an effort to obtain direct evidence for a FGAR-AT complex, analytical SEC was
carried out on PurS, smPurL, and A128T PurQ mixed at different ratios and concentrations in the
presence and absence of substrates (ATP, FGAR, glutamine, and Mg2+) and at different
temperatures. A typical set of results are shown in Figure 3.14, A. With the proteins alone or in
the presence of Mg2+-ATP, glutamine, or -FGAR, no evidence of complex formation was seen
at either 4 or 25°C.
The kinetics studies suggested that Mg2+-ADP facilitated formation of an active form of
the FGAR-AT, an observation further supported by the presence of a tight binding (Mg2+)3-ADP
in the structure of the lgPurL (12). Thus, 2 PurS: 1 smPurL: A128T PurQ was pre-incubated
with Mg2+-ADP. Analytical SEC again revealed no complex formation. However, if the
complex had been pre-incubated with Mg2+-ADP and glutamine and injected onto a column
equilibrated with glutamine, a decrease in the PurS/PurQ peak was observed concomitant with an
increase in the srnPurL peak (Figure 3.15). The eluted complex had a specific activity of 0.8
UT/mg, and the presence of all three proteins was confirmed by SDS-PAGE. Surprisingly,
substoichiometric percentages (49%) of PurS and A128T PurQ were present in the complex.
Finally, if both the FGAR-AT complex and the column were pre-incubated with Mg2+-ADP and
glutamine, the FGAR-AT was observed to fully form for the first time (84% of PurS and A128T
PurQ complexed) and had a specific activity of 2.1 U/mg (Figure 3.14, B). These results indicate
that complex formation is dependent on the presence of both Mg2+-ADP and the glutamine
substrate.
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Figure 3.14-SEC evidence for the importance of the small molecules glutamine and ADP in
complex formation. (A) Injection of 2 PurS: 1 smPurL: 1 PurQ gave complete separation of the
components. PurS and PurQ elute at 6.8 mL , while smPurL elutes at 5.2 mL. Inclusion of
glutamine, Mg2+-ATP, Mg2+-ADP, or f3-FGAR gave similar results. (B) Injection of 2 PurS: 1
smPurL: 1 PurQ pre-incubated with (glutamine, Mg2+-ADP) and inclusion of (glutamine, Mg2+_
ADP) in the elution buffer gave complex formation (confirmed by SDS-PAGE, inset). (C)
Injection of 2 PurS: 1 smPurL: 1 PurQ inactivated with DON and chromatographed with Mg2+_
ADP in the elution buffer also showed complex formation. Inset: 15% SDS-PAGE showing the
presence of PurS, PurQ, and smPurL in the 5.2 mL peak from (B).
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Figure 3.15-Partial complex formation observed with pre-incubation of 2 PurS: 1 smPurL: 1
PurQ with Mg2+-ADP and glutamine and elution with only glutamine included in the SEC buffer.
The solid line shows the FGAR-AT proteins eluted in only SEC buffer. The dotted line shows
formation of the GAR-AT complex initiated by including glutamine in the SEC buffer.
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Figure 3.16-Partial 2 PurS: 1 smPurL: 1 PurQ complex formation observed with DON-
inactivated PurQ. The solid line shows the 2 PurS; 1 smPurL: 1 PurQ proteins eluted in SEC
buffer. The dotted line shows the 2 PurS; 1 smPurL: 1 PurQ proteins eluted in SEC buffer after
DON-inactivation of PurQ.
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Previous studies on assembly of channeling complexes in other glutamine-requiring ATs
suggested that the presence of a glutamine analog such as DON facilitated complex formation
(24). The 2 PurS: I smPurL: 1 A128T PurQ complex was therefore inactivated with DON and
examined by analytical SEC in the absence of glutamine. While a complex was seen, it
contained only 46% of the included PurS and A128T PurQ (Figure 3.16). The addition of Mg2 +-
ADP to the column elution buffer resulted in 92% of the PurS and A128T PurQ complexed with
smPurL (Figure 3.14, C). These results indicate that the DON-inactivated A128T PurQ can also
trigger complex formation and suggest that the role of glutamine in complex formation may
result from glutamine bound as a thioester. Together this work shows that Mg2+-ADP and either
a covalently or non-covalently bound glutamine are absolutely essential to form the active
FGAR-AT complex. A tight, transient complex may form to specifically channel the ammonia
released from PurQ.
ADP Binding to the Salmonella lgPurL
The crystal structure of the Salmonella gPurL reveals a tightly-coordinated (Mg2+)3 -ADP
bound to the enzyme (12). ADP was not added during the purification or during the
crystallization, indicating that the nucleotide was inserted during heterologous expression in E.
coli and remained bound during lgPurL's purification. This observation immediately provided a
link between the gPurL crystal structure and observations made while examining activity of the
B. subtilis FGAR-AT in which Mg2+-ADP was shown to be necessary for activity and tight
complex formation. As a result of these observations, ADP binding to the Salmonella gPurL
was investigated. The ADP-lgPurL stoichiometry could easily be determined by precipitating
the enzyme and measuring the amount of ADP released into solution. These results indicated that
ADP was bound quantitatively to gPurL with a ratio of 1.02 ADP: 1 protein. Similar
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experiments carried out with the B. subtilis smPurL detected no aborbance at 260 nm, indicating
that ADP that had not co-purified with the enzyme.
Co-purification of stoichiometric ADP with the Salmonella lgPurL requires that it is
tightly bound. Efforts to detect ADP dissociation from lgPurL without enzyme denaturation
were unsuccessful. Neither extensive dialysis, nor exchange with 3H]-ADP into gPurL could
detect ADP dissociation. These results indicate that ADP is bound to Salmonella gPurL with
very high affinity.
isolation of smPurLADP Complexes
Since ADP did not co-purify with the B. subtilis smPurL, experiments were carried out to
see if a smPurLoADP complex could be isolated after mixing the protein with ADP. Incubation
of smPurL with [t4Cl-ADP resulted in 0.073 equivalents of nucleotide co-purifying with the
protein using Sephadex G-50 chromatography (Table 3.7). However, ADP binding to smPurL
was stimulated by the presence of A128T PurQ, PurS, and glutamine. Under these conditions
0.43 equivalents of ADP co-chromatographed with the protein (Figure 3.17, Table 3.7). No
evidence for dissociation during chromatography was apparent. When PurS and A128T PurQ
were mixed individually with smPurL, A128T PurQ appeared to have the greatest effect on ADP
binding since 0.27 equivalents of ADP could be isolated with the protein (Table 3.7). The
impact of PurS and A128T PurQ on ADP binding provides further evidence for the connection
between ADP and FGAR-AT complex formation.
Table 3.7: Quantitation of /'4 C]-ADP Binding to smPurL
Proteins Glutamine Ratio ADP:smPurL
smPurL ---- 0.073 + 0.005: 1
smPurL/PurS 20 mM 0.14 + 0.02: 1
smPurL/PurQ 20 mM 0.27 + 0.04: 1
smPurL/PurQ/PurS ---- 0.31 + 0.06: 1
smnPurL/PurQ/PurS 20 mM 0.43 + 0.03: 1
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Figure 3.17-Isolation of a smPurL:nucleotide complex by G-25 Sephadex gel filtration
chromatography. 150 yM of the FGAR-AT complex (2 PurS: 1 smPurL: 1 PurQ) was incubated
with 3 mM 14 C-ADP and 20 mM L-glutamine. Excess ADP was then removed by the G-25
Sephadex column. The solid and dashed lines represent the absorbance at 280 and 260 nm,
respectively. The dotted line represents the amount of radioactivity in each fraction (CPM).
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One result from these experiments that warrants further investigation is the low
ADPosmPurL stoichiometry (Table 3.7). Radioactive ADP that co-eluted with the protein from
the G-50 column always appeared as a sharp peak, with little discernable tailing (Figure 3.17).
This indicates that the smPurL°ADP complex was likely not equilibrating on the column. The
low stoichiometry could be indicative of protein misfolding and aggregation during the
experiment, which has been a common problem in studies of the B. subtilis FGAR-AT. Future
experiments designed to monitor both smPurL aggregation and nucleotide binding may be able
correlate these two phenomena.
3.4 Discussion
Amidotransferases (ATs) are enzymes that catalyze the reaction of ammonia (derived
from the amide moiety of glutamine) with a wide range of substrates found in many metabolic
pathways to generate an aminated product. Seminal structural experiments on two ATs,
phosphoribosylpyrophosphate AT (PRPP-AT or PurF, the first step in the purine biosynthetic
pathway) and carbamoyl phosphate synthetase (CPS, in the pyrimidine biosynthetic pathway)
suggested a general model for all ATs in which the glutaminase activity is located on a domain
that is spatially separated from the AT domain (24, 25). The separation between the active sites
in the two domains of PurF and CPS is, for example, 20 A and 45 A, respectively (24, 25). The
long distance and the biochemical evidence that the "NH 2" moiety of the glutamine amide is
found in the final product requires that ammonia is channeled between these two domains (26).
The structural composition and the mechanism of formation of the channels within proteins have
recently received much attention but as yet no general principles have emerged (8).
The B. subtilis FGAR-AT provides a new system to study communication between
several active sites and ammonia channeling in an AT complex. All ATs contain one of two
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highly conserved glutaminase domains either fused to the AT domain directly or on a separate
polypeptide (20). The triad glutaminase domain was identified based on conservation of a
putative catalytic triad of cysteine, histidine, and glutamic acid; however, in many cases, the
acidic residue has been shown not to be essential for activity, and, thus, the triad nomenclature is
a misnomer (27, 28) (see Chapter 5). The B. subtilis FGAR-AT is unique among all triad class
ATs in that the enzyme is composed of three proteins (PurS, PurQ, and smPurL) instead of two.
The affinities between the glutaminase and AT proteins in a number of systems have
been reported. In the cases of CPS, anthranilate synthase (TrpEG), and imidazole glycerol
phosphate synthase (HisHF), the glutaminase domain is tightly bound to the AT, and the subunits
remain complexed during purification (16, 29, 30). In the case of p-aminobenzoate synthase
(PabAB), the two proteins separate during SEC at 4°C (18). However, if PabA and PabB are pre-
incubated with glutamine at 37°C and SEC is performed at 25°C, complex formation is now
observed (31). The diversity of the strength of subunit interactions and the coordination of
activities and NH3 channeling between proteins raises many questions concerning general
mechanisms of AT catalysis. In particular, the mechanism of NH3 channeling between weakly
interacting subunits remains largely unknown. As noted in Chapter 2, the phenomenon of
channeling of chemically unstable intermediates via transient protein interactions has been of
long standing interest in the Stubbe Laboratory. The B. subtilis FGAR-AT complex offers
another system within purine biosynthesis to explore this phenomenon.
The weak interactions between PurS, PurQ and smPurL became apparent when despite
their heterologous co-expression in E. coli, the proteins separated during all chromatographic
efforts for purification. Under the co-expression conditions, the solubility and stability of
smiPurL were greatly enhanced relative to smPurL expressed alone or in the presence of PurS.
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These observations and the high levels of activity in crude extracts prior to purification suggested
that the FGAR-AT components are interacting in the cell.
An additional observation during the co-expression experiments concerned the activities
of the wt and A128T PurQs. When co-expressed, the activites of wt and A128T PurQ were
comparable; however, when PurQ was isolated individually, the enzymes behaved very
differently. The wt PurQ possesses much lower activity than the A128T PurQ mutant and could
not be purified to homogeneity. The reason for these differences in behavior is unclear given
that A128 is a non-conserved amino acid and is believed to be located on a solvent-exposed loop
based on threading models using the structure of gPurL. This loop appears to reside in a
location not involved in complex formation or catalysis.
Given the inability to isolate an assembled FGAR-AT complex, efforts turned towards
reconstituting the protein complex. The reconstitution was monitored by the glutamine-
dependent FGAM synthetase activity, and titrations suggest the active AT contains PurS,
smnPurL, and PurQ in a ratio of 2:1:1 (Figure 3.10). The stoichiometry of products produced by
the reconsituted FGAR-AT was 1.7 glutamates per ADP and FGAM. This uncoupling
propensity is shared by both the E. coli and S. typhimurium enzymes but not the chicken liver
enzyme (22). It is interesting to note that measurements made by Buchanan and coworkers on the
chicken liver lgPurL indicated that the glutaminase activity could be drastically uncoupled from
ADP formation using several glutamine analogs (21). For example, the enzyme hydrolyzed 5
equivalents of y-glutamylhydroxamate for each ADP consumed at 58% the rate of the normal
reaction.
Various degrees of reaction coupling have been reported in the literature for other ATs.
Both CPS and HisHF have been kinetically well-characterized and show stoichiometric product
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formation (32, 33). On the other hand, asparagine synthetase B possesses a glutaminase activity
I .5-fold faster than asparagine formation, similar to results obtained for FGAR-AT (34). A
detailed kinetic analysis of asparagine synthetase B suggests that uncoupling results from
glutamine hydrolysis in the absence of the adenylated-aspartate intermediate formed during
asparagine synthesis from aspartate and ATP and a 1:1 product ratio is only observed under sub-
saturating glutamine concentrations (34). In one extreme example, cobyrinic acid a,c-diamide
synthetase has been shown to hydrolyze 8 equivalents of glutamine for every product formed
(.35). The source of the reaction uncoupling in FGAR-AT is not understood; however, it may
related to difficulties in enzyme reconstitution, ADP co-factor binding, or aggregation. Due to a
lack of pre-steady state kinetic information, it is difficult to determine if the reaction uncoupling
is due to NH3 leaking from a putative channel between the glutaminase and FGAM synthetase
sites or if it is due to glutamine hydrolysis in the absence of the proper FGAR and ATP
intermediate in the AT site.
The most startling finding during these efforts to assemble an active FGAR-AT complex
was the dependence on Mg2+-ADP. Mg2+-ADP was necessary for both activity and isolation of a
protein complex by analytical SEC. An explanation for the role of ADP-binding became clear
when Ruchi Anand (Ealick Laboratory, Cornell University) solved the crystal structure of the
Salmonella gPurL enzyme at a resolution of 1.9 A (12). The N-terminal histidine-tagged
enzyme (specific activity 4.4 U/mg) was crystallized by addition of 2.0 M (NH 4 )2 SO4 to a 15
mrng/mL enzyme solution in 25 mM HEPES pH 7.1 and 1 mM glutamine. Of the 1295 amino
acids in the native enzyme, all could be fit to the electron density except for residues 448-466
which form a mobile loop that closes over the amidotransferase active site. The structure of the
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enzyme has been described in extensive detail elsewhere (12); so, only the results pertinent to
this chapter are discussed.
The structure of gPurL revealed that the enzyme contains 4, largely independent
domains (Figures 3.18 and 3.19). The N-terminal domain adopts an unusual half-barrel fold that
contacts both the glutaminase and AT-domains. The N-terminal domain is connected to the
body of the enzyme by a linker domain (18 residues) culminating in a 3-helix bundle (Figure
3.19). The length of the linker domain and its weak side chain electron density suggested that
the N-terminal domain may be highly mobile and interact only transiently with the glutaminase
and AT domains.
The active sites of the glutaminase and AT domains are spaced -30 A apart; however, a
well-defined NH. tunnel similar to that observed in CPS was not observed in the crystal
structure. The lack of a channel may be due to crystallization of the enzyme in a catalytically
incompetent conformation resulting from the presence of a glutamylthioester in the glutaminase
domain (described in greater detail in Chapter 5). Previous studies on E. coli gPurL indicated
that while a glutamylthioester adduct readily forms upon incubation of the enzyme in the
presence of glutamine, the resulting complex is neither kinetically nor chemically competent for
catalysis (11, 36). Like PurF, the NH3 tunnel in the FGAR-AT may be formed transiently during
the reaction, and elucidation of the NH3 tunnel is the focus of current crystallographic efforts on
lgPurL by the Ealick Laboratory. At this stage, two possible routes for NH3 have been identified
(Figure 3.20). The favored route (Figure 3.20A) includes many conserved residues and is
predicted to involve interactions with the N-terminal domain; however, this awaits experimental
verification.
182
Figure 3.tS-Structure of the Salmonella IgPurL enzyme. The N-terminal (green), linker
(yellow-orange), FGAM synthetase (blue), and glutaminase (red) domains are shown. Sulfates
present in the active site are shown in spacefilling representation. The (Mg2+)3-ADP cofactor is
shown in both spacefilling and stick representation (partially obscured by the FGAM synthetase
domain).
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Figure 3.19-Domains of the FGAR-AT. (A) the N-tenninal domain (notice the half-barrel
shape), (B) the linker domain, (C) the glutaminase domain, and (D) the FGAM synthetase
domain. The FGAM synthetase domain is colored to highlight the symmetry between the A lIB 1
(N-terminal) and A2IB2 (C-terminal halves). The active site lies in a cleft between the Al and
B1 domains. The (Mg2+))-ADP site is related to the active site by the symmetry of the pseudo-
dimeric fold. Figure courtesy of Ruchi Anand, Cornell University.
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BFigure 3.20-Stereoviews of 2 possible NH) tunnels present in the Salmonella IgPurL structure.
(A) shows the favored channel which contains the most conserved residues, involves active
participation of the N-terminal domain, and is the most direct path between the active sites. (B)
shows an alternate path which contains more hydrophobic residues than (A) and passes near the
ADP binding site. Figure courtesy of Ruchi Anand, Cornell University.
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The AT domain shows a high degree of 2-fold pseudosymmetry between the N-terminal
and C-terminal halves (Figure 3.19). These halves are also connected by a 27-residue linker
region. Sequence alignments of many gPurLs and mapping of conserved residues to the
structure indicated that AT active site resides in the N-terminal half of this domain.
Surprisingly, a tightly bound (Mg2+)3-ADP was found in the symmetry related-active site in the
C(-terminal half (Figure 3.21). The ADP was not added during either the purification or
crystallization and thus co-purified with enzyme isolated from E. coli. Analysis presented in this
chapter of ADP-binding to the Salmonella lgPurL indicated that ADP is bound stoichiometrically
with the enzyme and can only be removed by protein denaturation. Sequence and structural
information has indicated that the (Mg2+)3 -ADP binding site (referred to from now on as the
auxiliary nucleotide site) has degenerated from an active site over the course of lgPurL evolution
and is not a second active site. The current working model is that ADP is acting as a structural
cofactor that allows correct orientation of the glutaminase domain (which docks on top of the
auxiliary nucleotide site) above the FGAM synthetase active site. This orientation may be
essential for NH3 channeling.
Unlike lgF'urL, no ADP could be detected bound to purified B. subtilis smPurL. If ADP
is playing a similar role in smPurL to that proposed for lgPurL, then the weaker affinity could
explain why the addition of exogenous ADP was necessary for formation and activity of the B.
subtilis FGAR-AT complex. It is proposed that the requirement for Mg2+-ADP is due to the B.
subtilis smPurL requiring this metabolite to bind in its own auxiliary nucleotide binding site to
act as a structural cofactor for complex formation. In support of this proposal, sequence
alignments and homology modeling (Figure 3.22) show that Mg2+-ADP-binding residues are
remarkably well-conserved between the Salmonella lgPurL and B. subtilis smPurL. Only -0. 1
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Figure 3.21-Stereoview of the (Mg2+)3-ADPsite. Notice that the ADP is tightly coordinated.
Figure courtesy of Ruchi Anand, Cornell University,
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Figure 3.22-(Top) A structural model for the B. subtilis smPurL ADP-binding site. (Bottom)
Structure-based sequence alignment of B. subtilis smPurL and Salmonella IgPurL showing
conservation of residues in the auxiliary nucleotide site.
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equivalents of ADP were observed in attempts to isolate an ADP-smPurL complex by gel
filtration chromatography (0.073 ADP: 1 smPurL), and this indicates that ADP may be bound
more weakly to smPurL than in lgPurL and dissociate during protein purification. ADP binding
was stimulated by the presence of PurQ, PurS, and glutamine (0.43 ADP: 1 smPurL, Table 3.7),
which further highlights the relationship between ADP and formation of the FGAR-AT complex.
The results presented in this chapter describe the first biochemical characterization of an
FGAR-AT composed of three proteins. Chapter 4 describes the structure of several PurSs and the
formation of a structural model for the B. subtilis FGAR-AT that is consistent with the
biochemistry reported in this chapter. The data suggest that the FGAR-AT complex and lgPurL
enzymes will be structurally very similar. The weak protein interactions observed within the
FGAR-AT complex and their ability to change as a function of Mg2+-ADP and glutamine
binding are particularly intriguing. These results clearly demonstrate the role small molecule
metabolites can play in altering protein-protein interactions and highlights the importance of
studying protein complexes under a variety of physiological conditions. The influence of
glutamine on the complex formation is investigated further in Chapter 5. This work provides an
alternate system to PurF and PurD (Chapter 2) in the purine pathway for future investigations on
the importance of channeling of chemically reactive intermediates between weakly interacting
proteins.
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Chapter 4:
Biophysical Studies on PurS and the FGAR-AT Complex
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4.1 Introduction
In B. subtilis, FGAM synthesis is carried out by a complex of three proteins:
PurS (84 amino acids), PurQ (227 aa), and smPurL (742 aa). The first biochemical
characterization of this complex was described in Chapter 3. In those studies, PurS was
determined to have no enzymatic activity or sequence homology to any known protein;
however, it was necessary for glutamine-dependent FGAM synthesis. Maximal activity
was achieved when the protein complex was reconstituted with a ratio of 2 PurS: 1
smPurL: 1 PurQ. The requirement for a protein in addition to the glutaminase (PurQ) and
AT (smPurL) subunits makes the FGAR-AT complex unique among ATs with a triad
glutaminase domain. Experiments designed to co-purify the FGAR-AT complex resulted
in dissociation of the components during chromatography. Thus, PurS interacts weakly
with smPurL and PurQ. An isolatable protein complex could only be obtained when
Mg2+-ADP and glutamine were included in the elution buffer during chromatographic
analysis.
In order to facilitate elucidation of the role of PurS in FGAM synthesis, the
crystal structure of the B. subtilis PurS was determined (1). The structure revealed that
PurS is dimeric with 2800 A2 buried surface area and is structurally homologous to the N-
terminal domain of lgPurLs (Figure 4.1). The conservation of structure between the PurS
dimer and the N-terminal domain of lgPurL was surprising given that even after a
structure-based sequence alignment (Figure 4.1), the proteins share little sequence
homrnology. The structure of PurS clarifies two findings described in Chapter 3. First, the
need for PurS in glutamine-dependent FGAM synthesis becomes clear. The role of PurS
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Figure 4.1-(Top) A comparison of the B. subtilis PurS dimer (left) and the N-terminal
domain of the Salmonella IgPurL (right). The strong structural homology indicates that
the N-tenninal domain evolved from PurS after gene duplication and fusion events.
(Bottom) A structure based sequence alignment of PurS and the N-terminal domain
indicates very little sequence homology despite the similar structures.
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may be similar to the proposed role of the N-terminal domain of IgPurL: linking the
glutaminase and AT domains. Second, maximal FGAR-AT activity was achieved when
2 equivalents of PurS were incubated with 1 equivalent of PurQ and smPurL. The PurS
dimer recapitulates the structure of the N-terminal domain of lgPurLs.
Crystal structures of PurS were determined from 2 different crystal forms: P21
and C2 at pH 7.3 and 5.6, respectively. In both crystal forms, a tetramer of PurS was
observed (Figure 4.2) (1). The PurS tetramer forms by hydrogen-bonding interactions
between [3-strands of adjacent dimers and results in a 12-stranded 3-barrel structure.
While the barrels in the P2 and C2 crystal forms appear similar, the hydrogen bonding
interactions at the dimer:dimer interface shift register in the different crystal forms
(Figure 4.3).
Recently, the crystal structures of several PurSs from different organisms have
also been determined. The structure of the T. maritima PurS also forms a tetramer
(Figure 4.2); however, in this case the 3-barrel formed by the tetramer is more
asymmetric than that observed with the B. subtilis protein. A different tetramer structure
was observed for the M. thermoautotrophicum PurS (Figure 4.2) (2). In this case, a
histag used to purify the protein has been proposed to disrupt possible interactions
between 1-strands that comprise the 3-barrel, resulting in its crystallization in an alternate
tetrameric structure (1). Additional evidence for a M. thermoautotrophicum PurS
tetramer has been reported by size-exclusion chromatography (2).
Based on the structures of PurS dimers and tetramers and the Salmonella lgPurL
structure, a homology model for the B. subtilis FGAR-AT complex was created (Figure
4.4) (1). In the homology model, PurS plays an analogous role to the N-terminal domain
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B. subtilis
P21
T. maritima
B. subtilis
C2
M. thermoautotrophicum
Figure 4.2- Structures of PurS tetramers observed in various organisms. Clockwise
from Top Left: B. subtilis P2. crystal form (1TWlpdb), B. subtilis C2 crystal form
(1T4A.pdb), M. thermoautotrophicum (1GTD.pdb), T. maritima (1VQ3.pdb).
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AB
Figure 4.3- The dimer-dimer interface observed in the B. subtilis PurS tetramer (1). (A)
P2t crystal form. (B) C2 crystal form. Each interface is composed of just 4 hydrogen
bonds. In the C2 crystal form, 2 of these bonds are mediated by water molecules.
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Figure 4.4-(Top) In the homology model, a PurS dimer (green ribbon) is proposed to
link PurQ (red) and smPurL (blue). (Bottom) A tetramer of PurS has also been modeled
to form a 4 PurS: 2 smPurL: 2 PurQ complex. (1)
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of lgPurL and links PurQ to smPurL. Homology models were also built using the PurS
tetramer with no unfavorable contacts (1). The exercise of homology building thus raised
the possibility that the FGAR-AT complex might be composed of 4 PurS: 2 smPurL: 2
PurQ. The differences in appearance of the PurS tetramers from different organisms
(Figure 4.2) and the small dimer:dimer interfaces (composed of just 4 hydrogen bonds in
the B. subtilis PurS) suggested that the quaternary structure of FGAR-AT is likely to be
composed of 2 PurS: 1 smPurL: 1 PurQ.
The goal of this chapter is to determine the quaternary structure in solution of
PurS itself and the FGAR-AT complex. This goal has proven to be challenging due to
PurS's unusual shape and the propensity of PurQ and smPurL to aggregate.
Consequently, multiple biophysical techniques were utilized. The quaternary structures
of PurS and the FGAR-AT complex have been investigated using size-exclusion
chromatography (SEC) and sedimentation velocity analytical ultracentrifugation (SV-
AUC). In addition, the small size of PurS facilitated amide backbone assignments by 2D
and 3D-NMR methods, which has led to a series of experiments supporting its dimeric
structure. Finally, quantitative Western blotting of PurS, PurQ, and smPurL grown under
different culture conditions suggest that the protein concentrations used in SEC and SV-
AUJC experiments are similar to those observed in vivo. Together the data indicate that
PurS is a dimer in solution, and that the FGAR-AT complex is composed of 2 PurS: 1
smPurL: 1 PurQ.
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4.2 Experimental
Materials and Methods
All proteins were isolated and quantified as described in Chapter 3. AUC
experiments were carried out in the Biophysical Instrumentation Facility for the Study of
Complex Macromolecular Systems (Department of Chemistry, MIT). NMR experiments
were carried out by Jens W6nhert at the Insitlit fur Organische Chemie, Johann Wolfgang
Goethe-Universitat (Frankfurt, Germany).
Size-Exclusion Chromatography
SEC was performed using either a HiPrep 26/60 Sephacryl S-200 HR column (for
PurS and A128T PurQ, Amersham Biosciences) or a S-300 HR column (for smPurL and
the FGAR-AT complex, Amersham Biosciences) on a BioLogic LP system (Bio-Rad) at
4°C. The columns were equilibrated in either SEC buffer (50 mM KPj, 75 mM NaCl pH
7.25) or SEC buffer with 0.1 mM ADP, 5 mM MgCl 2, and 25 mM L-glutamine.
Samples (500 /L) were loaded at 100 /M of each protein: PurS, smPurL, or A128T PurQ
or 100 /M of the 2PurS: lsmPurL: 1 A128T PurQ complex. Proteins were eluted at a
flow rate of 0.5 mL/min and 3 mL fractions were collected. Fractions were monitored at
280 nm and elution of the complex was monitored by the glutamine-dependent Bratton-
Marshall assay as described in Chapter 3. A standard curve was generated using
thyroglobulin (670 kD), bovine y-globulin (158 kD), chicken ovalbumin (44 kD), equine
myoglobin (17 kD), and vitamin B 12 (1.4 kD) (Bio-Rad), E. coli PurL (141 kDa), and E.
coli his-PurM (a 76 kDa dimer) and linear-regression analysis of the data with
KaleidaGraph software (Synergy). Standard deviations of observed elution times were
calculated from triplicate experiments using the elution standards.
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Sedimentation Velocity Analytical Ultracentrifugation
SV-AUC experiments were performed with an An5OTi 8-hole rotor using an
Optima XL-1 analytical ultracentrifuge (Beckman Coulter, Fullerton, CA). Samples (400
yL) were placed in double-sector Epon centerpieces with either quartz or sapphire
windows depending on whether absorbance or interference optics were used to monitor
the sedimentation.
During the centrifugation, data was collected from each cell at 4-5 min
intervals, and -100 data sets equally-distributed during the length of the run were
included in the analysis. In all cases, SEDNTERP software from Dr. John Philo was used
to calculate buffer density, viscosity, and protein partial-specific volume from the amino
acid content (3). Data was analyzed by SEDFIT88 using a continuous sedimentation
coefficient distribution model derived from solutions to the Lamm equation (Equation
4.1) (4) wherein c is the concentration of the molecule of interest, t is time, r is the radial
position from the axis of rotaion, D is the diffusion coefficient of the molecule of interest,
s is the sedimentation coefficient, and w is the angular velocity obtained by the sample
during centrifugation. This equation describes the concentration distribution of species
with respect to their sedimentation and diffusion coefficients in a centrifugal field. The
implementation of the Lamm equation by SEDFIT88 has been described (5). The
distribution of species obtained by SEDFIT was then integrated using Kaleidagraph
software (Synergy).
dc l d [r dc2]
dc-= - SW 2r2c (4.1)
dt r dr dr
PurS: PurS was dialyzed for 20 h at 4°C in a Slide-A-Lyzer cassette (Pierce) with
a 7 kDa molecular weight cutoff (MWCO) membrane against either PBS (pH 7.1) or 50
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mM HEPES (pH 7.1), 20 mM MgCI2, 80 mM KCl. In the former case, sedimentation of
PurS (100, 500, or 1000 yM monomer) was monitored by interference optics while
centrifuging at 50,000 rpm for 20 h at both 10 and 25°C. In the later case, sedimentation
of PurS (66 or 132 yM monomer) was monitored by absorbance optics with
centrifugation carried out at 50,000 rpm for 20 h at either 10 or 25°C.
A128TPurQ: Samples (57 jiM) were dialyzed for 20 h at 4°C in a Slide-A-Lyzer
cassette (Pierce) with a 10 kDa MWCO membrane against PBS (pH 7.1). Sedimentation
was monitored by absorbance optics with centrifugation carried out at 45,000 rpm for 20
h at 10°C.
his-PurM, gPurL, and smPurL: Samples of E. coli histag-PurM (25 jIM), E. coli
lgPurL (7 yM), and smPurL (40 )M) were dialyzed for 20 h at 4°C in a Slide-A-Lyzer
cassettes (Pierce) with a 10 kDa MWCO membrane against PBS (pH 7.1).
Sedimentation was monitored by absorbance optics with centrifugation carried out at
40,000 rpm for 20 h at 10°C.
FGAR-ATComplex: A 2 PurS: 1 smPurL: 1 A128T PurQ complex (16 YM) was
dialyzed for 6 h at 4°C in a Slide-A-Lyzer cassette (Pierce) with a 7 kDa MWCO
membrane against 25 mM HEPES pH 7.2, 20 mM KCI, 20 mM MgCI2, 0.1 mM ADP,
and 20 mM glutamine. Sedimentation was monitored by interference optics with
centrifugation carried out at 40,000 rpm for 24 h at 10°C.
'
5N and '5N/'3C Labeling of PurS for NMR Analysis
Expression of PurS was carried out as described in Chapter 3 except that a 50 mL
starter culture was used to inoculate 500 mL of minimal media, which contained [15N1-
NH4CI (MARTEK BIO) and [U-_3C|-glucose (Cambridge Isotope Laboratories) as the
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sole nitrogen and carbon sources. The media (493 mL) contained 42 mM Na2HPO4, 22
mM KH2PO4, 8.5 mM NaCI, and 0.5% (w/v) NH4CI (pH 7.4) and was autoclaved. To
this solution, CaCl 2 (0.5 mL of a 100 mM solution, autoclaved), MgSO4 (4 mL of a 1 M
solution, autoclaved), glucose (0.5 mL of a 25% (w/v) solution, filter sterilized), and
thiamine (0.5 mL of a 5 mg/mL solution, filter sterilized) were added. Metals (0.5 mL)
were then added from a 1000lx stock solution containing 2.5 g/L CoC12o6H20, 1.5 g/L
MnCI2*4H20, 2.25 g/L CuSO 4 *5H20, 3 g/L boric acid, 1.4 g/L MoO3, 8.1 g/L ZnCl 2, and
62 mg/L FeCI3. The isotopically-labeled PurS was isolated as described in Chapter 3 to
give -15 mg protein/g cells with >95% purity.
General NMR Methods
All NMR-experiments were carried out on Bruker DRX 600 MHz, AV 700, or
AV 800 MHz spectrometers equipped with z-axis gradients and normal temperature or
cryogenic triple-channel (H, 3C, 15 N)-HCN probes. All spectra were processed and
analyzed using the Bruker NMRSUITE (XWINNMR 3.5) and XEASY (6). All NMR-
experiments were recorded in 90% H2 0/10% D2 0 at 298 K. 'H,15N-HSQC-spectra were
recorded using standard pulse sequences with dl=1.0-1.5s, 2-32 scans/increment, 1024
complex points and a spectral width of 16 ppm in the f2-dimension and 32-96 complex
points and a spectral width of 22-24 ppm in the fl-dimension.
Assignment of PurS Backbone Resonances
Backbone assignments (HN, N, Cac, C3, CO and Hc chemical shifts) for PurS
were obtained from analyzing a set of three-dimensional NMR-experiments carried out
with a 3C,'5N-labelled sample of 1.5 mM PurS in 20 mM KPj (pH 6.2), 20 mM KCI, and
2 mM 3-mercaptoethanol (NMR-buffer). The low pH of the buffer was used to increase
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the intensity of the signal of the proton associated with the amide by decreasing the rate
of exchange with solvent. -mercaptoethanol was used to prevent disulfide bond
formation during the days required for data acquisition.
Sequential assignments were obtained from analyzing 3D-HNCA (7) and 3D-
HNCACB (8) experiments. In the 3D-HNCA experiment each amide signal is correlated
with the Cot-chemical shifts of its own (HN(i) Cu(i)) and of the preceding amino acid
(HN(i) --> Cc(l)) (Figure 4.5). Amide signals that belong to sequential neighbors in the
protein sequence can therefore be identified by one shared Ca-chemical shift. However,
the Cc-chemical shift alone is often not sufficient to unambiguously link two amino
acids, since not all Cc-atoms in the protein have a unique CuX-chemical shift. The
resulting ambiguities can be resolved by the 3D-HNCACB-experiment. In this
experiment, each amide signal is correlated with the Ca- and the Cf3-chemical shifts of its
own (HN(i) -) Cc(j)/ C3(i)) and of the preceding amino acid (HN(i) -) Cu(i l)/C(il))
(Figure 4.5). Amide signals that belong to sequential neighbors in the protein sequence
can therefore be identified by one shared Ca-chemical shift and one shared Cf3-chemical
shift. HN(i) -) Cc(i/ C(i)-correlations can be distinguished from HN(i) C(il)/C3(i-)
correlations in the HNCA- and HNCACB-experiments by comparing these with a 3D-
CBCA(CO)NH-experiment (9) (Figure 4.5). In the latter experiment only the HN(i) -
CX(i_)/C3(i_) correlations are observable.
For all 3D-triple resonance experiments 1024 complex points with a spectral
width of 16 ppm were used in the f3 (H-detected)-dimension. The 1H-carrier frequency
was set at the water signal. A spectral width of 22 ppm was used in the 15N-dimension
(f2) in all 3D-experiments with the 15 N-carrier frequency set to 119 ppm.
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Figure 4.5-Schematic representation of the NMR experiments used to assign PurS
amide proton resonances. (Top) In the HNCA experiment, magnetization is transferred
from the amide proton to the Cn carbons on either side of the amide, which allows
assignment of each amide proton to two specific Cn carbons. (Middle) In the HNCACB
experiment, magnetization is transferred from the amide protons to the C~ carbons. This
method provides some information about the protein side-chains that appear on either
side of the amide (for example, if a peak appears in the HNCA spectra but not in the
HNCACB spectra, then the amide must be next to a glycine, which lacks a C~).
(Bottom) In the CBCA(CQ)NH experiment, magnetization is transferred from the C~
carbon to the amide of the next residue. This experiment gives information about the
amino acid that immediately precedes the amide in the protein sequence.
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The 3D-HNCA-experiment (7) was carried out over 1.5 days on a Bruker DRX
600 MHz spectrometer with 8 scans/increment, dl = 1 s, 80 x 32 complex points in fl
and f2 and a spectral width of 32 ppm in the fl-dimension. The 13C-carrier frequency
was set to 54 ppm in the middle of the Cac-chemical shift region.
The 3D-HNCACB experiment (8) was recorded over 2.5 days on a Bruker AV
800 MHz spectrometer with a cryogenic probe using 16 scans/increment, dl = 1.2s, 80 x
32 complex points in fl and f2, and a spectral width of 65 ppm in the fl (13C)-dimension.
The 13C-carrier frequency was set to 40 ppm in the middle of the Cat/C3-chemical shift
region.
A 3D-CBCA(CO)NH-experiment (9) was collected at 600 MHz over 2 days with
16 scans/increment, dl = . ls, 64 x 32 points in f and f2 and a spectral width of 65 ppm
in the fl-dimension. The 13C-carrier frequency was set to 40 ppm.
CO-chemical shifts were obtained from a 3D-HNCO-experiment (7) collected at
600 MHz over 11 h with 4 scans/increment, dl=l.Os, 64x32 points in f and f2, spectral
width =14 ppm in f , and the 13C-carrier frequency at 176 ppm.
Ha-chemical shifts were extracted from a 3D-HBHA(CO)NH-experiment (10) at
600 MHz with a cryogenic probe over 1.5 days with 8 scans/increment, dl = 1.2s, 90 x
34 points in f and f2, spectral width = 8 ppm in f , and the 13 C-carrier frequency at 36
ppm.
Identification of Secondary Structural Elements in PurS
In order to identify secondary structure elements of PurS in solution and compare
them to the crystal structure (1), the deviations from random coil chemical shifts were
calculated for Cct, H, N, and CO atoms and plotted against the residue number (11).
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A 3D- 1 5N-edited NOESY-HSQC spectrum with a mixing time of 100 ms was
recorded on Bruker AV 800 MHz spectrometer over 4 days on a 2 mM [15Nl-PurS sample
in NMR-buffer to confirm the presence of inter-strand NOEs in the 3-strand 13-sheet of
PurS (8 scans/increment, dl=2s, 110 x 48 complex points in fl and f2, spectral width=12
ppm in fl).
H/D Exchange Experiments to Monitor Solvent-Accessibility of Residues Proposed to be
Involved in Tetramer Formation
A 0.5 mM 15N-PurS sample in NMR-buffer was lyophilized and then
reconstituted in D20. A series of [H,' 5N]-HSQC-spectra were recorded to identify slowly
exchanging amide groups. The first spectrum was recorded 1 min after dissolving the
sample in D2(-) with 2 scans/increment and only 64 complex points in the fl-dimension
with d l=l s (experimental time = 4 min) on a Bruker 600 MHz spectrometer equipped
with a cryogenic probe. Further spectra were recorded 30, 90 and 270 min after
dissolving the sample in D20 using standard conditions (8 scans/increment, 1024
complex points and 16 ppm spectral width in f2, 96 complex points in f , 22 ppm spectral
width in f, 15N-carrier frequency at 119 ppm, dl=1.5 s).
DOSY Spectroscopy to Measure the Rate of PurS Diffusion and the Hydrodynamic
Radius of PurS
DOSY (diffusion ordered spectroscopy) experiments using the pulse sequence of
Jones et al. (12) were carried out with 0.5 mM or 0.2 mM 15N-labelled PurS-samples in
D20 with a 20-fold excess of dioxane (RH = 0.212 nm) as an internal standard in 20 mM
KPj, 20 mM KCI, and 2 mM 13-mercaptoethanol pH 6.2. Experiments were collected at
10 gradient strengths with 128 scans/experiment. Signal intensity was then plotted versus
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the gradient strength for both the dioxane standard and PurS NMR signals, which allow
comparison of the diffusion properties for dioxane versus PurS. HYDROPRO software
(13) was used to predict the radius of hydration for the monomeric, dimeric, and
tetrameric species of PurS and compared to results obtained from the DOSY experiment.
Measurement of Longitudinal and Transverse Relaxation Rates for PurS Amide Protons
and Comparison to Predicted Values for the Monomeric, Dimeric, and Tetrameric Forms
of PurS
Longitudinal (T 1) and transverse (T2) relaxation rates were measured using pulse
sequences as described by Wagner and coworkers (14) with a 115N1-PurS sample (1.5
mM) in 20 mM KPi (pH 6.2), 20 mM KCI, and 2 mM 3-mercaptoethanol. Experiments
were performed with 8 scans/increment, dl= 4s and 96 increments in fl. For the T 1-
measurements, seven different inversion recovery delays were used (10 mns, 50 mns, 100
ins, 250 ins, 500 mns, 750 ms, s). Experiments with delays of 100, 250, and 750 mns were
performed in duplicate. For T2-measurements, delays of 18 mis, 36 mns, 72 ms, 108 mns,
144 ins, 198 mrs and 252 ms were used. Experiments with 36 mns, 108 mns and 198 nms
delays were performed in duplicate. Heteronuclear 15N{'H}-NOE measurements were
made according to the pulse sequence of Kay et al. (15) with 16 scans/increment, dl=3s,
and 128 complex points in f . During the NOE experiments, alternating proton-
presaturated and non-presaturated spectra were recorded. Peak intensities were analyzed
using the programn Felix2000 (MSI). R and R2 relaxation rates were fitted from peak
heights to mono exponential two-parameter functions using macros provided by Palmer
and co-workers (16).
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HYDRONMR (17) was used to predict the R1 and R2 values for the monomeric,
dimeric and tetrameric forms of PurS based upon the crystal structure (1), and these
predictions were compared to the experimental values.
Western Blotting to Determine Concentrations of FGAR-AT Proteins in vivo
B. subtilis strain AG174 (pheA2 trpC2, Grossman Laboratory, MIT) was grown in
LB by inoculation of a culture (100 mL) with a single colony from a LB/agar plate. The
cells were then grown at 37°C with shaking at 200 rpm with a doubling time of -40 min.
Cells were collected by centrifugation at OD600= 0.7 during log phase and frozen at -
80°C. The number of cells per OD was determined by dilution of the cells, 105 to 107-
fold, into chilled LB media followed by plating of the resulting solutions onto LB/agar
plates. For each dilution, 3 different volumes were plated with 2 replicates per volume.
The cells/OD value was determined by counting colonies formed on each plate and
averaging the results of 3 separate experiments (>40 different plates).
Cells were also grown under defined nutrient conditions in S750 minimal media
(18, 19) according to procedures from the Grossman Laboratory. The medium (1 L) was
composed of 100 mL 10x S750 salts (104.7 g/L MOPS, 13.2 g/L (NH 4)2 SO 4 , 6.8 g/L
KH 2 PO4, pH 7.0), 10 mL 100x trace metals (0.2 M MgCl2, 70 mM CaC12, 5 mM MnCI 2 ,
0.1 mM ZnCl, 2 mM HCI, and 0.5 mM FeCI3), 1% (w/v) glutamate, 40 g/mL
tryptophan, 40 pg/mL phenylalanine, 1% (w/v) glucose, and 1 /g/mL thiamin. A purine-
rich medium was prepared by addition of 1 mM adenine and 1 mM guanosine to the
minimal medium. All media components were filter sterilized rather than autoclaved.
Cells were inoculated into 100 mL of minimal media using 2 mL of a saturated culture
grown overnight in LB. Prior to inoculation, the cells were washed with 2 x 5 mL of
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minimal medium. The cells (doubling time 2 h) were grown and collected as described
with LB medium.
To prepare cell lysate solutions for the Western blots, cells from a 100 mL growth
(-0.4 g) were resuspended in 5 mL of 50 mM Tris pH 7.8 and 1% (w/v) SDS. The
solution was then placed into a boiling water bath and stirred for 20 min to lyse the cells
followed by brief sonication (30 s) at room temperature to shear cellular DNA (3/32"
microprobe, VirTis). Protein concentration was determined using a Lowry assay with a
BSA standard. Samples were prepared for electrophoresis by mixing the cell lysate 1:1
with either 2x Laemelli buffer (smPurL) or 2x tricine gel loading buffer (PurS and PurQ).
Samples from the B. subtilis cell lysate were typically loaded at 1-10 /Ig lysate/well.
Standards were made by serial dilution of purified PurS, A128T PurQ, or smPurL
into solutions containing 0.1 mg/mL E. coli K12 cell lysate supernatent in 0.1 M Tris pH
8.0 to prevent non-specific protein binding and to mimic transfer conditions of the
proteins in the B. subtilis cell lysate. These solutions were then mixed 1:1 with 2x
Laemelli buffer (smPurL) or 2x tricine gel loading buffer (PurS and A128T PurQ). In
order to quantitate protein concentrations in vivo, 5-6 standards were run on each gel
along with 3-4 unknown samples from the cell lysate. Typically, 0.5-6 ng for smPurL
and PurQ and 0.1-0.8 ng for PurS were used to generate the standard curve.
Electrophoresis of PurS and PurQ was performed using 10-well 10% tricine SDS-
PAGE gels (Gradipore), and electrophoresis of smPurL was performed using 10-well
10% tris-glycine SDS-PAGE gels (Gradipore). Blotting was performed at 20°C using an
Invitrogen blotting apparatus for 2.5 h at 34 V onto PVDF membranes (Bio-Rad
Immunoblot) in 192 mM gly, 25 mM Tris, 10% methanol (pH 8.8). After blotting,
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membranes were typically blocked overnight at 4°C in 10% drymilk (w/v, Carnation) in
PBS with 0.1 %' Tween 20. Complete transfer of the proteins from the gel was confirmed
by staining with Coomassie dye, and two membranes were placed back-to-back to
confirm that the proteins had not overtransferred during these conditions.
Antibodies (Abs) for PurS, A128T PurQ, and smPurL were produced by Covance
in NWZ female rabbits. Due to its small size, PurS was derivitized with keyhole limpet
hemocyanin (KLH) by Covance to improve its antigenicity. Abs used in these studies
were all from the terminal bleed and were not purified before use. Blots were exposed to
the l°Ab for 'urQ or PurS using a 1:10,000 dilution into blocking buffer or for smPurL
using a 1:5,000 dilution. Blots were incubated for 1 h at 20°C followed by washing with
PBS (4 x 20 min). Blots were exposed to the 2° Ab (1:3,000 dilution, Goat Anti-Rabbit
IgG HRP conjugate, Pierce) for 1 h followed by washing with PBS as before. PurS blots
were developed using Pierce FemtoMax substrate, while PurQ and smPurL blots were
developed using Pierce Supersignal WestDura substrate. Each blot was then imaged and
band density determined using a Bio-Rad ChemiDoc system. To determine the amount
of protein in B. subtilis crude cell lysate, standard curves were generated based upon the
observed band densities for the standards and fit by linear regression analysis. The
concentration of each unknown sample from the same gel was determined for samples
falling within the linear range of the standards. Six different samples from 2-3 different
Western blots were averaged to determine the protein mass in the unknown samples (pg
protein/jg cell lysate) and standard deviation. The number of molecules of each protein
per cell (molecules/cell) was then calculated from the Western results by determining the
number of cells per g of cell lysate. Error in the calculation of the molecules/cell was
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determined by propagating the relative (or percent) errors of the protein mass and cell
counting according to Equation 4.2.
I 2 22%error ~~~I~error %error ~(4.2)%0errOrmolecules/cell = %errormass + errorount2 (4.2)
4.3 Results
SEC Indicates a 2: :1 FGAR-AT Complex is Present and that PurS and smPurL have
Unusual Migratory Properties
SEC is a common method used to determine protein quaternary structures. In this
method, the elution volume of a protein is monitored as it passes through a column whose
matrix contains channels into which a protein can diffuse. Smaller proteins can sample
more of the channel volume, leading to an increase in retention time and a later elution
volume. There are several limitations to this method. First, the elution volume of the
protein is dependent on the Stokes or hydrodynamic radius of the protein (Rs), rather than
directly upon the molecular weight. This leads to the common observation with many
proteins of aberrant SEC properties due to unusual molecular shapes (20). Second, the
SEC column must be calibrated with MW standards, and the ability to accurately predict
molecular weight is dependent on how well these standards mimic the hydrodynamic
properties of the unknown protein. Finally, unlike the analytical SEC columns used in
Chapter 3, proteins elute from traditional, high-resolution SEC columns over the course
of hours.
Results from the SEC experiments are shown in Figure 4.6 and listed in Table 4.1.
In these experiments, MW standards from Bio-Rad were used; however, lgPurL and
PurM were also used to calibrate the column as these proteins may mimic the elution
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Figure 4-6-SEC results for the B. subtils FGAR-AT. (A) Elution of PurS and PurQ
from a S200 column. PurS eluted as a 30 kDa species, and PurQ eluted as a 23 kDa
species. (B) Elution of smPurL and the FGAR-AT complex from a S300 column.
smPurL eluted as a 190 kDa species independent of the presence of MgADP. The
FGAR-AT complex eluted as a 153 kDa species in the presence of MgADP and
glutamine.
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properties of the FGAR-AT complex and smPurL, respectively. Calibration of the
column with a PurS-like standard is not possible since PurS has a unique shape and no
other characterized proteins could be found with a similar fold in the Structural
Classification of Proteins (SCOP) Database (http://scop.mrc-lmb.cam.ac.uk/scop/).
Table 4.1: Determination of MW by SEC
Predicted Calculated Observed
[Monomer] MW MW Quaternary
Sample (/M) (kDa) (kDa) Structure
His-PurM 100 38 76 Dimer
lgPurL 100 141 119 Monomer
PurS 100 10 30 Trimer
A 128T PurQ 100 25 23 Monomer
SmPurLa 100 80 190 ?
FGAR-AT Complex 100 124 153 2:1L:1Q2S: I : I~b100 124 153 2S: IL: IQ2S' IL: 1Qb
'Experiments carried out in the presence and absence of ADP in the
elution buffer. Experiments carried out in the presence of ADP and
glutamine in the elution buffer.
SEC experiments on A128T PurQ revealed a monomeric species. Experiments on
smiPurL and PurS were more problematic. smPurL migrated as a 190 kDa species and
not as the predicted 80 kDa monomer either in the presence of absence of Mg2+-ADP in
the elution buffer. PurS, on the other hand, migrated as a 30 kDa trimer in contrast to
either the dimer or tetramer predicted by the crystal structures. Similar results for both
PurS and smPurL were obtained when the proteins were studied by analytical SEC
(Chapter 3). These results suggest that both PurS and smPurL have unusual migratory
properties.
Given these results, the method of Siegel and Monte (20) was used to correct the
SEC data for the unusual migratory properties of PurS and smPurL. This method utilizes
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sedimentation coefficients obtained by analytical ultracentrifugation studies to determine
the MWs of proteins based upon SEC behavior according to Equation 4.3, in which S is
the sedimentation coefficient, N is Avogadro's number, is the solvent viscosity, Rs is
the Stokes radius obtained by SEC, v is the protein partial specific volume, and p is the
solvent density. By combining Rs values from SEC with the sedimentation coefficient
obtained by AUC, factors related to molecular shape or unusual migratory properties
become minimized, and accurate MWs (10% error) can be determined (20).
MW - SN(6rRs) (4.3)(1- vp)
The standard curves used in the SEC experiments were regenerated using values
for the Stokes radius (Rs) for each of the standards vs. elution time (Figure 4.7) (20, 21).
The elution times of smPurL and PurS gave rise to Rs values of 2.60 and 3.97 nm,
respectively. The SV-AUC experiments described subsequently allowed the
sedimentation coefficients for both PurS and smPurL to be determined (2.08 and 5.50 S,
respectively). After solving Equation 4.3 using the experimental values for S and Rs, a
MW of 22.7 kDa was obtained for PurS, indicative of a dimeric species. For smPurL, a
corrected MW of 91.8 kDa was obtained, indicative of a monomeric protein.
SEC on the FGAR-AT complex was carried out in the presence of MgADP and
glutamine in the elution buffer, which has been shown previously to maximize protein
association (Chapter 3). These experiments revealed a 153 kDa species (predicted 124
kDa), closer to a 2:1:1 complex than the 4:2:2 complex (Table 4.1). However, the
elution time of the FGAR-AT complex differed from that observed with the lgPurL,
which migrated as a 119 kDa species (Table 4.1). This was unexpected since these
proteins are predicted to have similar shapes. Based upon this observation and the
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Figure 4-7-SEC results for the B. subtils FGAR-AT reploted to derive the Stokes radius
(Rs) using literature values of Rs for the standards (A) S200 elution of PurS. (B) S300
elution of smPurL.
217
z
-J
0.9
0.8
7
250
1.4
1.3
1.2
.1
1
1.8
1.6
1.4
1.2
cr
z
-I
0.8
nr
300
unusual migratory properties of PurS and smPurL, additional methods were sought to
provide evidence for a PurS dimer and a 2:1:1 complex.
SV-AUC Experiments: Evidence for a 2:1:1 FGAR-AT Complex and a PurS Dimer
AUC is a very accurate method to determine the MW of a species in solution
since the sedimentation of a particle in solution is directly dependent on the MW and
three physical forces: the buoyant force, the frictional force, and the gravitational force.
The relationship of these forces to the molecular weight is described by the Svedberg
equation (Equation 4.4). In this equation, s is the sedimentation coefficient, which
corresponds to the velocity of the particle per unit of gravitational acceleration and is
proportional to the MW. v is the protein partial specific volume, p is the solvent density,
N is Avogadro's number, andf is the frictional coefficient. The molecular shape is
incorporated into the Svedberg equation byf, which is related to the protein radius (R)
and the solvent viscosity () (Equation 4.5).
MW(1-vp) (4.4)
Nf
f = 6rrR (4.5)
Both sedimentation equilibrium (SE) and sedimentation velocity (SV)
experiments are used to determine MW by AUC. However, given problems with PurQ
and smPurL aggregation, SE-AUC experiments were not feasible due to the times
typically needed to complete an experiment (days). Therefore, SV-AUC experiments
which can be completed in hours were used to determine the MW of the components and
the FGAR-AT complex using global data fitting to determine both the rate of
sedimentation and the shape of the sedimenting boundary to take into account the
diffusion properties of the protein (5, 22). The data analysis is carried out using SEDFIT
218
and the Lamm equation to model the sedimentation and diffusion parameters for a
continuous distribution of species in solution. The advantage of this method of analysis
is that it can accurately fit the MWs of multiple species in solution with high resolution,
and baseline resolution has been demonstrated for equimolar mixtures of species with a
30% difference in molar mass (5). This proved to be particularly important for studies on
the FGAR-AT complex as described below.
PurM and lgPurL were used as controls in the SV-AUC experiments.
Determination of their MWs by the methods described above gave values of 74 and 140
kDa, close to those calculated based on the amino acid sequence (Table 4.2). SV-AUC
was then carried out on PurS, A128T PurQ, and smPurL. In order to limit aggregation,
SV-AUC experiments for smPurL and A128T PurQ were carried out at 10°C and at rotor
speeds of 40,000 rpm to promote rapid sedimentation. Analysis of the data suggested
that both species are monomeric in solution (Table 4.2).
Table 4.2: Determination of MW by SV-AUC
Predicted Calculated
[Monomer I MW MW
Sample (PM) (kDa) (kDa)
His-
PurMs 25 38 74PurM"
lgPurLa 7 141 140
PurSh 1000 10 17
PurQa 57 25 22
smPurLa 40 80 81
aThese samples were monitored with absorbance
interference optics.
Observed
Quaternary
Structure
Dimer
Monomer
Dimer
Monomer
Monomer
optics. bThis
RMSD
of Fit to
% Observed
Abundance Data
92 0.009
95 0.008
94 0.005
85 0.007
95 0.007
sample was monitored by
The stability of PurS allowed a number of SV-AUC experiments to be performed
at 25° as well as 10°C, at different concentrations, and in different buffers to examine the
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propensity of the protein to oligomerize. A typical result of is shown in Figure 4.8 in
which 1 mM PurS was sedimented in PBS at 25°C and monitored with interference
optics. The PurS concentration was chosen to maximize tetramer formation; however,
even under these conditions, only the presence of a dimer is observed (Figure 4.8). In
fact no tetramer was observed under any of the conditions (see Experimental), providing
strong evidence that PurS is a dimer.
Examination of the FGAR-AT complex was carried out in the presence of both
0.1 mM ADP and 20 mM glutamine to maximize chances of detection of the "active"
complex. The presence of ADP required the use of interference optics to monitor the
progress of the sedimentation. Efforts to minimize aggregation involved shortening the
dialysis time and carrying out the experiments at 10°C and 40,000 rpm. The results of the
experiment are shown in Figure 4.9. The data indicates that multiple species were
present in solution based upon the observation of multiple boundaries in the
sedimentation profile, and this was confirmed by fitting the data (rmsd = 0.006 fringes).
Table 4.3: SV-AUC Results for the FGAR-AT Complex
Predicted Calculated Observed
MW MW Quaternary %
Assigned Peak (kDa) (kDa) Structure Abundance
PurS Dimer/PurQ 20/25 19.1 N/A 16.6
Dimeric PurQ Aggregatea 50 42.9 Aggregate 7.2
SmPurL 80 75.6 Dimer 17.7
FGAR-AT Complex 124 127.8 2S: L: 1Q 51.22S: L: 1Q
9 ?200.0 Aggregate? 5.3
277.7 Aggregate? 1.6
"This aggregate was assigned based on appearance of this peak in many SV-
AUC experiments on PurQ and PurQ mutant proteins (Chapter 5).
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Figure 4-8--Results from SV-AUC experiments on PurS. (Top) Interference data
obtained using a 1 mM solution of PurS at 50,000 rpm at 25°C in PBS. The data shows
the presence of a single boundary, indicating that there is predominantly a single species
in solution REF. (Bottom) Mass distribution of species in solution after SEDFIT
analysis of the SV-AUC data.
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Figure 4-9- Results from SV-AUC experiments on the FGAR-AT complex. (A)
Interference data obtained using a 16 M FGAR-AT complex solution in HEPES buffer
with 0.1 mM ADP and 20 mM glutamine. The data shows the presence of multiple
boundaries indicating that more than one species is present in solution. (B) Fitting of the
SV-AUC data (rmsd of the fit was 0.006 fringes) revealed that the predominant species in
solution was the 2 PurS: 1 smPurL: 1 PurQ FGAR-AT complex (128 kDa calculated, 124
kDa predicted).
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Analysis of the data by SEDFIT indicates that the predominant species in solution
has a MW of 128 kDa, in comparison to the 124 kDa calculated for a 2: 1 :1 complex
(Figure 4.9). Integration of the peaks obtained from the SEDFIT analysis indicates that
the abundance of the 2: 1: 1 complex is low (51%), and multiple other species are present
(Figure 4.9, Table 4.3). At lower MWs than the 2: 1: 1 complex, 3 species were observed
that account for -41% of the mass in the sample. It is likely that the 75.6 kDa, and 42.9
kDa peaks represent smPurL monomer (80 kDa) and an aggregate of A128T PurQ. The
A 128T PurQ aggregate has been seen in a number of SV-AUC experiments and typically
appears between 40-50 kDa (see Chapter 5). A large peak was also observed at 19.1 kDa
(16.6% abundance). It is possible that this represents the PurS dimer, although this peak
could also contain A128T PurQ. These results indicated that the complex was partially
dissociated during the SV-AUC experiment, and at least in the case of A128T PurQ,
some aggregation was observed.
Two peaks were observed at MWs higher than that of the 2: 1: 1 complex. Both
the 200 kDa and 278 kDa peaks had very low abundance (5.3 and 1.6%, respectively).
These peaks were assigned as aggregates and not as the 4:2:2 complex (248 kDa) since
the observed molecular weights were >10% removed from the predicted MW. However,
it should be noted that fitting the MW of such low abundance species is difficult and the
calculated molecular weight may have very large errors. Nevertheless, if a 4:2:2 complex
is present under these conditions, then it must be <10% of the 2:1:1 complex in
abundance, indicating that it is not the predominant species under these conditions.
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5N/'3C-Labeling of PurS for NMR Experiments
Given the difficulties encountered in crystallizing of the FGAR-AT complex,
additional methods were investigated to provide confirmation of the quaternary structure
of PurS and the FGAR-AT complex and to provide additional insight into the validity of
the homology model. Multidimensional NMR spectroscopy potentially has the power to
address both of these issues. As a starting point to investigate the feasibility of this
method, the proton NMR spectra in 10% D2 0 of PurS (1 mM) was examined in the
amide (8.1-8.8 ppm) and methyl (0-1.5 ppm) regions (data not shown). The data
indicated that PurS is stable and non-aggregated and the chemical shifts were sufficiently
sharp and dispersed to allow assignment with appropriate labeling techniques.
Isotopically-labeled PurS protein was produced in which the protein was either
fully-labeled with 15N or both 15N and 13C. These samples were prepared by expressing
PurS in E. coli BL21(DE3) grown in minimal media containing 15 NH4CI and [ 3C1-
glucose as the sole nitrogen and carbon sources. Expression and purification of the
labeled PurS proteins was carried out as described in Chapter 3 for unlabeled PurS with
similar yields (-15-20 mg /g cells).
Amide Backbone Assignments
In the NMR experiments described subsequently to study the PurS quaternary
structure, only the amide backbone proton resonances must be assigned. The amide-
backbone assignments were achieved with the use of a 13C, 5sNI-PurS sample and a
battery of multi-dimensional NMR experiments including HNCA, HNCACB,
CBCA(CO)NH, and HBHA(CO)NH (7-10). These experiments define in different ways
the connectivity of the amide proton to either the preceding or following amino acid side
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Figure 4.10-HSQC of amide protons in 15N-Iab.eledPurS (1.5 mM, recorded at 600
MHz). Peaks are labeled according to the appropriate PurS residue number. The
unlabeled peaks in the upper right are from glutamine and asparagine side chains. The
number of amides assigned was 75 out of a total of 84.
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chain (Figure 4.5). Together, the experiments allowed the complete assignment of amide
backbone resonances except for residues 14-18, 21, 65-66, and 70 (Figure 4.10).
Confirmation of PurS Secondary Structure in Solution
While a solution structure of PurS has not been determined, data obtained from
the amide assignment process has been used to determine PurS secondary structure in
solution based on observed deviations of the 13Cc and 13CO chemical shifts from those
observed in a random coil (11). Both the 13Cu and 13 CO nuclei are sensitive to the
peptide backbone torsion angles, and consequently, these nuclei typically exhibit
downfield shifts of -2.5 ppm when incorporated into helices and upfield shifts of -2.0
ppm in sheets compared to their random coil values (11). By plotting each residue's
deviation from a random coil chemical shift, secondary structure elements in proteins can
be readily identified by looking for patterns of positive (helices) and negative (strands)
deviations. Results from this experiment are shown in Figure 4.11 for the Ca carbons.
Comparison of the shift patterns to the secondary structural elements of PurS derived
from the crystallographic data indicate that PurS in solution adopts a similar secondary
structure as observed in the crystal structures (1). Further evidence in support of these
secondary structure assignments was obtained by observation of interstrand NOEs in the
3-strand -sheet found in the PurS monomer (data not shown).
H/D Exchange Experiments Indicate that Residues at the Crystallographic Dimer:Dimer
Interface are Solvent Accessible
The dimer:dimer interface proposed in the PurS tetramer can be directly probed
by NMR spectroscopy by measurement of the rate of amide hydrogen exchange in D2 0.
The rate of exchange can be measured by collecting 15 N-HSQC spectra at known
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Figure 4.11- Deviation from random coil chemical shifts of ea carbons in PurS.
Negative deviations are indicative of ~-strands, while positive deviations are indicative of
a-helices. For reference, the secondary structure assignment of PurS from the crystal
structure is indicated at the top of the figure. These results indicate that PurS in solution
has the same secondary structure as observed in the crystal structures.
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timepoints after reconstituting a lyophilized protein sample in D 20. If an amide proton is
exchanged for deuterium, its signal disappears from the HSQC spectrum. It is predicted
that if an amide is involved in hydrogen-bonding interactions that comprise the
dimer:dimer interface, then it should be shielded from solvent exchange and exchange
more slowly than solvent-accessible protons. While accessible protons exchange very
rapidly with solvent (50 s' at pH 7.0) (23), protons protected within a protein
environment may exchange over min to h time-scales (24).
The temporal-resolution in this experiment is limited by the amount of time
required to prepare the sample, tune and shim the NMR spectrometer, and collect
sufficient data for analysis using the HSQC method. The shortest time interval in these
experiments was 5 min and was achieved using a 600 MHz spectrometer and a cryoprobe
to increase the NMR signal and allow collection of HSQC spectra of PurS that were
complete with only 2 scans.
Comparison of the HSQC spectrum in Figure 4.10 with that taken after 5 min
exposure to D20 (Figure 4.12) indicates that the majority of the amide protons of PurS
have not exchanged. Those that have exchanged (Table 4.4) are predominantly surface-
exposed residues on PurS. One of the exceptions is V78, which resides at the
crystallographic dimer:dimer interface in both crystal forms (Figures 4.3 and 12). The
amide of V78 is thus behaving like a surface-accessible residue and is likely not involved
in a protein interface. After 30 min, the amide of Y76 (also predicted to be part of the
dimer:dimer interface, Figure 4.3) has also exchanged, indicating that it also is much less
shielded from solvent relative to the majority of amide protons (Figure 4.13). As a
control, amides at the monomer:monomer interface were examined. These residues
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Figure 4.12- Results from HID exchange experiments on PurS after 5 min of exposure
to D20. The positions of peaks resulting from the Y76 and V78 amides at the
dimer:dimer interface are boxed in red. After only 5 min, the V78 proton has already
completely exchanged with solvent deuterium.
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Figure 4.13- Results from HIDexchange experiments on PurS after 30 min of exposure
to D20. The position of peaks resulting from the Y76 and V78 amides at the dimer:dimer
interface are boxed in red After 30 min, both the Y76 and V78 protons have fully
exchanged, indicating that a stable tetramer is not present. Protons located at the
monomer:monomer interface (R38, G40, Y42, E44, and T46) are still present and are
labeled in red. This indicates that the PurS dimer is very stable and protons involved in
dimer formation are shielded from solvent.
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(R38, G40, Y42, E44, and T46) are all present at 30 min (Figure 4.13) and even after
270 min in 020, they have not exchanged (data not shown). These results indicate that
the PurS dimer is a very stable structure and that amides at the monomer:monomer
interface are shielded from solvent. In contrast, if a PurS tetramer is present, then ami des
at the tetramer interface are readily solvent-accessible, suggesting a "weak" interaction.
Table 4.4: PurS Amides that Have Exchanged
with 020 after 5 min
Residue
E12
S13
S20
H24
S28
M29
T30
N32
051
053
N68
T69
F. V78
V82
A83
Q84
NMR Experiments to Measure PurS Size in Solution Provide Evidence for a PurS Dimer
Several additional types of NMR methods can provide information about the
molecular size and shape of a protein in solution. For PurS, experiments were carried out
to determine its rotational correlation time (T Iff2 measurements) and the rate of
molecular diffusion along the long axis of the NMR tube (DOSY experiments). Each of
these methods independently provides evidence for a PurS dimer in solution.
Both the longitudinal (T 1 or Rl) and transverse (T2 or R2) relaxation times are
dependent on the correlation time for a molecule in a magnetic field (Tc, the time in which
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Figure 4.14- Measurement of magnetic relaxation properties of amide protons in PurS.
The ratio of transverse (R2) to longitudinal (Rl) relaxation was determined for the
indicated PurS residues (X). Missing data points represent residues for which relaxation
data could not be determined. Predicted R2/Rl ratios obtained by HYDRONMR are
shown for the PurS monomer (e), dimer (.), and tetramer (.). The data are closest to
that predicted from a PurS dimer.
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a molecule undergoes 1 radian of rotation). The correlation time is, in turn, dependent on
the molecular mass. Consequently, the ratio of R2/R1 can be informative about
molecular size (25, 26). As shown in Figure 4.14, different R2/R1 ratios are predicted
for the PurS monomer, dimer, and tetramer. These ratios were predicted by
HYDRONMR using the crystal structure of PurS, and results from this program typically
contain errors of 4.3% between the calculated and experimental values (27).
R1 and R2 values were determined for the PurS amide protons corresponding to
the non-loop regions of PurS (residues 1-12, 19, 22-48, 50-63, 66-68, and 70-81). The
RL/R2 ratios for each amide proton are shown in Figure 4.14. The experimental values
obtained for PurS are closest to those predicted for the dimer and are all far removed
from those predicted for the tetramer. These results indicate that in solution, the
rotational correlation time for PurS corresponds to a dimeric species.
Molecular size can also be determined by NMR by measuring the rate at which
molecules diffuse along the long axis of the NMR tube (12, 28, 29). These experiments
are carried out using DOSY spectroscopy in which a magnetic gradient is applied along
the length of the NMR tube. By applying an identical gradient after a time delay, proton
signals are only detected if the molecule experiences the same magnetic field strength
from both gradients, which only occurs if the molecule has not diffused significantly in
the NMR tube during the time delay. The changes in protein H peak intensities versus
magnetic field strength have thus been compared to an internal dioxane standard with a
known hydrodynamic radius (RHdioxane). The hydrodynamic radius of the protein (RHProtein)
can be calculated using the relationship shown in Equation 4.6 where ddioxane and dprotein are
diffusion parameters for dioxane and the protein, respectively,
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Figure 4.15--Measurement of diffusion properties of PurS by DOSY. The intensities of
PurS H methyl peaks were measured as a function of magnetic gradient strength ().
The sample contained an internal dioxane standard (*). Comparison of the diffusion
properties of Purs relative to dioxane indicate that PurS is a dimer in solution.
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obtained by monitoring the change in NMR signal intensity vs. the magnetic gradient
strength.
Rroteit.l ddioxane Rdioxane (4.6)
RH R'H 46
protein
Five experiments were carried out at two different PurS concentrations to
determine RH for PurS in comparison to dioxane. The results of a typical experiment are
shown in Figure 4.15. All of the experiments are in close agreement, giving a value of
2.4 + 0.2 nm for PurS. This value is closest to that predicted for a PurS dimer using
HYDROPRO hydrodynamic bead-modeling software, which gives Rat values of 2.3 nm
and 2.7 nm for the PurS dimer and tetramer. HYDROPRO uses a series of beads of
defined hydrodynamic properties to mimic the 3-dimensional structure of a protein.
Determination of RH values with HYDROPRO is very accurate and typical errors in this
calculation are 2% (13), indicating that dimer and tetramer can be distinguished based on
RH . Measurements of both the rotational correlation time (R2/R1) and translational
diffusion (DOSY) for PurS by NMR provide evidence that PurS is a dimer in solution.
Quantitative WIVestern Analysis of the FGAR-AT Complex Reveals an FGAR-AT Complex
is Present in High Concentrations in B. subtilis
One drawback of the biophysical methods described in this chapter, particularly
the NMR experiments, is that they are all carried out at high protein concentrations 10-
1000 jiM. Given the influence protein concentration may play on protein quaternary
structure and the problems associated with smPurL and PurQ aggregation, quantitative
Western blotting was used to determine the concentrations of the individual components
in vivo. As shown in Figures 4.16-18, antibodies produced against PurS, A128T PurQ, or
smPurL could easily be used to detect the proteins in B. subtilis cell lysates. The number
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Figure 4.16- Western blot analysis of PurS in B. subtilis cell extracts. Standards from
0.4- 2.0 ng of PurS were used to create a standard curve. This standard curve was then
used to calculate the amount of PurS present per Jlg of B. subtilis cell lysate. The
positions of the samples from the cell lysate on the standard curve are noted (VI, V2, and
V3).
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Figure 4.17- Western blot analysis of PurQ in B. subtilis cell extracts. Several strongly
cross-reacting bands were detected with the PurQ Ab. Standards from 0.2-1.2 ng of
A128T PurQ were used to create a standard curve. This standard curve was then used to
calculate the amount of PurQ present per }/-gof B. subtilis cell lysate. The positions of the
samples from the cell lysate on the standard curve are noted (U 1, U2, and U3).
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Figure 4.18- Western blot analysis of smPurL in B. subtilis cell extracts. Standards from
0.5 -4.0 ng of smPurL were used to create a standard curve. This standard curve was
then used to calculate the amount of smPurL present per Jig of B. subtilis cell lysate. The
positions of the samples from the cell lysate on the standard curve are noted (U 1, U2, U3,
and U4).
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of molecules per cell was then determined by comparison of samples of B. subtilis cell
lysate to results of a standard curve generated from homogenous proteins purified from E.
coli.
During these experiments, several controls were used to validate the Western
blotting procedure. After transfer of each protein from the SDS-PAGE gel to the PVDF
membrane, the gel was stained to ensure that all protein had been transferred to the
membrane. In addition, multiple membranes were placed back-to-back during the
transfer in the blotting apparatus to ensure that the samples were not being
overtransferred. Finally, the standards used in the assays were diluted with 0.1 mg/mL E.
coli cell lysate in order to buffer the proteins, prevent non-specific binding to microfuge
tubes or pipette tips, and to mimic transfer conditions out of cell lysate.
Table 4.5: Quantitative Western Results for the FGAR-AT
Proteins
pg protein/pyg cell lysate
Protein LB Minimal Minimal + Purines
PurS 50 + 15 800 + 144 51 + 12
PurQ 190+40 735+ 124 108+20
smPurL 480 +70 2806+360 362 + 105
The results obtained directly from the Western blotting analysis (pg protein/ pg
cell lysate) are summarized in Table 4.5 for B. subtilis grown in minimal media, purine-
rich minimal media with 1 mM adenine and guanosine, and LB media. The standard
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deviation for each sample is derived from an average of 6 samples from 2 or 3 different
Western blots. Typical errors in the mass were ",20% (fable 4.5). These results indicate
that there is a large upregulation in the FGAR-A T complex proteins in minimal media.
In order to calculate the number of molecules of each protein per cell, the number
of cells loaded per Jl-g of cell lysate was first determined by counting the number of
colony forming units per OD600 by replica plating and colony counting. This proved to be
a very error prone process giving a value of 3.2:t 1.4 x 108 cells per 1 OD600 (a 44%
error). The numbers of molecules per cell under the different growths are reported in
Table 4.6. Propagation of the errors from the Western Blotting (Table 4.5) and the cell
counting using Equation 4.2 result in errors of ",50% in values reported in Table 4.6.
However, these results indicate that under purine-rich conditions the FGAR-AT complex
is present at '"17,000 copies per cell and that the complex is increased ",5-fold in minimal
medium to ",90,000 copies per cell. These values can be used to determine approximate
concentrations for the complex in the cell using average B. subtilis cell dimensions of
1.38 x 0.6 Jl-m for cells grown in minimal media (30). Based upon these dimensions,
values of ",8 Jl-M FGAR-AT complex in the cell are obtained under purine-rich conditions
and ",40 Jl-M in minimal media.
LB
Table 4.6: Molecules per Cell of the FGAR-AT Proteins
PurS PurQ
Molecules per cell (xl0-4t 1.1 :t 0.6 1.6:t 0.8
Ratiob ~ 0.86 f: 0.28 ,1.3f: 0.3-
Minimal + Molecules per cell (xl0-4t 2.0:t 1.3 1.7 :t 1.0
Purines Ratiob'" 1.16 f: 0.44 0.97:t 0.33
M.. I Molecules per cell (xl0-
4t 26.3:t 16.4 9.4:t 5.9llllma
Ratiob 2.4:t 0.6 0.85 :t 0.18
aMolecules of PurS monomer. bRatio of PurS Monomer.
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smPurL
1.3 :t 0.6
1
1.7 :t 1.2
1
11.0:t 6.8
1
One interesting observation from these studies is that PurS is upregulated more
than smPurL and PurQ in minimal media. The ratio of each protein relative to smPurL
demonstrates that these changes result in a higher ratio of PurS under different growth
conditions (Table 4.6). In rich media, the ratio is -1 PurS: 1 smPurL: 1 PurQ; however,
in minimal media the ratio changes to -2 PurS: 1 smPurL: 1 PurQ. In the latter case, the
ratio observed is the same as that determined by biochemical studies for maximal activity
of the FGAR-AT (Chapter 3). How and why specific upregulation of PurS occurs
remains unknown.
4.4 Discussion
Results from this chapter provide strong evidence for the presence of a PurS
dimer in solution and a 2:1:1 FGAR-AT complex. SV-AUC experiments under multiple
conditions were only able to detect a PurS dimer in solution. These findings are
supported by several solution NMR experiments. DOSY experiments indicate that the
translational diffusion properties of PurS in solution most closely matched those
predicted for a PurS dimer. T and T2 relaxation measurements of amide protons also
support a dimeric structure for PurS. Finally, H/D exchange experiments indicate that
protons at the predicted dimer:dimer interface readily exchanged with solvent D2 0,
implying that this interface is readily solvent accessible. Together the data suggest that
PurS is a dimer in solution and that the crystallographic tetramers are crystallization
artifacts.
Data from SEC and SV-AUC were obtained that support the conclusion that the
FGAR-AT has a 2 PurS: 1 smPurL: 1 A128T PurQ stoichiometry. Experiments carried
out on the FGAR-AT complex were particularly difficult due to the susceptibility of the
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proteins to aggregate. While SEC allowed ready detection of the complex by
measurement of glutamine-dependent FGAM synthesis, many SV-AUC experiments
were carried out before conditions could be found that gave interpretable data with
minimum aggregation. Critical to the success of the SV-AUC experiments was
shortening the dialysis time prior to the experiment and centrifuging the samples at high
speed and low temperatures (40,000 rpm at 10°C) to promote rapid sedimentation. The
SEDFIT program was able to deconvolute the multiple species in solution, and indicated
that the predominant species was the 2:1:1 complex (51%); however, even under these
conditions some aggregation and dissociation of the complex was apparent. Several low-
abundance, high molecular weight species were also observed at 200 and 278 kDa;
however, these species could not be readily assigned.
Two interesting observations from the SEC studies are the unusual migratory
properties of PurS and smPurL. Using typical SEC procedures to determine MW, PurS
migrates as a trimer while smPurL migrates as a dimer. These results have been observed
in both phosphate and HEPES buffers with both standard SEC columns as well as the
analytical SEC columns utilized in Chapter 3. Since SV-AUC experiments allowed
determination of sedimentation coefficients for both PurS and smPurL to be determined,
the method of Monte and Siegel was applied to correct the SEC results (20). The
reanalysis of the SEC data gave MWs closer to a PurS dimer and smPurL monomer. The
unusual migratory properties for smPurL are surprising since it should be structurally
homologous to the PurM homodimer, which migrates close to its predicted molecular
weight.
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One drawback of many of the techniques used in this chapter is that they all
require high protein concentrations. SEC experiments were carried out at 100 PM, SV-
AUC experiments were carried out at 10-1,000 M, and NMR experiments were
conducted at 200-1000 M PurS. Because of aggregation problems and the insensitivity
of the biophysical methods, quantitative Western blotting was used to determine the
concentrations of PurS, PurQ, and smPurL in B. subtilis. The results summarized in
Table 4.6 indicate that the proteins are present at high concentrations inside the cell. In
purine rich media conditions, the proteins are present at -8 PM (17,000 copies/cell).
Furthermore, they are upregulated in the absence of purines to -40 PM (90,000
copies/cell). These concentrations are similar to values obtained by Johannes Rudolph
during studies of the E. coli purine biosynthetic proteins. In Rudolph's studies, lgPurL
concentrations ranged from 3.6-13 M under repressed and depressed conditions,
respectively (31). Analysis of other enzymes in the pathway showed concentrations
ranging from 1--50 M (31).
Since the SV-AUC experiments on the FGAR-AT complex were carried out at 16
pM, this method was probing physiologically relevant FGAR-AT concentrations. This
highest PurS concentration observed by Western blotting was 100 M in minimal
medium. While several SV-AUC experiments were carried out near 100 M (see
Experimental), the insensitivity of NMR required much higher PurS concentrations to be
used than are observed physiologically; however, no evidence for tetramerization was
obtained using several methods.
The high concentrations of the proteins found in vivo also clarifies results from
Chapter 3 which showed a strong concentration dependence on the specific activity of the
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FGAR-AT. In those studies, activity dropped sharply below 0.1 IM. This result may be
explained by the observation that the FGAR-AT normally exists at PM concentrations
inside the cell, and at lower concentrations the complex may never form.
The data from this chapter provide no evidence for the 4: 2: 2 model that has
previously been proposed (Figure 4.4B) (1). This simplifies future studies aimed at
understanding the role of PurS in FGAM synthesis. Based upon analogy with the N-
terminal domain of gPurL (Figure 4.1), PurS may play a role in linking PurQ and
smPurL, possibly during NH3 channeling. A simplified 2 PurS; 1 smPurL: 1 PurQ model
for the FGAR-AT complex will make testing this model more straightforward since it
eliminates the possibility of a PurS tetramer coordinating activities between two sets of
PurQ:smPurL complexes in a 4: 2: 2 model.
The amenability of PurS for NMR studies has important implications for future
analysis of the FGAR-AT. So far, crystallographic studies of the assembled B. subtilis
have not been successful. In addition, efforts to study complex assembly by isothermal
titration calorimetry (to determine dissociation constants) resulted in extensive
aggregation and precipitation of PurQ and smPurL. It may be possible to use NMR to
provide evidence for the docking model (Figure 4.4A) by titrating PurS with PurQ and
smPurL. Sites in PurS that interact with PurQ and smPurL could be identified by looking
for changes in the chemical shifts of PurS residues, and this type of titration may even be
able to determine Kds for PurS in the FGAR-AT complex under different conditions (+/-
glutamine, for example). Data from future NMR experiments may provide the evidence
needed to clarify the role of PurS in NH3 channeling between PurQ and smPurL.
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Chapter 5:
Mutagenesis of PurQ and Studies on FGAR-AT Complex Formation
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5.1 Introduction
Amidotransferases (ATs) contain one of two types of glutaminase domains (1).
The NTN domain contains a catalytic cysteine at its N-terminus (hence the designation
N-terminal nucleophile or NTN). These domains are always found on the same
polypeptide chain as the AT, and PurF is the prototype for this class of ATs. The second
glutaminase domain is the triad domain and always contains a conserved CX80- 00HPE
motif, in which the cysteine is the catalytic nucleophile. Anthranilate synthase (TrpEG,
Figure 5.1), imidazole glycerol phosphate synthase (HisHF, Figure 5.1), p-aminobenzoate
synthase (PabAB, Figure 5.1), and the FGAR-AT (gPurL or the PurS, smPurL, PurQ
complex) all contain triad class glutaminase domains, and these domains may be found
either fused to the AT or as a separate protein, usually in tight complex with the AT.
PurQ is an atypical member of the triad AT family since it does not form a tight complex
with smPurL and PurS, and the FGAR-AT complex can only be isolated in the presence
of Mg2+-ADP (a structural cofactor for smPurL) and glutamine (Chapter 3).
Recently interest in triad glutaminases has resurfaced due to several remarkable
features of these enzymes. First, biochemical studies on the CPS and PabAB have
indicated that the glutamate residue in the triad motif is not necessary for catalysis,
indicating that these enzymes do not require a catalytic triad (2, 3). This result is
intriguing since the acidic residue is universally conserved in all triad domains, implying
that it may have another essential, non-catalytic function. Both the Raushel and Walsh
groups have speculated that the conserved glutamate may be involved in coordinating
interactions between the AT and glutaminase (2, 3).
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Figure 5.1-AT reactions catalyzed by HisHF, PabAB, and TrpEG.
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Second, in the absence of the AT subunit and/or the AT-substrate complex, triad
glutaminase domains posess very low levels of glutaminase activity. For example, results
from Chapter 3 indicated that in the absence of smPurL and PurS, A128T PurQ possesses
a glutaminase activity of only 0.002 s'. In the presence of the other subunits and ATP,
the glutaminase activity is stimulated to 0.044 s- , and the activity is further stimulated by
the presence of FGAR to a rate of 2.5 s-1. These findings are typical of many triad AT
enzymes, and this phenomenon has best been studied in the case of HisHF in which the
glutaminase activity is stimulated 4900-fold in the presence of the AT substrate N'-[(5'-
phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamide ribonucleotide (PRFAR)
(4). How binding of an AT substrate stimulates glutaminase activity is still not well
understood.
The present chapter utilizes a variety of site-directed mutants of PurQ in order to
address enzyme activity of PurQ and features that are important for formation of the
FGAR-AT complex. Mutations were made in an A128T PurQ background to either the
conserved triad residues (C86, H194, or E196) or residues involved in glutamine-binding
(D55 and Q90). The latter residues were identified in PurQ by homology to the
glutaminase domain of Salmonella lgPurL (28% identity), which has been crystallized
with a glutamylthioester in the glutaminase active site (Figure 5.2) (5). Each mutant's
impact on complex formation was assessed by the use of competition assays against the
active enzyme. Interpretation of these results was complicated due to difficulties in
measuring glutamine binding to the proteins; however, results from D55 and Q90
mutants provide additional support for the model reported in Chapter 3 that glutamine-
binding is important for FGAR-AT complex formation. The C86A and C86S mutants
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Figure S.2-Structure of the glutamylthioester present in the glutaminase active site of
the Salmonella IgPurL crystal structure (1t3t pdb). Salmonella residues are numbered in
black, and the homologous residues in B. subtilis PurQ are numbered in red. The
conserved triad glutaminase residues are Cl135, H1260, and E1262. Dashed lines
represent hydrogen-bonding interactions observed in the crystal structure.
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indicate that a PurQ-glutamylthioester is not necessary for complex formation during
turnover. Interestingly, neither the E196A nor E196D mutants were competitive against
wt PurQ, despite the observation that E196A was an active glutaminase and can support
FGAM synthesis. This result is discussed in light of similar findings in CPS, HisHF, and
PabAB. A role for E196 in complex formation is presented based upon observations
from the Salmnonella gPurL crystal structure.
5.2 Experimental
Materials and Methods
A 128T1' PurQ, PurS, and smPurL were purified as described in Chapter 3. The
Bratton-Marshall assay to monitor FGAM formation was carried out as described in
Chapter 3. Circular dichroism and analytical ultracentrifuge data were collected at the
Bioinstrumentation Facility for the Study of Complex Macromolecules (Department of
Chemistry, MIT).
Mutagenesis of PurQ
PurQ mutants were generated using the pET-A128T-PurQ plasmid and the
Quikchange Mutagenesis kit (Stratagene). Due to the inability to purify and characterize
the WT enzyme (see Chapter 3), all mutants were generated in the A128T PurQ
background. Mutations were made to the catalytic triad residues (C86S, C86A, H194Q,
E196D, E196Q, and E196A) and the residues proposed to be involved in glutamine-
binding (D55A, D)55N, Q9OA, and Q9OE). The primers (Invitrogen) used are listed Table
5.1. In all cases the reverse primer is the exact complement of the forward primer.
Sequences of the mutants were confirmed by DNA sequencing at the MIT Biopolymers
Facility.
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Table 5.1: Primers Used in PurQ Mutagenesisa
Mutant Forward Primer
C86A GAAAACCTGTTCTTGGCGTCGCAAACGGATTCCAGATTTTACAGG
C86S CCTGTTCTTGGCGTCAGTAACGGATTCCAGATTTT
D55A AGGATTTTCTTACGGCGCTTACTTAAGATGCGGCG
D55N GAGGATTTTCTTACGGCAATTACTTAAGATGCGGCGC
Q9OA TGGCGTCTGTAACGGATTCGCAATTTTACAGGAGCTTGGGC
Q9OE GTCTGTAACGGATTCGAGATTTTACAGGAGCTTGG
E 96A GCCTCACCCTGCGCGCGCGGTCG
E 96D GCCTCACCCTGACCGCGCGGTCG
E 196Q GCCTCACCCTCAGCGCGCGGTCG
H 194Q GGCATGATGCCTCAGCCTGAGCGCG
T 128A G ACGAAACCTTATTCACAGCATGGTACGAAAAGGGAG
'In all cases the reverse primer is the exact compliment of the forward primer. The site of
the mutation is in bold.
Expression and Purification of Mutant PurQ Enzymes
Expression and purification of the C86A, C86S, D55N, D55A, Q9OA, and Q9OE
A128T PurQs were carried out as previously described for A128T PurQ (Chapter 3). For
the remaining mutants, a slightly altered expression and purification protocol was
employed. To obtain soluble protein with the E196D and E196Q PurQs, bacterial growth
was carried out at 25°C, and protein expression was induced at OD 6 0o of 0.7 with 1 mM
IPTG and grown for an additional 6 h. For H194 or E196 PurQs, the purification was
essentially as described in Chapter 3 except that 0.05 volumes of 10% (w/v) streptomycin
sulfate was used to precipitate the DNA and 200 U of DNase I (Roche) was included in
the lysis buffer. Subsequent to purification, the identity of each mutant was confirmed
by ESI-MS (MIT Biopolymers Facility).
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PurQ Activity Assays
The modified Bratton-Marshall assay was used to determine activity of the PurQ
mutants by monitoring glutamine-dependent FGAM formation from the assembled
FGAR-AT complex (6). In this assay, the FGAR-AT complex (10 /iM) was made by
mixing 10 yM smPurL, 10 pM PurQ double mutant, and 20 M PurS in 50 mM HEPES
pH 7.2, 20 mM MgC 2, 80 mM KCI, 20 mM L-glutamine, 10 mM ATP, and 0.1 mM
ADP. The mixture was incubated on ice for 5 min before each assay.
Assays were performed in standard B. subtilis FGAR-AT assay buffer: 50 mM
HEPES pH 7.2,20 mM MgCl2, 80 mM KCI, 10 mM ATP, 0.2 U PurM, 1 mM FGAR,
and 20 mM L-.glutamine. Enzyme was diluted between 1:100 and 1:20 into the assay
buffer, and the reaction was allowed to proceed at 37°C for 2-30 min before being
quenched as previously described (Chapter 3). Km and kcatdeterminations for glutamine
were made by varying the glutamine concentration from 0-200 mM in the presence of 1
mM FGAR and 10 mM ATP. Data were fit with Kaleidagraph software (Synergy) to
Equation 5.1.
Vmax [SlV Vmax [S (5.1)
K. + [SI
Competition Assays between A128T and Mutant PurQs
A stock solution of PurS (40 /M) and smPurL (20 /M) was first made in 50 mM
HEPES pH 7.2, 20 mM MgC 2, 80 mM KCI, 10 mM ATP, 0.1 mM ADP, and either 20 or
200 mM glutamine. A separate solution containing A128T PurQ (20 PM) and variable
amounts of the double mutant PurQs (0 to 10 equivalents) was then made in the same
buffer. The PurQ solution (50 L) was then combined with the PurS:smPurL solution
(50,uL) and allowed to incubate on ice for 5 min before each assay. After incubation, the
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solution was diluted 1:100 into assay buffer and glutamine-dependent FGAM synthesis
was monitored using the Bratton-Marshall assay.
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectra of each PurQ mutant were collected on an AVIV
Model 202 CD spectrophotometer (AVIV Biomedical, Inc., Lakewood, NJ). Proteins
were dialyzed before the experiment against 2 x 500 mL of 10 mM KPj pH 7.2 buffer for
16 h using a Slide-A-Lyzer cassette with a 10 kDa molecular weight cutoff (MWCO)
membrane (Pierce). Samples were then diluted to 10 pM in argon degassed dialysis
buffer. Spectra were collected with five replicates at 25°C in a 0.1 cm path length quartz
cuvette by scanning from 300-190 nm in 1.0 nm increments with a 0.5 s integration time
and 1 nm bandwidth.
Sedimentation Velocity Analytical Ultracentrifugation (SV-A UC)
Before each SV-AUC experiment, protein samples were dialyzed against PBS pH
7.2 (2 x 1L) for 24 h in a Slide-A-Lyzer cassette with a 10 kDa MWCO membrane
(Pierce). Centrifugation was performed using an Optima XL-1 analytical ultracentrifuge
(Beckman Coulter, Fullerton, CA) with a 400 L sample volume in double-sector Epon
centerpieces with quartz windows in an AnSOTi 8-hole rotor at 45,000 rpm.
Sedimentation of each sample (57 M) was monitored at 10°C for 20 h with continuous
scanning at 280 nm. Experiments with the C86S and C86A A128T double-mutants were
also performed in PBS buffer containing 50 mM glutamine.
SEDNTERP software from Dr. John Philo was used to calculate buffer density
(g/mL), viscosity (Poise), and protein partial-specific volume from the amino acid
content (mL/g) (7). Data (200 traces for each experiment) were fit using Sedfit88 from
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0.5 to 10 S using a continuous distribution of sedimentation coefficients derived from
solutions to the Lamm equation (8). The resulting distributions were then integrated
using Kaleidagraph software (Synergy).
Analytical Size-Exclusion Chromatography (SEC)
Analytical SEC to determine the extent of PurQ aggregation under the enzyme
assay conditions was performed at 4°C using a BioCAD Sprint perfusion chromatography
system (Applied Biosystems) with an analytical Bio-Silect SEC250 column (300 mm x
7.8 mm, Bio-Rad). The column was equilibrated and eluted in filtered and degassed SEC
buffer (50 mM KPi, 75 mM NaCI, pH 7.25). Prior to injection, each mutant PurQ was
incubated in FGAR-AT assay buffer at 100 pM for 5 min at 37°C in the absence of PurS
and smPurL. The sample was then applied to the column using a 100-pL injection loop
and eluted with a flow rate of 1 mL/min. Peak volumes were determined by integration
with Kaleidagraph software (Synergy).
Expression of histag-A128T and histag-WTPurQ in B. subtilis
Histag-A128T-PurQ in plasmid pET-28a contained the A128T PurQ gene and a
N-terminal hexahistidine tag (MGSSHHHHHHSSGLVRGSH-) and was a gift of the
Ealick Laboratory, Cornell University. The tagged construct was amplified using PCR,
the Kod HiFi Polymerase (Novagen), and the primers Q-HindIII (5'-
GCAAGCTTFAAGGAGGAAGCAGGTATGGGCAGCAGCCATCAT-3') and Q-SphI
(5'- GCGCATGCTCAAGCAGTAGTGACATGAGTTTCCC-3'). The forward primer
incorporates both a 5' HindIII restriction site (bold) and an optimized B. subtilis
ribosomal binding site (underlined) (9). The reverse primer incorporates a 3' SphI
cleavage site (bold).
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In order to express histag-PurQ in B. subtilis, the PCR product was digested with
HindIII and SphI and ligated into the pDG148 vector (9) digested with the same
enzymes. This vector is commonly used for expression of proteins in B. subtilis. The
ligation product was transformed into DH5cu E. coli grown on 50 ug/mL ampicillin, and
plasmids containing the insert (pDG148-his-A128T-PurQ) were isolated and sequenced.
The plasmid containing the wt PurQ sequence (pDG148-his-wt-PurQ) was made by
Quikchange mutagenesis (Stratagene) of the pDG148-his-A128T-PurQ plasmid using the
T128A primers (Table 5.1).
In order to obtain plasmid DNA suitable for transformation of B. subtilis,
plasmids were transformed into the recA mutant E. coli strain AG 1111 (araD139 (ara-
leu)7697 lacX74 galU galK rpsL hsdR F' proAB+ laclq lacZM15 TnlO, Grossman
Laboratory, MIT) grown on 50 yg/mL ampicillin and plasmids were isolated using
standard miniprep and maxiprep procedures (Qiagen).
B. subtilis strain AG174 (trpC2 pheAl, Grossman Laboratory) was transformed
using a procedure developed by the Grossman Laboratory (MIT). A single colony was
used to inoculate 5 mL of LB media and allowed to grow overnight at 37°C to saturation.
This culture (100 pL) was then used to inoculate 3 mL of LB media and the bacteria
allowed to grow at 37°C for 2 h until OD60 = 1.0. A portion of this culture (0.5 mL)
was then used to inoculate 9.5 mL of MD media in a 125 mL flask (MD media contains
9.3 mL 1.1 x PC media (10x PC media contains 107 g/L K2HPO4, 60 g/L KH2PO4, 10g/L
trisodium citrate dihydrate, adjusted to pH 7.5 with KOH), 0.4 mL 50% glucose, 0.188
mL 100 mg/mL potassium aspartate, 37.5 uL 10 mg/mL L-tryptophan, 37.5 YL 10
mg/mL L-phenylalanine, 37.5 uL 2.2 mg/mL ferric ammonium citrate, and 22.5 pL 1 M
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MgSO4 ). The flask was shaken at 37°C for 4 h, after which time the bacteria were
competent for DNA transformation.
Cells were transformed by mixing 0.3 mL of the competent cells with 5-50 g of
plasmid DNA and incubating at 37°C for 30 min before plating on LB/agar plates with
2.5 pg/mL neomycin. After overnight incubation at 37°C, single colonies were used to
inoculate 5 mL of LB with 20 g/mL kanamycin and allowed to grow overnight at 37°C.
Cells from the liquid culture were streaked onto LB/agar plates containing 20 pg/mL
kanamycin and incubated as before. The resulting colonies were used to inoculate
cultures for expression of histag PurQs.
Expression of histag-A128T or histag-wt PurQ was performed by addition of
IPTG to B. subtilis cells transformed with the appropriate plasmid during growth at 37°C
in minimal media (see Chapter 4) containing 20 yg/mL kanamycin. IPTG was added to a
final concentration of 0.1 mM when the cells reached an OD600 of 0.1, and growth was
allowed to proceed until an OD 600 of 0.7-0.9 was reached at which time the cells were
harvested and frozen. Expression levels of the histag-PurQs was monitored by Western
blotting as described in Chapter 4, and the expression conditions described above resulted
in expression levels that closely match that of the wt protein.
Use of a Ni2+-,Affinity Column to Isolate the FGAR-AT Complex
Cells (--0.5 g) were resuspended in 4 mL of PD buffer (50 mM HEPES pH 7.2, 1
mM imidazole, 80 mM KCI, 20 mM MgCI2). Experiments were also conducted with PD
buffer containing 0.1 mM ADP and/or 20 mM glutamine. When added, these compounds
were present at all stages of the experiment. Control experiments were performed using
identical procedures with B. subtilis cells not transformed with pDG148-his-wt-PurQ or
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pDG148-his-A128T-PurQ. Lysozyme (Sigma) was added to the cell suspension to a
final concentration of 10 mg/mL, and the solution was stirred at 37°C for 15 min
followed by brief sonication of the reaction mixture on ice for 30 s at 50% power (3/32"
microprobe, VirSonicl00, Virtis). The lysate was then cleared by centrifugation at
14,000 rpm at 4°C for 10 min.
The resulting supernatant (3.8mL) was combined with 1 mL of Ni-NTA resin
(Qiagen) equilibrated in the appropriate PD buffer. The supernatant was slurried with the
resin for 1 h at 20°C with gentle rocking. The resin was then placed into a 1 x 5 cm
disposable column (Bio-Rad) and the supernatant removed by gravity flow. The resin
was washed with 25 mL of PD buffer, followed by 25 mL of PD buffer with 15 mM
imidazole until no protein could be detected in the eluate by Bradford assay. Proteins
were eluted with 5 mL of 300 mM imidazole in PD Buffer and analyzed by Western
blotting using procedures described in Chapter 4.
A slightly altered procedure was used to study the effects of DON-inactivation on
the isolation. Cells were resuspended in PD buffer (without ADP or glutamine) and lysed
as described above. Following centrifugation, the supernatant was brought to 0.1 mM
ADP, 10 mM ATP, 10 mM DON, and 1 mM FGAR. The lysate was then incubated for
15 min at 370C. A small amount of precipitate formed during this time and was removed
by brief centrifugation. The resulting solution was then mixed with Ni-NTA resin, and
the procedure was followed as described above using PD buffer in all the subsequent
steps.
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5.3 Results
PurQ Mutagenesis and Mutant Protein Expression
Mutagenesis using the Quikchange protocol was used to prepare PurQs containing
mutations in either the conserved triad residues (C86A, C86S, H194Q, E196D, E196Q,
and E196A) or to glutamine binding residues (D55N, D55A, Q9OE, and Q9OA) based
upon homology to the Salmonella gPurL crystal structure (Figure 5.2). Given the
problems encountered in attempting to purify the wt PurQ enzyme (Chapter 3), all of the
mutant PurQs were in the A128T PurQ background.
The PurQ double mutants were grown, expressed, and purified using the protocols
for A128T PurQ with some minor modifications (see Experimental). Typical yields for
each mutant were 10 mg/g cells. The PurQ mutants were judged to be >90% pure based
upon SDS-PAGE analysis (Figure 5.3) and the identity of each mutant was confirmed by
ESI-MS (Table 5.2).
Table 5.2: ESI-MS Results for PurQ Mutants
Protein Calculated MW Observed MW
A128T 24814.1 24816.0
C86S/A128T 24798.1 24801.4
C86A/A128T 24782.1 24785.4
D55N/A 128T 24813.2 24816.6
D55A/A128T 24770.1 24773.2
Q9OA/A128T 24757.1 24760.4
Q9OE/A 128T 24815.1 24818.3
H 194Q/A 128T 24805.1 24801.5
E196D/A128T 24800.1 24807.5
E196A/A 128T 24756.1 24751.5
E196Q/A 128T 24813.2 24807.0
Kinetic Characterization of PurQ Mutants
The activity of the PurQ mutants were determined using using the Bratton-
Marshall assay in the presence of smPurL and PurS to monitor glutamine-dependent
261
1 2 3 4 5 6 7 8 9 10 11 12
Figure 5.3-15% SDS-PAGE of the purified A128T double mutant PurQs. (Lanes 1 and
8) Bio-Rad MW markers, (Lane 2) C86A, (Lane 3) C86S, (Lane 4) H194Q, (Lane 5)
E196A, (Lane 6) E196D, (Lane 7) E196Q, (Lane 9) D55A, (Lane 10) D55N, (Lane 11)
Q90A, (Lane 12) Q90E. Approximately 2 Jlg of protein was loaded into each well.
A128T PurQ typically runs slightly heavier than its true molecular weight (24.8 kDa).
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FGAM formation. With each mutant, the FGAR-AT complex was reconstituted by
mixing 2 PurS: 1 smPurL; 1 A128T PurQ double mutant at a final complex concentration
of 10 M. The complex was then diluted into the assay buffer. Product formation in this
assay depends on the glutaminase activity of PurQ, the ability of PurQ to form a complex
with PurS and smPurL, and the ability of NH3 released from glutamine upon thioester
formation to be effectively transferred between the active sites. The advantage of using
this assay over monitoring glutaminase activity directly with glutamate dehydrogenase
(GDH) is that it avoids many of the problems encountered with GDH at high glutamine
concentrations and with low enzyme activities. In fact, the glutaminase activity of
A 128T PurQ in the absence of smPurL and PurQ (0.12 min-') already approaches the
lower limit of detection -0.05 min-' for the assay. In addition, the low glutaminase
activities observed with the PurQ mutants were difficult to distinguish from an E. coli
glutaminase that often co-purifies with PurQ (see Chapter 3). By monitoring FGAM
formation, specificity for glutaminase activities related only to the PurQ mutants was
obtained.
The effects of the mutations on PurQ enzymatic activity matched predictions
based on studies of other triad ATs including carbamoyl phosphate synthase (CPS),
PABA Synthase (PabAB), and anthranilate synthase (2, 3, 10-14). Mutation of Cys86,
involved in covalent-catalysis, to either a serine or an alanine inactivated the enzyme
(lower limit of detection <0.001 s-'l). H194, thought to be required for deprotonation of
the catalytic cysteine was mutated to glutamine, was also found to be inactive (Table
5.3). This phenotype of the analogous histidine to glutamine mutation has been
previously observed in CPS and PabAB (3, 15). It is interesting to note that while
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mutation of the triad residue E196 to either an aspartate or a glutamine inactivated the
protein, the alanine mutant retained considerable activity (kcat = 0.38 s-'), 10% of the
A128T PurQ (Table 5.3). These results indicate that E196 is not essential for activity,
consistent with results from the corresponding mutants in PabAB and CPS (2, 3).
Subsequent experiments designed to monitor PurQ aggregation (SV-AUC and SEC)
revealed that the E196Q mutant was extensively aggregated during these experiments;
consequently, work on this particular mutant was not pursued further.
Table 5.3: Kinetic Parameters for the PurQ Mutants
determined during FGAM Synthesis'
Mutant Km Gln (mM) kcat (s -1)
A128T 1.3 2.5
C86S/A128T NDb ND
C86A/A128T ND ND
D55A/A128T ND ND
D55N/A128T 5.7 0.0307
Q9OA/A 128T ~ 72 -0.054
Q9OE/A 128T ~282 ~0.5322
H194Q/A128T ND ND
E196A/A128T 34 0.38
E196Q/A128T ND ND
E196D/A128T ND ND
'Kinetic parameters were determined using the
Bratton-Marshall assay to monitor FGAM formation
from a 2 PurS: 1 smPurL: 1 PurQ mutant complex.
bND = no detectable activity
Predictably, mutation of residues thought to interact with the carboxylate (Q90)
and amino (D55) moieties of glutamine resulted in enzymes with elevated Km(gln) values
and reduced kcats. Only in the case of the D55N mutation could an actual rather than an
apparent Km and kcat be determined (Table 5.3) due to problems saturating the mutants
with glutamine (as shown in Figure 5.4 for the Q9OA mutant).
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Figure 5.4-Determination of the Km for glutamine for the Q9OA mutant PurQ. As was
typical of many of the PurQ mutants, the enzyme could not be saturated with glutamine
due to the solubility limit of the substrate (200 mM). Therefore, an approximate Km was
determined (72 mM).
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Competition Experiments between A128T PurQ and Glutamine-Binding Mutants
The ability of each mutant PurQ (D55A, D55N, Q9OA, and Q9OE) to form a
FGAR-AT complex during turnover was assessed using competition assays against wt
PurQ. Based on observations from Chapter 3 in which glutamine is necessary for
complex assembly, it was predicted that the mutant's ability to compete with the wt
protein should be dependent on its ability to bind glutamine, as reflected by its Km. In
addition, if the mutant becomes saturated with glutamine, then it should be able to
interact with smPurL/PurS with the same affinity as the wt enzyme, resulting in a 50%
inhibition of activity with the addition of 1 equivalent of mutant.
This hypothesis was first tested with the D55N PurQ mutant (Km = 5.7 mM). At
20 mM glutamine, the mutant showed competitive behavior with A128T PurQ (Figure
5.5A). A reciprocal plot shows that the data can be fit to a straight line (Figure 5.5B),
and predicts that 1 equivalent of D55N results in 28% inhibition of activity. Increasing
the glutamine concentration to saturate the D55N mutant results in an increase in the
competitive behavior (Figure 5.5A). A fit to this data (Figure 5.5B) indicates that at
saturating glutamine concentrations, 1 equivalent of D55N can now inhibit activity by
45%. Thus, under saturating glutamine concentrations the D55N mutant is acting as a
competitive inhibitor of A128T PurQ. This result confirms previous findings for the
importance of glutamine-binding to formation of the FGAR-AT complex.
Unfortunately, analysis of the other glutamine-binding mutants (D55A, Q9OE,
and Q9OA) is not as straightforward. Accurate Kms for glutamine could not be
determined for either Q9OA or Q9OE, and the Kd for glutamine could not be determined
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Figure 5.5-Competition assays with the D55N PurQ mutant at 20 and 200 mM
glutamine. (A) The D55N mutant (Km 5.7 mM) was competitive with A128T PurQ at 20
mM glutamine. The mutant became more competitive at a saturating level of glutamine
(200 mM). (B) A reciprocal plot shows that the inhibitory effects of the D55N mutant can
be fit to a straight line (y = 0.0053x + 0.00087, R2 = 0.98 at 20 mM glutamine and y =
0.0079x + 0.0101, R2 = 0.95 at 200 mM glutamine).
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Figure 5.6-(A) Competition results for the inactive D55A mutant and the Q90E mutant
(K.n ,..,,282mM). (B) The Q90A mutant (~ ,.."72 mM) showed an increase in competitive
behavior at 200 mM glutamine compared to 20 roM.
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for the inactive D55A mutant. The Q9OE mutant (Km -282 mM) was not competitive
with A128T PurQ (Figure 5.6A); however, a large enough amount of glutamine could not
be added to the solution to determine if it is a competitive protein under saturating
conditions. Results obtained for Q9OA (Km -72 mM, Figure 5.6B) indicated that it does
possess some glutamine-dependent increase in competitive behavior; however, this
enzyme could also not be saturated with substrate under the assay conditions.
Competition Assays between A128T PurQ and Conserved Triad Mutants
Competition assays were also carried using PurQs containing mutations to the
conserved triad residues C86, H194, and E196. Unfortunately, since all of these mutants
except E196A are inactive, glutamine Kms could not be determined. Efforts to measure
glutamine binding by other methods such as isothermal titration calorimetry (ITC) and
fluorescence titration were unsuccessful. Thus, all of the experiments reported below
contain the caveat that the amount of glutamine bound to PurQ is unknown; however, it is
assumed that the mutants exhibit similar glutamine-binding properties as A128T PurQ
and are saturated under the experimental conditions.
As shown in Figure 5.7A, the C86A and C86S double mutants were both
competitive with A128T PurQ. Reciprocal plot analysis of the data (Figure 5.7B)
indicates that the inhibition of activity observed with the C86 mutants is linear and that 1
equivalent of C86A or C86S is enough to decrease the observed activity by 54% and
45%, respectively. The simplest interpretation of the data is that the mutants are acting as
competitive inhibitors of A128T PurQ and can interact with smPurL and PurS with
comparable affinity as A128T PurQ. The ability of the C86A mutant to form a FGAR-
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Figure 5.7-Inhibition of wt A128T PurQ FGAR-AT complex formation by C86X
A128T Pur mutants in the presence of 20 mM glutamine. (A) Both C86A and C86S
double mutants competed effectively with A128T PurQ. (B) A reciprocal plot showed
that the inhibitory effects of each mutant can be fit to a straight line (y = 0.01201x +
0.00097, R2 = 0.99 for the C86A mutant and y = 0.00657x + 0.011436, R2 = 0.99 for the
C86S mutant).
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AT complex is particularly informative since it indicates that a covalent PurQ-glutamine
complex is not essential for FGAR-AT complex formation during turnover conditions.
Similar results have been obtained by Walsh and coworkers on PabAB using a C79S
mutation (3).
Competition assays with the inactive H194Q PurQ showed that it is also able to
compete with A 128T PurQ, and -8 equivalents are necessary to decrease the observed
activity by 50% (Figure 5.8A). Surprisingly, none of the E196 mutants are competitive
with wt PurQ at either 20 or 200 mM glutamine (Figure 5.8B). E196A, in particular,
warrants further investigation since this is an active enzyme, capable of supporting
FGAM synthesis with only a 10-fold decrease in kcat. The Km for glutamine for this
enzyme is 34 mM, and at 200 mM glutamine, the glutamine binding site is saturated. If
E196A formed an FGAR-AT complex under these conditions, one would have expected
only 10% remaining activity at a ratio of 10:1 mutant:A128T PurQ. However, no
significant loss of activity is observed (Figure 5.8B). These results indicate that the
E196A mutation substantially alters interactions between PurQ and smPurL/PurS and
suggests that E196 may play an important role in complex formation.
Biophysical Characterization of PurQ Mutants
The necessity for altered expression and purification protocols for several PurQ
mutants due to aggregation and solubility problems prompted an investigation of the
PurQ mutant proteins by CD spectroscopy, SV-AUC, and analytical SEC. CD spectra of
the A128T PurQ displayed features at 208 and 220 nm (Figure 5.9A). These features
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Figure 5.8- Competition assays between conserved triad residue PwQ double mutants
(Hl94Q, El96A, El96D) and A128T PwQ. (A) Hl94Q, which is inactive, was partially
competitive with A128T PwQ at 20 mM glutamine (black), and a slight increase in
competitive behavior was observed at 200 mM glutamine (red). (B) The El96 mutants
were not competitive with A128T PwQ at either 20 or 200 mM glutamine.
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were similar in all mutants studied (C86A, C86S, H194Q, D55A, D55N, Q9OA, and
Q9OE) except for E196. E196A, D, and Q PurQs all show a sharpening at 208 nm,
indicating an increase in either the ax-helical or random coil content of the protein relative
to A128T PurQ (Figure 5.9B).
SV-AUC experiments were then used to determine whether PurQ mutants have
aggregated and if so, to what extent. As listed in Table 5.4, the amount of aggregate
present in each sample varied greatly. In particular, the C86 and E196 mutants contained
large amounts of aggregate by SV-AUC (Figure 5.10A and B). Furthermore, the
inclusion of glutamine in the SV-AUC experiment did not substantially alter the amount
of aggregate present in the C86 mutants (Figure 5.11). The results with the C86 mutants
are inconsistent with results from the competition experiments described above. Based
on the level of aggregation observed by SV-AUC, substantial increases in the amount of
PurQ mutant needed to achieve 50% inhibition would have been expected. An alternate
method was used to determine the amount of aggregate in PurQ samples under conditions
used for the competition experiments.
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Figure S.9-CD spectra of A128T and double mutant PutQs. (A) Most of the PurQ
mutants show CD spectra similar to A128T PurQ. The spectra of A128T PurQ is
characteristic of a mixed alP-protein with features at 208 and 220 nIn. The CD spectra of
all the double mutants except for those to El96 are similar to that of A 128T, and data for
the C86A and C86Smutants are shown (data is offset for easier comparison). (B) CD
spectra of the E 196 mutant proteins show a sharpening and increase in the 208 nm feature
relative to the 220 nm peak (arrow). This indicates an increase in either the a-helical or
random coil content of the mutant proteins.
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Figure S.10-Quantitation of the amount of aggregate present in PurQ mutants by SV-
AVC. (A) The distribution of species present in solution for the A128T (black),
C86A1A128T (red), and C86S/A128T proteins (blue). (B) The El96 double mutants
contained substantially more aggregate than other mutations.
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Figure 5.11- Efforts to try to reverse or prevent aggregate formation by inclusion of
glutamine in the SV-AVC experiment SV -AVC was carried out in the presence of 50
roM glutamine with the inactive C86A and C86S double mutant PurQs. Comparison of
experiments in the presence (dashed lines) and absence (solid lines) of glutamine shows
that it had little effect on the aggregate content
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Table 5.4: Quantitation of Aggregated Species Present
in Mutant PurQs by SV-AUC and SEC
% % o
Mutant Active Aggregate Aggregate
by SV-AUC by SEC
A128T Yes 15 8
C86S/A128T No 41 8
C86A/A128T No 50 15
D55A/A 128T No 24 NDb
D55N/A128T Yes 31 ND
Q9OA/A 128T Yes 7 ND
Q9OE/A128T Yes 8 ND
H194Q/A128T No 13 ND
E 196A/A 128T Yes 47 18
E196Q/A128T No 78 53
E196D/A 128T No 57 16
aDetermined from analytical SEC results presented in
Chapter 3 bND = not determined
The C86 and E196 PurQ mutants were incubated in FGAR-AT assay buffer for 5
min at 37°C, after which time the solution was applied to an analytical SEC column to
determine the extent of protein aggregation. As shown in Figure 5.12A and B, the
amount of aggregation observed using this method was significantly less for the C86A,
C86S, E196A, and E196D mutants relative to what was observed by SV-AUC (Table
5.4). In addition, the extent of aggregation was comparable to that seen with A128T
PurQ. These studies indicate that the mutants likely aggregated during the dialysis step
prior to performing the SV-AUC experiment. The E196Q mutant showed substantial
amounts of aggregate using both methods, indicating that this mutant is highly prone to
aggregation (Table 5.4).
Histag Affinity Purification of the FGAR-AT Complex from B. subtilis
The studies presented above and in Chapter 3 on heterologously-expressed and
purified PurS, PurQ, and smPurL suggest that glutamine is essential in formation of the
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Figure 5.12- Analytical SEC analysis of the amount of aggregate present in C86 and
E196 PurQ mutants during assay conditions. For the C86A, C86S, E196A, and E196D
mutants, the amount of aggregate present is less than what was observed by SV -AVC,
indicating that these mutants aggregated during dialysis or centrifugation. Large amounts
of aggregate were observed by both SV-AVC and SEC for the E196Q mutant.
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FGAR-AT complex. The complex formation occurs at relatively high concentrations of
glutamine due to the high Km exhibited by PurQ (1.3 mM). Given that the intracellular
glutamine concentration in B. subtilis is also very high (1-7 mM) (16), this suggested that
glutamine might also be important for formation of the FGAR-AT complex in vivo. In
order to test this hypothesis, a method was developed to affinity purify the B. subtilis
FGAR-AT from the native organism either in the presence or absence of glutamine with
the use of a histidine-tagged PurQ. By comparing the amounts of PurS and smPurL
isolated under the varying conditions, the impact of glutamine on isolation of the
endogenous FGAR-AT can be addressed. Previous studies
have indicated that histag-A 128T PurQ has the same activity as A 128T PurQ and can
reconstitute the FGAR-AT complex in vitro (data not shown).
In order to express histag-PurQ in B. subtilis, the gene was first placed into the
pDG148 vector (9). This vector encodes low-copy origins of replication for both E. coli
and B. subtilis allowing the vector to be propagated in E. coli before transformation into
B. subtilis, which requires 5-50 ,g of plasmid per transformation. Once inside B. subtilis,
protein expression from pDG148 is under control of the lac promoter and can be induced
with IPTG.
The histag-wt-PurQ and histag-A128T-PurQ genes were readily subcloned into
pDG 148. After transformation into B. subtilis strain AG 174, it was determined that
induction with 0.1 mM IPTG during log phase growth in minimal media gave expression
levels of his-PurQ that closely matched that of the endogenous PurQ (-40pM, Chapter
4). Under these conditions, his-wt PurQ was expressed at a ratio of 0.8 + 0.1 his-wt
PurQ: 1 endogenous PurQ, while histag-A128T-PurQ was expressed at a level of 0.9 +
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Figure 5.13- Induction of either his-wt-PurQ or his-Al28T -PurQ in B. subtilis with
IPTG. B. subtilis was transformed with plasmids containing either the his-wt-PurQ
(WT) or his-A 128T-PurQ (AI28T) genes under control of an IPTG-inducible lac
promoter. Expression levels compared to the endogenous proteins were determined by
Western blotting to be 0.8 .:t..O.lhis-wt PurQ:l native PurQ and 0.9.:t 0.1 his-A128T-
PurQ: 1 native PurQ.
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0.1 his-A 128T PurQ: 1 endogenous PurQ (Figure 5.13). Additional experiments showed
that the expression of his-PurQ does not alter the expression levels of PurS or smPurL
(data not shown). This means that his-PurQ and the endogenous PurQ are competing for
PurS and smPurL in the cell.
Efforts to purify the complex from the crude cell lysate using Ni2+-affinity
chromatography were carried out under a variety conditions with either PD buffer, PD
enriched with 0.1 mM ADP, enriched with 20 mM glutamine, or enriched with both ADP
and glutamine. n addition, a similar experiment was carried out in the presence of the
glutaminase-inhibitor DON. The results of these experiments are shown in Figure 5.14
and summarized in Tables 5.5-7. PurS is only isolated with histag PurQ in the presence
of either glutamine or DON. Glutamine or DON-inactivation had little effect on the
amount of smPurL isolated with the histag-A128T PurQ, but dramatically increased the
amount isolated using histag-wt PurQ (Table 5.7). Based on these results, glutamine also
plays a role in complex assembly for wt PurQ and between endogenous B. subtilis
proteins.
It is also interesting to note that the presence of ADP in the buffer did not affect
the amount of complex isolated (Figure 5.14, Lanes 1 and 2). Based on results from
Chapter 3, it is likely that the endogenous smPurL already contains the ADP cofactor.
Unlike smPurL over-expressed in E. coli, ADP appears to be tightly bound to the
endogenous B. subtilis smPurL and did not dissociate during the purification.
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Figure 5.14- Results from the affinity purification experiments using histag PurQs.
Affinity purifications were performed using B. subtilis transformed with either histag-wt-
PurQ or histag-A 128T-PurQ and a control containing no plasmid (left column).
Purifications were performed with the same crude lysate under different conditions using
either PD buffer (Lane I), PD buffer with ADP and/or glutamine (Lanes 2-4), or by
DON-inactivating the cell lysate (Lane 5). Proteins were then detected by Western
blotting using the 10 Abs listed in the right column. The band intensities in each
horizontal row are directly comparable. PurS could only be detected in experiments
containing glutamine (Lanes 3 and 4) or when the cell lysate was DON-inactivated (Lane
5).
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Table 5.5: Normalized Amounts of his-PurQ Isolated after Affinity Purification
PD Buffer Components
Plasmid Protein -- +ADP +Gln +ADP/GLN +DON
His-wtQ PurQ 1.03 0.89 0.71 1 0.99
His-A128T Q PurQ 1.05 1.21 0.98 1 0.97
Table 5.6: Normalized Amounts of PurS Isolated after Affinity Purification
PD Buffer Components
Plasmid Protein -- +ADP +Gln +ADP/GLN +DON
His-wtQ PurS ND ND 0.84 1 0.66
His-A128T Q PurS ND ND 0.55 1 0.68
Table 5.7: Normalized Amounts of smPurL Isolated after Affinity Purification
PD Buffer Components
Plasmid Protein -- +ADP +Gln +ADP/GLN +DON
His-wtQ smPurL 0.04 0.09 0.94 1 0.70
His-A128T Q smPurL 0.73 0.54 0.91 1 0.83
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Figure S.tS-Analysis of the ratio of PurS:PurQ:smPurL obtained in the affinity
purification experiments by Western blotting. Lane 1 contains a standard with a ratio of
2 PurS: 1 smPurL: 1 A128T PurQ. Lane 2 is the complex isolated with his-wt-PurQ in
the presence of ADP and glutamine. Band intensities in lanes 1 and 2 are directly
comparable and each lane contains approximately the same amount of PurQ.
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While the results from the affinity purification experiments are intriguing, these
experiments had several faults. First, FGAM synthesis could not be detected in any of
the isolated complexes. Second, as shown in Figure 5.15, a 2 PurS: smPurL: 1 PurQ
complex was not isolated. With both the histag-wt and histag-A128T PurQs, the histag
PurQ was in large excess of smPurL and PurS. One reason for the inability to isolate a
2:1:1 complex is due to the presence of both histag and endogenous PurQ in the cell.
Based upon quantitative Western blotting results from cells grown in minimimal media
(Chapter 3), this limits the maximum amount of PurS and smPurL that can be isolated
with histag PurQ to 1 PurS: 0.5 smPurL: 1 PurQ. Still, analysis of the results presented
in Figure 5.15 indicate that the amount of PurS and smPurL isolated falls well-below
these values, with an estimated yield of 10%. The lack of a 2:1:1 complex likely
explains the inability to detect activity in the isolated complexes and indicates that the
FGAR-AT complex may be dissociating during the affinity purification. Future attempts
to isolate the in vivo FGAR-AT complex may benefit from the construction of a gene
knockout strain of B. subtilis to remove the endogenous PurQ and the use of a higher-
affinity FLAG or myc-tag to facilitate active complex purification.
5.4 Discussion
The B. subtilis FGAR-AT is unique among triad glutaminases for several reasons
including the fact that it is the only triad AT that requires an auxiliary protein with no
enzymatic activity (PurS) for function. In addition, while high levels of activity can be
obtained from the reconstituted FGAR-AT with a protein ratio of 2 PurS: 1 smPurL: 1
A 128T PurQ, the protein complex can only be isolated in the presence of Mg2+-ADP and
glutamine (Chapter 3). Structural analysis of the Salmonella gPurL and homology
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modeling of the B. subtilis smPurL indicate that ADP is acting as a structural cofactor (5,
17). The necessity for glutamine for complex assembly is less clear since most ATs do
not require glutamine for interaction between the glutaminase and AT domains (or
proteins). The results of this reconstitution are strikingly similar to those required to
isolate a PabAB complex. PabAB catalyzes formation of 4-amino-4-deoxychorismate
from chorismate and glutamine during the first step of p-aminobenzoate synthesis (Figure
5.1), with PabA catalyzing the glutaminase activity and PabB the AT activity. PabAB is
the only other AT system exhibiting weak protein interactions between the AT and
glutaminase. In this case, pre-incubation of the proteins with glutamine is also required
to isolate a complex by SEC (18), and it has recently been discovered that PabB contains
a tightly bound tryptophan that may be acting as a structural co-factor analogous to ADP
in smPurL (19).
Glutamine Binding but Not an Active PurQ is Important for FGAR-AT Complex
Formation during Turnover Conditions
Initial studies using SEC analysis indicated that glutamine is required to detect
complex formation in the FGAR-AT. To provide additional evidence for the necessity of
glutamine binding to PurQ for complex assembly, competition assays between mutant
PurQs with altered glutamine-binding properties and A128T PurQ were used. The model
predicts that mutant PurQs that cannot bind glutamine would be unable to compete with
A128T PurQ and consequently decrease FGAM synthesis activity. However, upon
saturation of the mutant with glutamine, the ability to compete should be restored. This
hypothesis was tested with the D55N PurQ mutant (Figure 5.5). When the mutant was
not saturated with glutamine, 1 equivalent of D55N only decreased the activity by 28%.
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Under saturating conditions, the mutant became a stronger inhibitor of FGAM synthesis
and 1 equivalent could decrease the observed activity by 45%. Similar experiments were
attempted with the D55A, Q9OA, and Q9OE mutants. While some of these mutants were
competitive (Figure 5.6), interpretation of the data in these cases was complicated by the
inability to saturate the mutants with glutamine and measure accurate Kms.
The C86A and C86S mutants were able to compete most effectively with A128T
PurQ (Figure 5.7) with 1 equivalent of mutant inhibiting activity by -50%. Physical
characterization of these mutants relative to A128T PurQ by SEC suggest that they are
monomers with -10% of protein in an aggregated state; although, the mutants do have an
increased tendency to aggregate during SV-AUC. The efficient competition suggests
binding of glutamine equivalent to A128T PurQ, as was assumed. Thus, during turnover
conditions, an active PurQ is not necessary for complex formation with smPurL and
PurS.
The Conserved Triad Glutamate is Important for FGAR-AT Complex Formation
The results mentioned in the previous section support studies from Chapter 3 that
suggested glutamine is essential for FGAR-AT complex formation. Competition
experiments can also serve as a probe for identifying residues in PurQ important for
FGAR-AT complex formation. As was mentioned in the introduction, mutation of the
conserved triad glutamate in CPS and PabAB has resulted in speculation that this residue
may be playing a role in linking the glutaminase and AT domains (2, 3). In the case of
CPS, mutation of E355 to either an alanine or an aspartate resulted in an enzyme with wt
levels of glutamine hydrolysis and carbamoyl phosphate synthesis; however, in an E355Q
mutant, coupling between the glutaminase and ATPase activities was lost and no
287
carbamoyl phosphate was synthesized (2). This result led Raushel and co-workers to
speculate that this residue was involved in communication between the AT and
glutaminase.
In the case of PabAB, mutation of the conserved residue E170 to either an alanine
or aspartate resulted in an active enzyme, while the glutamine and lysine mutants were
inactive (3). In addition, the E170Q mutant was competitive with active PabA for
complex formation with PabB, while E170K was not. Walsh and coworkers suggested
that in lieu of an essential chemical role, El70 may be playing a role in PabA and PabB
interactions (3).
Results from the E196 PurQ mutants corroborate findings made by Raushel and
Walsh that the glutamate is not part of a catalytic triad. The E196A PurQ has 10%
activity of A128T PurQ (Table 5.3). This supports the idea that E196 does not play a
direct chemical role in glutamine hydrolysis; however, this residue may still be important
for correctly positioning H194 in the PurQ active site. Surprisingly, despite this activity,
E1 96A is not competitive with A128T PurQ even in 200 mM glutamine where the mutant
should be saturated with glutamine (Km = 34 mM). In fact, none of the E196 mutants
were competitive under the conditions examined. One hypothesis for these observations
is that E196 is essential for complex formation between smPurL and PurQ. Mutation of
this residue may result in a small structural change that effects the PurQ:smPurL
interface. CD spectra of the E196 mutants (Figure 5.9) supports the possibility of an
altered structure for the protein.
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Structural Insight into the Role E196 May Play in Complex Formation
The crystal structure of the Salmonella lgPurL provides insight as to why
mutations to E196 may affect PurQ's interface with smPurL (Figure 5.16) (5). The
residue immediately adjacent to the triad glutamate (E1262) is an arginine (R1263) that is
involved in an interdomain contact with the AT (via D657). These residues are
conserved in the B. subtilis FGAR-AT (Figure 5.16). The connection of E1262 is
through a H 2 0 molecule to the 6-nitrogen of R1263. Mutation of the glutamate could
alter interactions between R1263 and D657. Whether a similar connectivity occurs in B.
subtilis FGAR-AT is not known; however, this model could be tested via further
mutagenesis studies.
E196 Could Also Play a Role in Coupling Glutaminase and AT Activities
Recent studies from the Davisson lab on HisHF (Figure 5.1) have implicated the
importance of R1263 in communication between the AT and glutaminase domains of the
FGAR-AT (20). Davisson's group has identified a pair of interdomain contacts in HisHF
that appear to be important for coupling glutaminase and AT activities. As shown in
Figure 5.17, an interdomain contact between glutaminase residue K196 and AT residue
D357 was observed in the HisHF crystal structure. Importantly, K196 is on the same
loop and is immediately adjacent to the conserved triad glutamate residue, E195.
Mutation of K196 and D357 resulted in uncoupling of glutaminase and AT activities in
HisHF (up to 110 glutamines were hydrolyzed per AT product formed), and MD
simulations suggest that interactions between D357, K196, E195, and H193 are
responsible for triggering the glutaminase activity of HisHF in the presence of the AT
substrate (20). Davisson has suggested that many triad ATs utilize a similar mechanism
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vFigure 5.16-Possible role for the conserved triad glutaminase residue E1262 in linking
the glutaminase (red) and AT domains (blue). Residues from the Salmonella IgPurL
structure are labeled in black, and the glutamylthioester (GTE) is shown at C1135.
Homologous residues in B. subtilis PurQ and smPurL are labeled in red and blue,
respectively. A salt-bridge between 0657 and R1263 has been proposed to playa key
role in linking the glutaminase to the AT domain. E1262 is adjacent in sequence to
R 1263 and is hydrogen-bonded to that residue via a bridging water molecule. In
experiments with the B. subtilis FGAR-AT complex, mutation of E196 in PurQ may
disrupt this connection and alter the RI97-D431 interaction proposed between PurQ and
smPurL.
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Anthranilate
Synthase
HisHF
Figure 5.17 - Interdomain contacts implicated by Davisson and coworkers that may be
essential for linking the AT (blue) and glutaminase domains (red). (Top) In the structure
of anthranilate synthase containing a glutamylthioester at C85, E174 is hydrogen bonded
to triad residue H172 and is adjacent to 8175 which interacts with the AT domain residue
0367. (Bottom) In the structure of HisHF inactivated with acivicin at C83, E195 interacts
with triad residue H193 and is adjacent to K196 which interacts with AT domain residue
0357.
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of activating the glutaminase domain for catalysis, and in most cases, the residue
immediately adjacent to the triad glutamate is involved in a key interdomain contact. For
example, in the case of anthranilate synthase (which is highly homologous to PabAB),
S175 was observed to be in an interdomain contact with D367 (Figure 5.17). S175 is
immediately adjacent to the conserved triad glutamate E174. Given the interaction
between D657, R1263, and E1262 observed in the gPurL crystal structure (Figure 5.16),
these residues may also be important for coupling AT and glutaminase activities in
FGAR-AT. Further mutagenesis studies are needed on PurQ to address the importance of
interactions between E196, R197, and smPurL residue D431 on FGAM synthetic activity.
Glutamine is Also Important for Assembly of the Endogenous B. subtilis FGAR-AT
Given the difficulties that have been encountered in assembling the B. subtilis
FGAR-AT, questions were raised concerning FGAR-AT assembly inside the cell. To
address this issue, a histag-PurQ was expressed at physiologically relevant levels in B.
subtilis and used to affinity purify the FGAR-AT complex either in the presence of
absence of glutamrnine. The results from these experiments (Figure 5.14) indicate that
glutamine also plays an important role for holding the FGAR-AT complex together in B.
subtilis, and PurS could only be co-purified in the presence of glutamine or by DON-
inactivating the cell lysate. Thus, it seems unlikely that observations made in vitro are
artifacts of using heterologously expressed and purified enzymes.
Future Studies
Future studies on the role of glutamine binding to PurQ should focus on several
areas. First, a structure of PurQ is needed to address conformational changes that may
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occur upon glutamine binding, complex formation with smPurL/PurS, and conversion to
an active glutaminase. So far, neither of the PurQs from B. subtilis or T. maritima have
been crystallized. Given that PurQ is a relatively small enzyme (24 kDa), structural
information may be obtained by NMR methods if conditions are found to limit protein
aggregation. Work on 15 N-labeled PurQ by Professor Jens Wohnert (U. Texas Medical
Center- San Antonio) has already indicated that PurQ is folded and stable under NMR
conditions for short time periods (personal communication). NMR may be particularly
useful in addressing dynamic motions of PurQ that may occur upon substrate binding or
during activation of the glutaminase activity.
Second, kinetic work should be done to further investigate the role glutamine
plays in FGAR-AT complex formation. The work presented here and in Chapter 3
strongly indicates that glutamine is required for complex formation, and results from the
C86A mutant indicates that complex formation is not contigent on formation of a PurQ-
glutamylthioester. The implication of this finding is that the FGAR-AT has evolved to
specifically recognize the PurQ-substrate complex. Evidence to support this model could
come from kinetic studies that compare the rate of FGAR-AT complex formation to the
rate of glutamylthioester formation in the PurQ-glutamine complex. If complex
formation proceeds faster than glutamylthioester formation, then the FGAR-AT complex
may have evolved to specifically interact with the non-covalent PurQ-substrate complex.
Finally, the recent results by Davisson and coworkers on HisHF provide a new
avenue to examine reaction coupling in the FGAR-AT (20). Mutations to R197 in PurQ
and D431 in sPurL should be made and thoroughly investigated with respect to both
kinetics and product stoichiometry. Based on results presented in this chapter and the
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crystal structure of the Salmonella lgPurL, E196 may also be involved in this interaction
and should be included in these studies. These experiments may illuminate how PurQ
becomes activated for glutamine hydrolysis during FGAM synthesis; however, how ATP
and FGAR binding information directly impacts the D657(smPurL):R197 (PurQ)
interaction over a distance of -25 A will require more thorough investigations.
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Chapter 6:
Identification of Residues Essential for PurL Catalysis and Relationship of these
Residues to Other PurM-Superfamily Members
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6.1 Introduction
When the crystal structure of PurM was determined in 1999 by the Ealick and Stubbe
Laboratories, it was discovered that the enzyme possessed a unique fold and served as the
prototype of a new superfamily of ATP-binding enzymes defined by a conserved DX4GAXP
motif in which the aspartate was believed to be essential for ATP binding (1). Only 5 members
f this superfamily have thus far been identified: PurM, PurL, thiamine monophosphate kinase
(ThiL), selenophosphate synthetase (SelD), and an ATP-dependent hydrogenase maturase
protein (HypE) (1). Each of these superfamily members is thought to transfer the y-phosphate of
ATP to substrate in either a kinase reaction (ThiL and SelD) or during formation of a proposed
phosphorylated-substrate intermediate (PurM, PurL, HypE) (Figure 6.1). The common
chemistry of the superfamily members was proposed to be an iminophosphate. In the cases of
ThiL and SelD, the phosphorylation was proposed to involve a phosphoryl-enzyme intermediate
in which phosphate is transferred to the amide backbone of a conserved amino acid in the active
site (2).
Structures of the Salmonella lgPurL, T maritima smPurL, and A. aeolicus ThiL have
recently been determined and the identity of the superfamily has been confirmed by observation
of common fold (Figure 6.2) (2). The central feature of the PurM-superfamily is a dimeric
protein in which an 8-stranded 3-barrel forms the monomer:monomer interface. In the case of
snPurL and lgPurL, the monomers have been fused to create a single chain that exhibits
pseudosymmetry about the central barrel. Based upon the location of conserved residues and
ATP site-labeling studies on PurM withp-fluorosulfonylbenzoyl adenosine (FSBA), the active
sites of the enzymes are believed to exist in a cleft between the N-terminal and C-terminal halves
of each monomer, with 2 active sites per dimer (1-3).
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Figure 6.1-Members of the PurM-superfamily of enzymes. PurL, PurM, and HypE are
proposed to use the y-phosphate of ATP to generate an iminophosphate intermediate. In HypE,
this is proposed to occur on an enzyme-liked thiocarbamate. SelD and ThiL are kinases that
phosphorylate selenide and thiamin monophosphate, respectively, and have been proposed to
also utilize iminophosphate intermediates, possible derived from an amide of the protein
backbone.
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Figure 6.2--Comparison of the crystal structures of T. maritima smPurL (1vleJ.pdb), the AT
domain of Salmonella IgPurL (lt3tpdb), E. coli PurM (lcli.pdb), and ThiL (lvqv.pdb). In
smPurL and IgPurL, the N- and C-terminal halves of the pseudodimer are colored in blue and
red, respectively. The linker domains connecting the N- and C-terminal halves are shown in
green. In PurM and ThiL, subunits of the homodimer are colored in blue and red. Each structure
shows a conserved fl-barrel core, the center of which is noted with the black dot.
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Despite structures of several members of this superfamily, analysis of the active site has
been complicated because neither lgPurL nor PurM has yet been crystallized with substrates or
products. Given that these enzymes possess a novel ATP-binding motif, difficulties have been
encountered in efforts to model ATP or purine substrates into the active sites, making
identification of residues important for catalysis difficult. Experiments in the past few years
sought to crystallize the B. subtilis smPurL with ATP and FGAR in hopes that it would be able
to provide new information about the active site architecture in this superfamily; however, as
noted in the preceeding chapters, aggregation problems encountered throughout studies on
smPurL have thus far inhibited these efforts.
In order to provide new information about the active sites of PurM-superfamily members,
the T maritima smnPurL was cloned, expressed, and purified in collaboration with the Ealick
Laboratory. Structures of T maritima smPurL in complex with FGAR, ATP, ADP, and a ternary
complex with FGAR and ,y-methyleneadenosine 5'-triphosphate (a non-hydrolyzable ATP-
analog, AMP-PCP) have very recently been determined by Maria Morar and Ruchi Anand in the
Ealick Laboratory. The solutions of the T maritima structures were facilitated by the structure
of T maritima smPurL in the apo form which has recently appeared from the Joint Center for
Structural Genomics (1 vk3.pdb). These structures identified for the first time the mechanism of
ATP-binding by members of the PurM-superfamily and identified two histidine residues in the
active site that may be important for catalysis. Mutagenesis studies of these residues to alanines
confirm their importance for activity. A mechanism is proposed for fomation of a putative
inminophosphate intermediate by smPurL using the active site architecture. Model structures
have also been created for HypE and SelD and features of the active sites of these enzymes are
compared to structures of PurM, PurL, and ThiL. These results indicate that while ATP-binding
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is highly conserved in the PurM-superfamily, conserved histidines identified in PurL are not
conserved in all superfamily members.
6.2 Experimental
Materials and Methods
1-FGAR was prepared from chemically synthesized ca/3-GAR using the PurT
glycinamide ribotide transformylase as previously described (4). The PurT plasmid was a gift
from H. Holden, University of Wisconsin-Madison (5). E. coli PurM containing a N-terminal
histidine tag was purified as described (his-PurM, specific activity 1-2 U/mg) (1). ATP, ADP,
PEP, NADH, and pyruvate kinase/lactate dehydrogenase (a pre-mixed glycerol solution 660
U/mL PK/ 1350 UIJ/mL DH) were purchased from Sigma. NH4Cl was from Mallinckrodt. All
spectrophotometric assays were carried out on a Cary 3 UV-Vis spectrophotometer with
temperature regulation using a Lauda water bath. Circular dichroism and analytical
ultracentrifugation experiments were carried out in the Biophysical Instrumentation Facility for
the Study of Complex Macromolecular Systems (Department of Chemistry, MIT).
Cloning of the T maritima purL Gene
The T. maritima purL gene was cloned from genomic DNA (ATCC) by standard PCR
procedures using the KOD HiFi DNA polymerase (Novagen) and the primers TML-NdeI: 5'-
GCCATATGAAGTTGAGATATCTGAACATTCTCAAGG-3' and TML-NotI: 5'-
AAATIATGCGGCCGCTCACCTCGAGAGCGTTCCGATCTCCTTC-3'. Taq DNA
polymerase (Invitrogen) was then used to create 3'-A overhangs on the PCR product, which was
then ligated into the pCRII-TOPO vector (Invitrogen) in a topoisomerase-dependent reaction to
make pCRII-TOPO-TML. Colonies containing the insert were then selected by blue-white
screening on X-Gal containing media. The insert was isolated from the pCRII-TOPO-TML
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plasmid by digestion with NdeI and NotI (New England BioLabs) and ligated into pET-24a
(Novagen) at the same restriction sites to create pET-TML. Sequencing of the gene by the MIT
Biopolymers Facility revealed a silent mutation at nucleotide position 891 corresponding to a
ATC-ATT change in the ile codon.
Mutagenesis of T. maritima smPurL
H32A and H72A mutants of T maritima smPurL were created from the pET-TML
plasmid by Ruchi Anand (Ealick Laboratory, Cornell University) using Quikchange mutagenesis
and the details will be described elsewhere (Morar, M. et al., manuscript in preparation).
Protein Expression and Purification
Both the wt and mutant T maritima smPurLs were expressed and purified by Ruchi
Anand and Maria Morar (Ealick Laboratory, Cornell University) using identical procedures. The
pET-TML plasmid containing either the wt or the mutant smPurL gene was transformed into
Rosetta(DE3) E. coli (Novagen). Single colonies were used to inoculate 5 mL of LB with 35
[ig/mL kanamycin and 30 [tg/mL chloramphenicol and allowed to grow overnight at 37°C. The
saturated culture was then used to inoculate 1 L of LB media containing the same antibiotics.
The culture was grown at 37°C with shaking at 200 rpm, and after an OD6 0 0 of 0.7 was reached,
the temperature was lowered to 25°C, and cells were induced with 200 gM IPTG for 6 h. The
cell pellet was collected by centrifugation and stored at -80°C (yield 4 g/L).
Cells (-4 g) were resuspended in 40 mL of TM buffer (50 mM HEPES pH 7.8, 100 mM
NaCl) with the addition of COMPLETE Protease Inhibitors (Roche) and lysed by sonication
while cooling in an ice water bath. Cell debris was removed by centrifugation at 17,000 rpm for
20 min. The lysate was then loaded onto a HiTrap MonoQ FF column (10/10, Pharmacia)
equilibrated in TM buffer and washed until the A280 < 0.1. The protein was eluted with a 0.1 to
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]L M NaCl gradient (150 x 150 mL) at a flow rate of 2 mL/min while collecting 5 mL fractions.
Fractions containing smPurL eluted at -200 mM NaCl and were concentrated to 10 mL using a
YM30 Centricon (Millipore).
The concentrated protein was desalted with a Hi-Load Superdex 75 column (26/60,
Pharamacia) equilibrated in TM buffer. Protein was eluted with TM buffer at a flow rate of 2
mL/min, and 2 mL fractions were collected. Protein containing fractions were concentrated to
10 mg/mL and frozen in liquid N2. Typical protein yields were -10 mg protein/g cells.
Crystallization and Structure Determination of the T. maritima smPurL
The crystal structures of the T maritima smPurL in complex with FGAR, ADP, ATP,
and a ternary complex with FGAR and ,y-methyleneadenosine 5'-triphosphate (AMP-PCP)
were determined by Maria Morar and Ruchi Anand by molecular replacement using the structure
of apo-smPurL (1 vk3.pdb, unpublished) solved by the Joint Center for Structural Genomics
(JCSG). The details will be described elsewhere (Morar, M. et al., manuscript in preparation).
Sedimentation Velocity Analytical Ultracentrifugation (SV-A UC)
SV-AUC experiments were performed using an Optima XL- 1 analytical ultracentrifuge
(Beckman Coulter, Fullerton, CA). Before each experiment, protein samples were dialyzed
against 50 mM Tris, 20 mM KCl, 20 mM MgCl 2 pH 8.0 for 24 h in a Slide-A-Lyzer cassette
with a 10 kDa molecular weight cut-off (MWCO) membrane (Pierce). Samples (400 PL) were
then diluted to 9.7 tM and placed in double-sector Epon centerpieces with quartz windows in an
An6OTi 4-hole rotor. Sedimentation was monitored by continuous scanning at 280nm along the
length of the cell at 30,000 rpm for 24 h at 25°C.
SEDNTERP software from Dr. J. Philo was used to calculate buffer density (1.00197
g/mL), viscosity (0.01002 Poise), and protein partial-specific volume from the amino acid
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content (0.7444 mL/g) (6). Data (-100 traces for each experiment) were fit using SEDFIT88
from 0.5 to 20 S using a continuous distribution of sedimentation coefficients derived from
solutions to the Lamm equation (7).
Circular Dichroism Spectroscopy
Circular dichroism (CD) Spectra were collected on an AVIV Model 202 CD
spectrophotometer (AVIV Biomedical, Inc., Lakewood, NJ). Proteins were dialyzed before the
experiment against 10 mM KPi pH 7.0 buffer for 16 h using a Slide-A-Lyzer cassette (Pierce)
with a 10 kDa MWCO membrane. Spectra were collected for each sample (5 [tM) at 25°C in a
0.1 cm path length quartz cuvette in argon-degassed dialysis buffer by scanning from 300-190
nm at 0.5 nm increments with a 0.2 s integration time.
Enzyme Assays
T maritima smPurL was assayed in the absence of PurS and PurQ by monitoring NH4Cl-
dependent FGAM formation. FGAM synthesis was monitored directly using a coupled,
discontinuous assay with his-PurM and the modified Bratton-Marshall assay (8). Each assay
contained in a final volume of 400 VL: 100 mM Tris pH 8.0, 20 mM KCI, 20 mM MgCl 2, 1.5
mM PEP, 10 U/mL PK, 20 U/mL his-PurM, 750 mM NH4Cl, 10 mM ATP, and 2 mM -FGAR.
The reaction was initiated by the addition of enzyme ( -10 g) and incubated at 37°C before
being quenched with 100 gL of 1.33 M KPi pH 1.4/20% tricholoracetic acid followed by
derivitization and quantitation of AIR (8).
ADP synthesis was monitored using a coupled assay at 37°C with PK and LDH,
monitored continuously with NADH oxidation at 340 nm ( = 6200 M- lcm' l). The assay buffer
was the same as described above except that it also contained 0.2 mM NADH, 20 U/mL PK, and
42 U/mL LDH.
305
Determination of Kinetic Constants
Kinetic parameters for ATP were determined using the PK/LDH coupled assay with 0-10
rnM ATP in the presence of sub-saturating amounts of FGAR (2 mM) and saturating amounts of
NH4C1 (750 mM). Kinetic parameters for FGAR were determined using the Bratton-Marshall
assay with 0 to 5 mM FGAR in the presence of saturating amounts of ATP (10 mM) and NH4C1
(750 mM). For the H72A T maritima smPurL, the concentration of FGAR was varied from 0 to
32 mM. Parameters for NH4C1 were determined using the Bratton-Marshall assay with 0 to 750
mM NH4 C1 in the presence of saturating amounts of ATP (10 mM) and sub-saturating amounts
of FGAR (2 mM). Data was analyzed using a nonlinear regression analysis with KaleidaGraph
(Synergy) computer software and Equation 6.1.
V = Vmax[S]/ l(Km + I[S]) (6.1)
Structure-Based Sequence Alignments and Modeling of SelD and HypE
CLUSTALW (http://www.ebi.ac.uk/clustalw/) was initially used to perform a sequence-
based alignment with E. coli PurM (1 cli.pdb), T. maritima smPurL (1 vk3.pdb), and A. aeolicus
ThiL (lvqv.pdb) (9). The text file for the alignment was then manually edited based upon the
secondary structure information from the crystal structures. Using the edited sequence
alignment, ESPript 2.2 (http://espript.ibcp.fr/ESPript/ESPript/) was used to create the structure-
based alignment (10).
Model structures for E. coli SelD and HypE were generated using the programs HHpred
and Modeller ver. 7 (http://protevo.eb.tuebingen.mpg.de/toolkit/) based upon the crystal
structures for E. coli PurM (1 cli.pdb), A. aeolicus ThiL (1 vqv.pdb), the N-terminal half of the
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AT domain of Salmonella lgPurL (1 t3t.pdb), and the N-terminal half of T maritima smPurL
(lvk3.pdb) (1], 12).
6.3 Results
Expression and P'urification of T. maritima smPurL
Expression and purification of smPurL was carried out by Maria Morar and Ruchi Anand
in the Ealick Laboratory. In order to express T. maritima smPurL in high yield, the Rosetta
(DE3) cell line was used which contains additional copies of the "rare" tRNAs for the AUA,
AGG, AGA, CUA, CCC, and GGA codons. Protein was then purified from the cell lysate in a
single step by MonoQ Sepharose chromatography followed by desalting with a Sephadex G75
gel filtration column.
Structure of the Ternary Complex with AMP-PCP and FGAR
While several crystal structures of T maritima smPurL were obtained by the Ealick
Laboratory, the results presented in this chapter will focus on the structure obtained from co-
crystallization of smPurL with FGAR and a non-hydrolyzable ATP analog (AMP-PCP) at 2.7 A
(Figure 6.3). The structure of the AMP-PCP binding site reveals a function for the conserved
DX4GAXP motif. The corresponding asparate (D94) serves as a ligand to a magnesium ion
bridging the and y phosphates of AMP-PCP (Figure 6.3). The role for the remaining 3 residues
in the consensus motif is less clear since they do not come into contact with either substrate.
These residues are located on a turn that follows D94 and may be involved in stabilizing the 3-
barrel structure at the core of the enzyme and forming the hydrophobic pocket (42, L45, V474)
for binding of the adenine ring.
A close examination of the FGAR-binding site reveals that the amide that is converted to
an amidine during the reaction is located between two histidines (His32 and His 72, Figure 6.4).
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Figure 6.3-Stereoview ofFGAR and AMP-PCP bound to the active site of T. maritima
smPurL. D94 is part of the conserved D)4GAXP motif and is responsible for coordinating a
magnesium ion located between the f3- and y-phosphates of AMP-PCP. Figure courtesy of
Maria Morar (Cornell University).
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Figure 6.4--Close up of conserved FGAR-binding residues and distances observed in the
ternary complex crystal structure. In the structure, the carbonyl oxygen of the FGAR amide is
not in line for direct attack on AMP-PCP. Small conformational changes during turnover may
bring the y-phosphate and oxygen into alignment. Conformational changes may also occur in
H32 so that this residue may be directly hydrogen-bonded to the carbonyl, y -phosphate of ATP,
or a proposed phosphorylated intermediate. The ~N of H32 has no hydrogen-bonding
interactions.
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The amide oxygen of FGAR is positioned 3.6 A from the y-phosphate of AMP-PCP; too far for
effective interaction and the oxygen is not oriented correctly for in-line attack. The proximity of
the histidines to the amide of FGAR and the observation that these histidines, along with a
glycine hydrogen-bonded to H72, are absolutely conserved across both large and smPurL
sequences implicated a role for these residues in catalysis or FGAR-binding. Neither of the ring
nitrogens of the H132 are involved in hydrogen-bonding interactions in the crystal structure, and a
similar relationship between histidine and ATP could only be found in nucleoside diphosphate
kinases (which utilize a phospho-histidine intermediate) (13) and in phosphoenolpyruvate
carboxykinase (in which the histidine also acts as a ligand to an essential Mn2+) (14). The
importance of H32 and H72 in catalysis was examined by preparation of the corresponding
a]lanine mutants.
Activity of wt smPurL
In order to study the mutant enzymes, an assay was developed to detect FGAM
formation with the wt enzyme. Given that a T maritima FGAR-AT complex has not yet been
reconstituted from smPurL, PurQ, and PurS, smPurL, activity must be monitored by NH4Cl-
dependent FGAM synthesis. This assay has previously been shown to be effective in measuring
the activity of B. subtilis smPurL (Chapter 3). Both ADP and FGAM formation can be
monitored using either PK/LDH or PurM as the coupling enzymes.
At 37°C and pH 8.0, T maritima smPurL FGAM synthetase activity was readily
observable and the enzyme had a specific activity of 0.34 U/ mg. Assays were attempted at
higher temperatures in order to replicate physiological conditions for the thermophilic enzyme;
however, protein precipitation was observed at > 50°C. Therefore, efforts to study the reaction
under physiological conditions were not pursued further. It is possible that the enzyme is only
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heat-stable as the assembled FGAR-AT complex. As with the B. subtilis enzyme, the NH4Cl-
dependent activity is not ADP-dependent since inclusion of PEP and PK in the assay buffer
(which rapidly removes any ADP generated during turnover) had no effect on the observed
activity.
Table 6.1: Kinetic Parameters for the T maritima smPurL
Km (mM) kcat (s')
WT Enzyme
FGAR 1.05 + 0.06 0.40 + 0.01
ATPa 0.35 + 0.04 0.34 + 0.01
NH4 Cla 153 + 7 0.39 + 0.01
1t32A Mutant NDb < 0.001 S-l
H72A Mutant
FGARC -38 mM -0.02
aThese are apparent Kms due to subsaturating FGAR. No
activity could be detected above the lower limit of detection for
the Bratton-Marshall assay. The enzyme could not be saturated
with FGAR; therefore, these values are approximations.
A kinetic analysis of the enzyme revealed several interesting features (Table 6.1).
First, the kcat for both the ATPase and FGAM synthetase activities are similar (0.34 vs. 0.4 s ,
respectively), indicating that ATP hydrolysis is coupled to FGAM formation. The lower ATPase
kcat is the result of using a subsaturating amount of FGAR (2 mM). The kcat values are nearly
1 ()-fold higher than those obtained for the B. subtilis smPurL under similar conditions (kcat =
0.044 s'l). The high activity is surprising since the enzyme is being assayed at nearly 50°C less
than its temperature optimum under physiological conditions. Second, it is interesting to note
that the enzyme can be readily saturated with NH4Cl (Km = 153 mM at 2 mM FGAR, Figure
6.5). Assuming that the enzyme uses NH3 as its actual substrate, this corresponds a Km of 5.7
mM at pH 8.0 indicating that the enzyme displays a similar Km for NH3 as the B. subtilis smPurL
(Km = 3.5 mM).
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Figure 6.5-Km determination for NH4C1 for wt T. maritima smPurL. At 750 mM NH4C1,
the enzyme can be saturated with substrate (Km = 153 mM).
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Figure 6.6--Comparison of the Michaelis-Menten plots for FGAR for the wt (A) and (B) H72A
mutant T maritima smPurL enzymes. (A) The wt enzyme could easily be saturated with FGAR
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inhibition was observed in multiple experiments (X).
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A ctivity of H32A and H72A smPurL
Assays of the H32A and H72A smPurL mutants revealed that both residues are important
for the function of the enzyme (Table 6.1). No FGAM formation was detected with the H32A
mutant at enzyme concentrations up to 11.6 mg/mL after 1 h of incubation in the presence of 10
mnM ATP, 4 mM FCGAR, and 750 mM NH4Cl. Given the sensitive nature of the Bratton-
Marshall assay for aminoimidazole formation, a lower limit of detection on activity for this
mutant could be set at < 0.1 nmol/min/mg, 1/4000 the activity of the wt enzyme. Thus, His32 is
essential either for binding or catalysis.
The H72A mutant displayed very low levels of FGAM production and exhibited a
dramatically increased Km for FGAR (kcat 0.02 s, Km - 37.9 mM, Table 6.1). Interpretation
of the kinetic data for this mutant was complicated since unlike the wt enzyme, the H72A mutant
could not be saturated with FGAR and severe substrate inhibition that could not be modeled with
standard equations was observed above 16 mM FGAR (Figure 6.6). While the source of this
inhibition has not yet been identified, one possibility is that residual triethylamine from the
purification of FGAR is interfering with the assay at high FGAR concentrations. These data
indicate that mutation of H72 to an alanine results in decreased affinity for FGAR and retains
-5% of wt activity. While H72 is not essential for catalysis, it is important for FGAR binding
due to its possible interactions with both amides of FGAR (Figure 6.4).
Biophysical Characterization of wt and mutant smPurL
Given the problems encountered with B. subtilis smPurL aggregation, it was important to
determine that the effects on activity observed with the wt T maritima smPurL and the H32A
and H72A mutants are not the result of protein aggregation or misfolding. Folding of the mutants
relative to the wt protein can be analyzed by CD spectroscopy and aggregation by SV-AUC
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experiments. In addition, the H72A mutant has been crystallized by Maria Morar in the presence
of AMP-PCP.
As shown in Figure 6.7, CD spectra of the wt and mutant enzymes are very similar,
providing evidence that the mutant smPurLs are folded. To interrogate protein aggregation, SV-
AUC was carried out, and the data (Figure 6.8) indicate that the predominant species in solution
for both the wt and mutant enzymes is the smPurL monomer. The observed molecular weights
were very close to the calculated value (wt calculated 65,969 Da, wt observed = 66,030 Da
(rmsd = 0.0045), H32A observed = 64,554 Da (rmsd = 0.0044), H72A observed = 71,081 Da
(rmsd = 0.0044)). The H72A mutant enzyme, however, contained a high molecular weight
species (likely an aggregated dimer of smPurL, 26% abundance). Despite the presence of
aggregate, the H72A mutant has been crystallized in the presence of AMP-PCP and its structure
determined. Superposition of the wt ternary complex structure and the H72A structure revealed
that the mutant has little effect on the overall structure or to the active site architecture (Figure
6.9); however, it is possible that a correctly folded, non-aggregated species was selectively
crystallized out of an heterogeneous solution of the H72A mutant.
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Figure 6.9---Backbone overlay of the ternary complex ofwt smPurL with FGAR and AMP-PCP
(blue) and the binary complex crystal structure of the H72A mutant with AMP-PCP (black).
AMP-PCP and His32 are shown in stick representation and labeled in the structures. The active
sites of the mutant and wt enzymes are superimposable indicating that the mutation did not cause
a large conformational change in the enzyme.
318
6.4 Discussion
The structures of smPurL in complex with substrate and substrate analogs have provided
the first insight into the mechanisms of ATP-binding by the PurM-superfamily. The ATP-
binding site is characterized by a hydrophobic pocket for the adenine ring at the
rnonomer:monomer interface and coordination of phosphates by bridging magnesium ions. The
aspartate of the DX 4GAXP motif provides a ligand to the magnesium ion coordinating the 3,y-
phosphates of AMP-PCP. The remainder of the motif (GAXP) lies in a turn between an ac-helix
containing the aspartate and a 3-strand that composes part of the central 3-barrel in the pseudo-
dimeric structure. The location of the DX4GAXP motif is conserved in all structures of PurM-
superfamily members available to date.
Co-crystallization of the enzyme with FGAR has provided insight into the ribonucleotide
binding site. The most striking feature of this site is the presence of two conserved histidine
residues located near the proposed site of chemistry. H72 is positioned between the two amides
of FGAR, while H132 lies between the nucleophilic oxygen of the FGAR amide and the y-
phosphate of ATP (Figure 6.4). No other residues are observed in the proximity of the
phosphorylation site, Since these histidines are absolutely conserved among all smPurL and
lgPurL, sequences, they must be involved in binding and/or catalysis.
Proposed Mechanisms for Amidine Formation
Research by Westheimer and coworkers demonstrated that methyl metaphosphate can
facilitate the addition of aniline to ethylbenzoate to produce O-ethyl-N-phenylbenzimidate and
methylphosphate (15). A mechanism to account for this observation is shown in Figure 6.10 in
which methyl metaphosphate generated from fragmentation of methyl hydrogen erythro- 1,2-
dibromo- 1 -phenylpropylphosphonate activates the ester for nucleophilic attack. This reaction
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Figure 6.10-Examples of carbonyl reactivity towards phosphorous compounds. (A) A reaction
scheme proposed by Westheimer for reaction of ethylbenzoate with methyl metaphosphate (15).
Methyl metaphosphate is proposed to be generated by fragmentation of the phosphonate in (1).
The methyl metaphosphate then is proposed to activate the ester carbonyl in (2) for nucleophilic
attack by aniline. This scheme has been proposed to be an excellent model for the PurL-
catalyzed reaction. (B) Popov et al. have studied amide catalyzed hydrolysis of diphenyl
chlorophosphate (8-20). For N-monosubstituted amides, an associative mechanism has been
proposed involving a five-membered ring transition state and a pentacoordinate phosphorous
species. (C) In a model for the HypE reaction, Bock and co-workers were able to dehydrate S-(-
n-decyl) thiocarbamate with ethyl polyphosphate followed by base treatment (25). An
imrninophosphate intermediate was proposed, but not isolated.
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with an ester carbonyl is similar to that of ATP, using a dissociative transition state, activating
the amide oxygen of FGAR for attack by NH3. This work allowed Westheimer to propose two
possible mechanisms for amidine formation (Figure 6.11) (15). In the first case, the reaction
proceeds by a tetrahedral intermediate generated by NH3 attack on the amide followed by ATP-
mediated phosphorylation. While in the second case, an iminophosphate is initially formed by
ATP, which is followed by NH3 attack. Westheimer's demonstration of carbonyl reactivity
towards metaphosphate favors the iminophosphate mechanism, although a phosphorylated
FGAR intermediate has yet to be identified during FGAM synthesis despite extensive efforts by
the Stubbe Laboratory.
Recently, dehydration of amides without the direct use of ATP has been demonstrated in
several non-ribosomal peptide synthetase systems during the synthesis of thiazole or oxazole
rings (16, 17). However, the 180-transfer experiments carried out by Schendel in the Stubbe
Laboratory provide strong evidence that ATP is directly involved in the transfer mechanism in
the case of lgPurL, and presumably smPurL, since the 80-label was transferred from the FGAR
amide to phosphate during the reaction (8).
Insight into the mechanism of nucleophilic activation of an amide oxygen has more
recently come from studies of Popov et al. This group has demonstrated that amides can
catalyze hydrolysis of benzoylchloride and diphenyl chlorophosphate in an aprotic medium (18-
20). Two mechanisms were proposed for these reactions: nucleophilic attack by the amide
oxygen or general base catalysis. Structure-function studies using a variety of amides favored
the former mechanism (18-20). While no intermediates were trapped in their experiments, for N-
monosubstituted amides, it was been postulated that the reaction proceeds via an associative
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Figure 6.11-Proposed reaction mechanisms for PurL by Westheimer (J5). The reaction is
believed to proceed either through an iminophosphate intermediate (black arrows) or by initial
tetrahedral intermediate formation (red arrows).
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mechanism by formation of a pentacoordinate phosphorous species in a five-membered ring
transition state (Figure 6.10B) (20).
In addition, it has been known since the 1930s that amides react with POCl 3 (21), which
in the presence of amines can lead to amidine formation (22). However, there have been no
mechanistic studies on these reactions, and only two reports of isolation of a putative
phosphorous adduct to the amide oxygen (23, 24). In both cases, the adduct was isolated in
anhydrous solvent (ether or THF) and characterized by optical and IR spectroscopy. Further
evidence for amide reactivity comes from a model system for the HypE catalyzed reaction
(Figure 6.1 0C). HypE catalyzes formation of an enzyme-linked thiocyanate from a
thiocarbamate (Figure 6.1). In a model system for this reaction, S-(n-decyl) thiocarbamate was
readily dehydrated in the presence of ethyl polyphosphate (PPE) in CHCI3 followed by the
addition of triethylamine (25). While no intermediates were isolated, the reaction gave the
corresponding thiocyanate in 55% yield, and an iminophophate intermediate was proposed.
The active site structure of the smPurL*FGARoAMP-PCP ternary complex offers a new
opportunity to think about the mechanism of amidine formation. An early hypothesis, despite
mismatched pKas,was that H72 deprotonated the amide of FGAR to activate the oxygen for
nucleophilic attack on ATP with a neutralized charge on the y-phosphate. However, based on
literature precedent, deprotonation of FGAR is not required for the amide to function in this
capacity. This may explain why the H72A mutant retains some activity and avoids the
requirement for perturbation of the pKa's for H72 or FGAR so that deprotonation of an amide by
an imidazole to occur. In addition, given the current structural information, it is unclear how the
charge on the y-phosphate would be neutralized to allow nucleophilic attack to proceed. A
bridging Mg2+ is observed between the A- and y-phosphates; however, no positively charged
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protein sidechains interact with the y-phosphate in the structure with AMP-PCP. One possibility
is that H32 is protonated and can interact with ATP during turnover conditions, and this
possibility is discussed in greater detail below. Given the observations detailed above, an
alternate role for H72 may be to fix the position of the amide nucleophile of FGAR with respect
to the y-phosphate of ATP and lower the entropic barrier of the reaction. A similar effect of
constraining the position of the nucleophiles has been observed in model phosphoryl transfer
reactions (26) and has been implicated in nucleoside diphosphate kinases (27). In the former
case, hydrolysis of phosphorylated pyridines by Mg(OH) + was proposed to be accelerated by
correct positioning of the hydroxide ion and the phosphate group due to interactions between the
phosphate and Mg24 (26). In the latter case, nucleoside diphosphate kinases utilize a
phosphoryl-histidine intermediate to transfer phosphate from ATP to a NDP. Herschlag and
coworkers have mutated this catalytic histidine to glycine and have studied the ability of
imidazole or other small nucleophiles to rescue ATP hydrolysis activity (27). These results
suggested that free imidazole cannot fully substitute for the histidine side-chain and positioning
of the histidine nucleophile by the enzyme is an important component of catalysis (27).
In the model studies of Popov et al., amide reactivity was studied using electrophiles
containing a very good leaving group (CI-) (18-20). In order for ADP to act as a good leaving
group, charges on the phosphates must be neutralized. Unlike many ATP-binding sites, the
active site of smPurL does not contain positively charged residues that interact with the
phosphates of ATP, nor is the nucleotide located in a position for charges to be stabilized by a
helix dipole (Figure 6.3). Neutralization of the negative charges on the phosphates appear to
stem entirely from interaction with the two Mg2+ ions, while interactions from the hydroxyl
group of Y35 and the backbone amide proton of A239 may help orient the phosphate chain. The
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only other residue in the active site capable of stabilizing negative charge is H32. This residue is
located in between the FGAR amide and the y-phosphate of AMP-PCP, but in the ternary
complex structure, it is not in hydrogen-bonding orientation to either group. The lack of
hydrogen bonds to 32 leave its protonation state undetermined; however, the orientation of the
residue may change during catalysis or in the presence of ATP in order to provide hydrogen-
bonding interactions with the y-phosphate. In this case, a protonated H32 may help to stabilize
negative charge on either ATP or a phosphorylated FGAR intermediate. Mutagenesis results
from the H32A mutant indicate that this residue is important for catalysis; however, further
studies using H32Q mutants may provide additional clues concerning the role of this residue in
FGAM synthesis.
The lack of residues capable of neturalizing phosphate charge within the smPurL active
site also indicate that the reaction might proceed via a dissociative mechanism of phosphate
transfer. This mechanism would require less charge neutralization in the transition state than an
associative mechanism (Figure 6.12) (28, 29). Hydrolysis of ATP in solution has been well
studied and is known to proceed via a dissociative mechanism (28). Phosphoryl-transfer
reactions in enzymes are less well-understood; however, there have been several examples in
which dissociative mechanisms have been proposed (29). If the reaction proceeds with a
dissociative. metaphosphate intermediate, than the reaction of ATP and FGAR will be analogous
to model reactions carried out by Westheimer (Figure 6.1 A).
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Figure 6.12-Dissociative and associative models for phosphoryl transfer from ATP to an
alcohol (ROH). In the dissociative mechanism, a metaphosphate transitation state is proposed
with a single negative charge on a phosphoryl oxygen. In the associative mechanism, a
pentacovalent phosphorane is proposed in the transition state with three negative charges on the
phosphorous oxygens. This figure was adapted from (28).
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Histidines are Not Part of a Conserved Mechanism of Catalysis in the PurM-Superfamily
While the function of conserved histidines H32 and H72 is still not understood, their
location in the smPurL structure and their importance for enzyme activity suggest that similar
histidines may be involved in catalysis in other PurM-superfamily members. All superfamilies,
by definition, have a common mechanism (30), and in this case, the use of histidines to stabilize
negative charge on the phosphate-leaving group may be the common mechanism that unites
members of the PurM-superfamily. However, previous sequence alignments alone failed to
identify any conserved histidines.
Given the recent structures of a number of PurM-superfamily members, one can now
perform structure-based sequence alignments previously not possible. Structure-based sequence
alignments generated for smPurL and PurM (Figure 6.13) indicate that H32 and H72 are not
conserved in PurM. However, when the structures of PurM and smPurL are superimposed using
Swiss PDB-Viewer, two conserved histidines in PurM (His190 and His247) become readily
apparent (Figure 6.14). These residues are in the same approximate locations as the residues in
smPurL, but they have been flipped 180° to the other side of the active site. The reason for the
change in location may be due to movement of the site of phosphorylation to the terminal amide
of FGAM from the internal amide of FGAR. Thus, their presence may imply conservation of
mechanism (Figure 6.1). However, this proposal contains the caveat that FGAM may bind
differently to PurM than FGAR does to smPurL. Simple rotations of the FGAR side chain about
the C '-N 1, C2-C3, or C3-N4 bonds are not enough to bring the terminal amide near H190 and
H247 in PurM. In addition, neither smPurL residue H74, which ligates the 5'-phosphate of
FGAR, nor E280, which ligates the 2'-OH of FGAR, are conserved in PurM and homologous
residues are not easily identified. This has complicated identification of the FGAM-binding site
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Figure 6.13-Structure-based sequence alignment of E. coli PurM with the N-tenninal domain
of T. maritima smPurL. The DX4GAxP motif is shown in blue and in each structure the aspartate
is found in an a-helix, while GAxP occurs in a turn between the helix and a ~-strand. H32 and
H72 from smPurL are denoted with red stars. Neither of these histidines are conserved by
structure or sequence with PurM.
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Figure 6.14-Identification of conserved histidines in PurM (red) by superimposition of the
smPurL structure (blue). Structures were superimposed using the Co backbone with Swiss
PDB- Viewer (http://www.expasy.orglspdbv/). FGAR and AMP-PCP are shown in stick-figure
representation, and the Mg2+ ions are shown as grey spheres. The ATP-binding sites of smPurL
and PurM aligned and the conserved aspartates of the D~GAXP motifs are superimposable
(D93 and 94). H190 and 247 in PurM may be analogous to H72 and H32 in smPurL,
respectively. Histidines in PurM are not located on the same secondary structural elements as in
smPurL and appear to occupy a different orientation in the active site.
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in PurM, and leads to uncertainty concerning the role of H190 and H247 in the absence of
crystallographic or biochemical data. Efforts to extend these observations to other members of
the PurM superfamily indicate that histidines are not conserved active site residues. Conserved
histidines were identified by CLUSTALW sequence alignments of >20 diverse ThiL, SelD, and
HypE genes. These results are summarized in Table 6.2. With the use of Modeller and sequence
Table 6.2: Conserved Histidine Residues among PurM-Superfamily Members
In the Active
Protein Residue Site? Location
smPurL H32 Yes Adjacent to y-phosphate of ATP and FGAR
amide(T maritima)amd(T maritima) H72 Yes Ligand to FGAR amides
PurM H190 Yes FGAM Binding site (predicted)
(E. coli) H247 Yes Adjacent to y-phosphate of ATP (predicted)
ThiL H50 No Part of Monomer:Monomer Interface
(Aquifex H185 Yes In the same region as H190 of PurM
aeolicus) H305 Unknown At the disordered C-terminus
HypE H165 Yes In the same region as H190 of PurM
(E. co/i,(E. coli, H280 No Surface
modeled)
SelD H13 No Surface
H 198 No Surface(E. coli,modeled) H23698 No SurfaceH2 36 No Buried
alignments between family members (Figure 6.15), model structures of E. coli SelD and HypE
were made based upon all available crystal structures for PurM-superfamily members (Figure
6.16). Both the 3-sheet regions that comprise the monomer:monomer interface, the active site
cleft, and residues involved in ATP binding could be identified in the modeled structures. These
landmarks allowed the position of each conserved histidine within a family member to be
determined relative to the enzyme active site. These results indicate that a histidine located near
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Figure 6.1S-Sequence alignment of E. coli HypE, E. coli PurM,A. aeo/icus ThiL, E. coli SeID,
and T. maritima smPurL. Residues are numbered according to smPurL. The conserved
Dx..GAXP motif is shown in blue. Conserved histidines in smPurL (H32 and H72) are shown
with red stars. Conserved histidines in PurM (H 190 and H247) are shown with black stars. The
conserved glycines highlighted in this alignment are not part of the active site. They are instead
part of the central f3-barrel.
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smPurL
N-terminal Domain
PurM
ThiL
HypE Model SaiD Model
Figure 6.16---Comparison of HypE and SelD model structures to those observed for smPurL,
PurM, and ThiL. In all cases, the active site is a cleft located in the center of the structure. In the
smPurL structure, AMP-PCP and FGAR are bound in the cleft. In the PurM, structure sol- is
observed in the cleft. The clefts in ThiL, HypE, and SelD have been marked with a black oval.
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the y-phosphate of ATP is not conserved across PurM-superfamily members (Table 6.2) and
rules out a common phosphorylated-histidine intermediate or the use of a conserved histidine in
electrostatic stabilization. However, it is possible that like members of the crotonase superfamily
(30), members of the PurM-superfamily share a common mechanism without conservation of
active site residues. A common dissociative mechanism of phosphoryl-transfer may be the
unifying feature of the PurM-superfamily; however, testing this hypothesis will require extensive
investigation into several superfamily members.
Future experiments on PurL mechanism should be aimed at providing direct evidence for
an iminophosphate intermediate, assuming the reaction does not proceed through initial
tetrahedral intermediate formation (Figure 6.11). smPurL may provide a new direction for
efforts to trap an iminophosphate. Previous efforts by Ernest Mueller in the Stubbe Laboratory
to detect a phosphorylated intermediate either directly or by ATP/ADP exchange and positional-
isotope-exchange (PIX) experiments were unsuccessful in the case of lgPurL (31). In the case of
PurM, efforts to detect an iminophosphate could be difficult since after phosphorylation,
intramolecular attack by FGAM creates the aminoimidazole. With smPurL, it is possible that the
irninophosphate could be generated by withholding the NH3 nucleophile necessary for FGAM
formation. These experiments may be particularly successful on the T maritima smPurL, which
shows a 10 O-fold higher rate of NH3 -dependent FGAM formation than other PurLs and may give
rise to successful PIX experiments. A second strategy that could be employed is to reduce the
iminophosphate in the active site of smPurL. Due to the absence of the N-terminal (PurS) and
glutaminase (PurQ) domains, the active site of smPurL may be more open than in lgPurLs.
Reducing agents may be able to diffuse into the active site without denaturing the protein and
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trap a phosphorylated-FGAR intermediate in order to finally provide evidence for
iminophosphate formation.
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Appendix
Additional NMR Experiments to Determine PurS Quaternary Structure
Background:
In addition to the NMR experiments carried out by Jens Wonhert in Chapter 4, several
other NMR methods were utilized to determine PurS quaternary structure. NOESY data were
obtained for PurS in an effort to detect NOEs across the putative dimer:dimer interface. In
addition, residual dipolar couplings (RDCs) were measured for PurS to determine the orientation
of PurS in an aligning media and compare these results with predictions made from the crystal
structure. However, these experiments were not conclusive, and current NMR investigations are
focused on providing additional RDC and NOESY data.
Experimental:
NOESY Experiments
A 3D-15N-edited NOESY-HSQC spectrum with a mixing time of 100 ms (Bruker AV
800 MHz, 8 scans/increment, dl=2s, 110 x 48 complex points in fl and f2, spectral width=12
ppm in fl, 4 days) was recorded on a 2 mM ' 5N-only-labelled PurS sample in NMR-buffer.
Using the backbone assignments obtained in the 3D-triple resonance experiments, the 3D-'5 N-
edited NOESY-HSQC spectrum was analyzed for presence of long-range NH-NH-NOEs across
the 3-strands comprising the monomer:monomer and dimer:dimer interfaces.
RDC Measurements to Determine the Orientation of PurS in an Aligning Media
Residual dipolar couplings were measured by collecting H,'5N-HSQC-spectra without
proton-decoupling in the fl-dimension or using H, 5N-HSQC-experiments, where the Inphase-
and the Antiphase-component of the NH-doublet are recorded in separate spectra in an
interleaved fashion (Ottiger, M., Delaglio, F., Bax, A. (1998) J. Magn. Reson., 131, 373-378) of
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0).5 mM ' 5N-labelled PurS in NMR-buffer in the presence or absence of 10mg/ml of the
filamentous phage Pfl (Hansen, M. R., Mueller, L., Pardi, A. (1998) Nat. Struct. Biol., 5, 1065-
l[ 074). The residual dipolar couplings (DNH) were calculated by measuring the difference in the
splitting of the signals for each NH-group in the presence of phage (JNH+DNH) and subtracting
the splitting in the absence of phage (JNH). The measured residual dipolar couplings together with
the structures of the hypothetical dimeric and tetrameric forms of PurS (as extracted from the x-
ray structure of the tetramer) were used to calculate the orientation of the alignment tensor of the
protein using the program ORDERTEN_SVD (Losonczi, J. A., Andrec, M., Fischer, M. W.,
Prestegard, J. H. (1999) J. Magn. Reson., 138, 334-342). The experimentally determined
alignment tensor was then compared with the alignment tensor predicted for the dimeric and
tetrameric PurS by the program PALES (Zweckstetter, M., Bax, A. (2000) J Am. Chem. Soc.
122:3791-3792).
Results and Discussion:
NOESY Experiments
Despite the observation of NOEs across the monomer:monomer interface, no NOEs were
detected across residues predicted to be involved in the dimer:dimer interface of PurS. While
this would suggest that the tetramer is not present, the data was inconclusive for several reasons.
First, based on the PurS tetramer crystal structures, the distances predicted to be measured in the
NOESY experiment are very long: 4.6 A between the amide protons of Y76 and V78 in the P21
crystal form and 5.9 A between the amide protons of E77 and A79 in the C2 crystal form. This
means that any observed NOEs would by very weak. In addition, due to amide proton exchange,
NOEs observed from amides are inherently weak. Finally, the NOEs predicted between Y76 and
V78 would appear very close to the diagonal, which increases noise and artifacts in the NOESY
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spectrum. Consequently, the lack of NOEs in the spectrum from residues at the proposed
tetramer interface could be explained by reasons other than lack of tetramer formation. In order
to provide more conclusive NOE evidence, additional NOESY data are being collected on a [2H,
13C, 5N]-PurS sample. This should allow direct observation of NOEs between amide protons
and the carbonyl carbons believed to be part of the tetramer interface.
RDC Experiments
In the presence of an aligning media such as filamentous phage, proteins will
preferentially orient themselves with respect to the applied magnetic field. This orientation is
dependent on molecular shape. For PurS, the dimer and tetramer were predicted to have
different alignments (Figure A. 1, Top). Comparison of PurS HSQCs in the presence and
absence of phage allowed the residual dipolar couplings (RDCs) for the protein to be determined
as previously described, and this in turn was used to calculate an alignment tensor and
orientation for the protein in the magnetic field. As shown in Figure A. 1, the measured RDCs
match those predicted for a molecular alignment corresponding to a PurS dimer (R2 = 0.91).
This result indicates that the orientation of PurS in the magnetic field is indicative of the
molecular shape of the PurS dimer. While the above result is compelling, additional RDC
experiments are needed in different aligning medias to confirm that these results are not an
artifact of PurS interacting with the phage.
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Figure A.I-Alignment ofPurS in a magnetic field based upon RDCs. (Top) The PurS dimer
and tetramer are predicted to orient themselves differently in magnetic field along Szz. (Bottom)
Correlation between observed RDCs and those predicted from the PurS dimer structure. The
agreement between the predicted and observed values indicates that a PurS dimer is present in
solution.
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